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Abstract 
The assessment of myocardial perfusion using dynamic contrast enhanced 
magnetic resonance imaging (DCE-MRI) is a powerful tool for diagnosing 
myocardial ischaemia due to coronary heart disease, which affects nearly 2.7 
million people in the UK and for which there is an effective treatment.  Although 
visual analysis of DCE-MRI data performs well diagnostically, a quantitative 
estimate of myocardial blood flow (MBF) makes the diagnosis objective and 
could increase diagnostic performance.  Obtaining MBF estimates from DCE-
MRI data is a multi-step process requiring: 
- the localisation of the myocardium and arterial input function (AIF) to 
generate signal intensity vs. time curves; 
- the conversion of signal intensity data to contrast agent concentration 
values; 
- the application of a perfusion model to generate a quantitative MBF 
estimate; 
- the interpretation of MBF estimates to make a diagnostic assessment of 
myocardial ischaemia. 
There are a range of approaches for solving each of these problems.  The aim 
of the work presented in this thesis has been to provide clinically relevant 
evidence for choosing between these approaches.  Myocardial localisation 
contour error tolerance levels are suggested based on simulations using a 
volunteer dataset.  A non-linear signal intensity to contrast agent concentration 
conversion method is presented and tested using simulations and phantom 
data.  An investigation into the best way to interpret quantitative MBF estimates 
is then presented.  Finally a comparison of four, widely applied, perfusion 
models is conducted.   
Where possible, methods have been compared on a sizeable patient dataset in 
terms of diagnostic performance rather than MBF estimate accuracy.  This 
provides evidence suitable for informing clinical decisions on the best 
methodology for quantitative perfusion.  Such evidence could contribute to a 
standard methodology for quantitative cardiac MR perfusion.  This is necessary 
for large clinical trials, which are essential before quantitative MBF estimates 
can be accepted into routine clinical practice.   
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1. Introduction 
1.1. Background 
Coronary heart disease (CHD) is the formation of plaque in the coronary 
arteries that supply blood to the heart.  The resulting arterial narrowing can 
reduce blood flow to the heart causing myocardial ischaemia leading to painful 
angina symptoms.  Complete obstruction, most commonly through thrombus 
formation on a vulnerable plaque, may result in myocardial infarction (cardiac 
cell death), know as a heart attack.  CHD affects 2.7 million people in the UK (1) 
but, if a patient is diagnosed, there is an effective treatment by coronary 
angioplasty or coronary bypass grafting (see section 3.3).   
 
The methods for diagnosing CHD and myocardial ischaemia are many and 
varied (see section 3.4).  However, the role of magnetic resonance imaging 
(MRI) in the assessment of myocardial perfusion is becoming more and more 
recognised within the cardiology community.  At the time of writing two of the 
largest clinical trials for cardiac MR perfusion have shown that the cardiac 
dynamic contrast enhanced (DCE)-MRI perfusion test is as specific and more 
sensitive than the current standard assessment, nuclear medicine, in 
diagnosing CHD (2,3).  Furthermore, there is reason to hope that these figures 
will improve in the future as subendocardial defects become more easily 
detectable with ever increasing image resolution and signal to noise ratio (SNR) 
capabilities in MRI. 
 
These assessments were performed using a visual analysis of the MR data.  
Corresponding large scale diagnostic performance studies using quantitative 
myocardial blood flow (MBF) estimates based on cardiac DCE-MRI data are 
lacking.  Such studies would show whether quantitation can improve diagnosis 
of CHD.  Of particular interest is the impact on diagnosing three vessel disease, 
where stenoses in all three coronary vessels can confound visual detection as 
there is no healthy myocardium to compare against.  Apart from the extra 
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complexity and time-consuming nature of many aspects of quantitative image 
acquisition and analysis, a further obstacle to researchers seeking to undertake 
such trials is the lack of consensus on the analysis method. 
 
Image 
Acquisition
Localisation
Uptake Curve 
(SI -> Conc.)
Perfusion 
Model
Diagnosis
MBF
Mapping
Quantitative
 
Figure 1-1 – Flow diagram depicting the analysis pathway for quantitative DCE-
MRI cardiac perfusion.  After the DCE-MRI dataset has been acquired the 
myocardium and blood pool arterial input function (AIF) must be identified on 
every image frame (localisation).  Typically the myocardium is then subdivided 
into regions related to different coronary arteries (mapping).  Signal intensity (SI) 
vs. time uptake curves must then be generated from each frame and then 
converted to contrast agent concentrations.  A perfusion model is then applied 
to the two uptake curves in order to generate a quantitative estimate of 
myocardial blood flow (MBF).  This MBF value must then be interpreted in order 
to make a diagnosis as to whether the myocardial region is ischaemic or not.  
Only quantitative, or semi-quantitative, analysis requires the steps within the 
box. 
 
The analysis pathway for quantitative perfusion is outlined in Figure 1-1.  Each 
of the steps in Figure 1-1 has been the subject of substantial research effort 
and, as a result, there are a variety of techniques available to tackle each one 
and each solution has its own set of advantages and disadvantages.  This 
leaves the research community with a vast array of options for performing 
quantitative analysis.  The lack of a standardised consensus approach for 
quantifying MBF limits the generalisability of any trial using quantitative MBF 
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values, as any differences in methodology could feasibly affect the results.  
What evidence is there upon which to formulate a consensus methodology?  
Validation of each new innovation has been in terms of the measured MBF, 
either using animal studies, or an independent measurement in humans such 
as PET.  One comparison of quantitative perfusion models on the same dataset 
has been performed showing good agreement of MBF values between 
perfusion models (4).  However, differences in MBF between different studies 
can be quite profound.  For example compare the results of (5) and (6) rest 
MBF 0.52 + 0.11 ml/g/min to 0.88 + 0.28 ml/g/min and stress MBF 1.78 + 0.53 
ml/g/min to 2.32 + 0.46 ml/g/min.  Both of these studies were performed in 
healthy volunteers having previously reported good correlations with PET. 
   
The ultimate purpose of the MBF measurement is to diagnose ischaemia.  
Therefore, the most powerful evidence base for a consensus opinion on 
quantitative analysis is a comparison of diagnostic performance between 
methods on real-world clinical data.  Differences observed in terms of diagnostic 
performance will have a more profound influence on clinical choices, and real-
world clinical datasets differ from healthy volunteer studies.  Clinical datasets 
are more prone to patient dependent problems, such as poor breath-holding 
and unreliable ECG data, and of course include perfusion defects and lower 
MBF values.  Therefore, when attempting to distinguish methods for clinical 
use, it is important to use data that includes patients suffering from CHD.  
Furthermore, in the context of imperfect, real-world imaging it may be that the 
distinguishing factor between methods is not the accuracy of the measurement 
but the robustness to imperfections in the datasets enabling application to a 
wider cohort of patients. 
 
1.2. Aims 
The primary aim of this research was to compare quantitative perfusion models 
in terms of diagnostic performance.  This involved providing a method for non-
linear conversion of the MR signal to contrast agent concentration values and 
automated methods for processing large volumes of DCE-MRI data.  A 
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comparison of methodologies for obtaining a diagnosis from MBF estimates has 
also been performed.  The aims of this research are related to the 
methodological steps outlined in Figure 1-1 as follows: 
Aim 1 – To compare quantitative perfusion models in terms of diagnostic 
performance (perfusion model). 
Aim 2 – To compare methodologies for interpreting regional quantitative MBF 
estimates in terms of diagnostic performance (mapping). 
Aim 3 – To provide myocardial contour error tolerance levels for quantitative 
perfusion purposes (localisation). 
Aim 4 – To provide a methodology for converting MR signal values to 
concentrations, specific to the pulse sequence used in this research (uptake 
curve). 
Aim 5 – To provide fully automated quantitative perfusion uptake curve 
processing algorithms. 
 
1.3. Overview 
Chapter 2 provides a description of the basic physics of MRI before describing 
the imaging pulse sequences applied to cardiac perfusion imaging.  The 
choices and compromises that must be made when designing a perfusion 
imaging sequence are then described taking into account the extra 
considerations pertinent to quantitative imaging. 
 
Chapter 3 gives a brief description of cardiac anatomy and physiology before 
describing coronary heart disease and its treatment.  A review of medical 
imaging modalities for diagnosing CHD and myocardial ischaemia is given 
before a more detailed discussion is made of the advantages and 
disadvantages of cardiac perfusion MRI including a review of the diagnostic 
performance literature.   
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Chapter 4 provides an explanation of the models used to make estimates of 
MBF.  Semi-quantitative methods are described briefly before a detailed 
mathematical description of the quantitative methods used in this thesis is 
given. 
 
Most of the research presented in this thesis is based on two datasets.  Chapter 
5 describes in detail the acquisition protocol for the dual-phase study and the 
CE-MARC trial.  The original purposes of the investigations are given along with 
the pulse sequence parameters.  A description of the manual contouring 
methodology applied in all cases is then provided.  The automated methods 
used for uptake curve pre-processing (prior to quantitative analysis) are then 
described and tested qualitatively. 
 
Chapter 6 explains the method used to convert signal intensity values into 
contrast agent concentrations.  The pulse sequence for the acquisition of the 
perfusion DCE-MRI data is represented as a mathematical model.  The 
assumptions of this model are then tested using computer simulations.  The 
model is then further tested using images acquired of a T1-gel phantom using 
the perfusion imaging sequence. 
 
Chapter 7 describes a novel method used to derive tolerance limits for 
myocardial contours.  In order to assess the affect of myocardial contour errors 
on MBF estimates, contour errors are simulated on manual contours applied to 
a dataset of healthy volunteers.  These simulations are used to describe the 
relationship between contour errors and MBF errors.  This relationship is then 
used to provide a basis for setting an allowable error rate in the context of 
global and regional perfusion analysis. 
 
Chapter 8 describes the subset of patients taken from the CE-MARC trial before 
describing the exclusion process for this dataset.  The dataset is then used to 
investigate whether the non-linear concentration conversion described in 
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chapter 6 improves diagnostic power.  Separate investigations are then 
performed to attempt to find the best way to use regional MBF estimates for 
diagnosing myocardial ischaemia.  The use of separate MPR cut-offs for each 
of the coronary arteries is investigated.  An investigation into whether the mean 
or minimum regional MPR value should be used is conducted.  Finally the 
comparative power of using only the middle imaging slice, as opposed to all 
three slices, is carried out and the diagnostic performance when global analysis 
is used instead of regional analysis is evaluated. 
 
In chapter 9 four quantitative perfusion methods are compared in terms of 
diagnostic performance.  Model-independent deconvolution, Fermi-constrained 
deconvolution, the uptake model and the one-compartment model are 
implemented on the entire CE-MARC subset.  The diagnostic performance of 
these four models is then compared using the methods derived in chapter 8. 
 
Chapter 10 draws general conclusions from the research described in this 
thesis, details the limitations of the research and provides recommendations for 
future work. 
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2. Background: perfusion MRI physics 
2.1. Introduction 
Although the basics of MRI have been described many times in the literature 
this thesis will have cause to analyse the evolution of longitudinal magnetization 
Mz in detail and so would not be complete without a description of this concept.  
Numerous MRI texts have described the basics of magnetic resonance with 
reference to spin-up and spin-down energy eigenstates.  However, other 
authors argue that this has led to confusion and that the classical description is 
adequate for understanding magnetic resonance imaging (7,8).  For this reason 
the description given in this thesis follows that of Levitt (8), and is an entirely 
classical description.  After describing the origins of the MR signal, the basic 
gradient recalled echo sequence is described.  A brief description of the 
extensions to this sequence that are most commonly applied in cardiac 
perfusion imaging is then presented.  A discussion of the multiple factors that 
must be taken into account when designing a perfusion sequence and the 
inevitable compromises that must be struck between competing demands on 
the resulting image is then given.  This latter part is based on sections of a 
review paper recently published in JCMR (9), written by the author of this thesis. 
 
2.2. The origin of the MR signal 
Nucleons possess a magnetic moment and an angular momentum by virtue of 
an intrinsic property called „spin‟.  The spin angular momentum S and magnetic 
moment μ are proportional to each other and are oriented either parallel or anti-
parallel to each other dependent on the sign of the gyromagnetic ratio  : 
     
Equation 2-1 
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Figure 2-1 - In the presence of an external magnetic field, Bo, the spin magnetic 
moment   precesses around Bo at an angular frequency   describing a cone 
shape. 
 
The spin angular momentum is a vector which can point in any direction in 
three-dimensional space, thus the magnetic moment can also point in any 
direction.  In the presence of an external magnetic field, Bo, the combination of 
the angular and magnetic moments of the spin causes it to precess around the 
external magnetic field describing a cone, keeping a constant angle between 
the spin magnetic moment and Bo (Figure 2-1).  The frequency of precession is 
known as the Larmor frequency,   , and is given by the Larmor equation: 
        
Equation 2-2 
2.3. Longitudinal recovery  
By virtue of the fact that the spins are initially randomly orientated the net 
magnetization over any macroscopic sample is zero.  Once placed into an 
external magnetic field the spins all precess at the same angular frequency 
(assuming a completely homogeneous Bo) but this has no affect on the net 
magnetization due to the arbitrary phase of each precessing spin.  However the 
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molecules that carry the protons are in constant motion.  This in itself has no 
effect on the orientations of the spins, which maintain their orientation 
independent of molecular orientation.  However each molecule possesses small 
localised magnetic fields.  The magnetic field at a given time is the sum of Bo 
and contributions from the immediate molecular neighbourhood.  Thus, each 
spin experiences small fluctuations in magnetic field strength which lead to 
small changes in the cone angle between   and Bo.  Over time the magnetic 
moment wanders over the complete range of possible cone orientations. 
 
The magnetic energy between two magnetic moments is at a minimum when 
those two moments are parallel.  At finite temperatures it is slightly more 
probable that each spin is driven to an orientation with low magnetic energy 
than to a high magnetic energy (8).  Thus, as the spins wander through cone 
angles there is a slight preference for alignment with Bo.  Over time this leads to 
a stable state where there is a finite net magnetization parallel with Bo.  This is 
denoted Meq as it is the magnetization at thermal equilibrium.  At any one time 
the net magnetization is Meq however the individual spins are still constantly 
changing orientation and the net magnetization is due to the slight preference in 
the system toward low energy magnetization orientations. 
 
The transition to thermal equilibrium after exposure to Bo is not instantaneous.  
The net magnetization in the z-direction at time t, Mz(t), increases exponentially 
to Meq: 
             
  
     
Equation 2-3 
T1 is the longitudinal relaxation time and describes the rate at which the system 
arrives at thermal equilibrium.  Importantly for magnetic resonance imaging 
(MRI) T1 is different for different substances.  Fundamentally T1 depends on the 
correlation time of the molecular motion, i.e. how fast the molecules move.  By 
acquiring data at different times on the T1
 recovery curve MRI is able to 
generate images with different Mz values for different tissues and this is one of 
the sources of image contrast in MRI. 
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2.4. Transverse magnetization  
The longitudinal net magnetization is almost undetectable along the z-axis in 
the presence of the large Bo field.  In an MR experiment, in order to be able to 
detect the net magnetization, it is flipped into the transverse plane.  This is done 
by applying, for a brief time, a second magnetic field, B1, which is perpendicular 
to Bo.  The spins, still precessing around Bo, now begin to precess around B1 
resulting in the net magnetization spiralling into the transverse plane.  Because 
the spins are precessing at    the B1 field must oscillate at the same frequency 
in order for each spin to experience a constant magnetic field relative to its 
constantly changing orientation.  The rate of oscillation required is in the 
radiofrequency range of the electromagnetic spectrum (Figure 2-2).     
z
x y
B1
a) Stationary frame of reference
z
x y
B1
b) frame of reference rotating at  
μ μ
 
Figure 2-2 – a) The net magnetization simultaneously precesses about Bo and a 
second magnetic field oscillating at exactly    causing the net magnetization to 
spiral into the transverse plane.  b) Viewed from a frame of reference rotating at 
   the oscillations of B1 are removed and the net magnetization appears to 
simply flip directly into the xy-plane. 
 
The preference in the spins for alignment with Bo has now been rotated 90
o 
from the z-axis and manifests as a preference to precess in phase in the xy-
plane. The net magnetization now rotates around the z-axis with an angular 
frequency   .  Once in the xy-plane the net magnetization can be measured by 
the strength of electric signal it induces in a wire coil placed near the sample 
and this is the basis for all MR measurements.  The net magnetization will 
return to align with Bo at a rate dictated by T1 as described in section 2.3.  
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However, the transverse magnetization decays by a separate mechanism.  
Directly after the B1 field has been switched off the spins start to dephase and 
the transverse net magnetization rapidly deteriorates. Fluctuations in the 
microscopic magnetic field that each spin experiences cause small changes in 
precessional frequency which lead to dephasing and deterioration of the net 
transverse magnetization.  In real-world MR experiments spatial 
inhomogeneities in the generated Bo field are also responsible for dephasing.  
The transverse magnetization, Mxy(t), decays exponentially according to the 
transverse relaxation time constant T2 (or T2* when Bo inhomogeneities are not 
corrected for) according to: 
           
  
    
Equation 2-4 
2.5. Generating an image: localisation 
The process described so far leads only to the measurement of an oscillating 
electric signal in a conducting coil placed near the substance.  How can these 
signals be interpreted to generate an image?  Almost all image localisation in 
MRI is performed using temporally variable magnetic gradients1.  These are 
generated by additional coils positioned inside the bore of the main 
superconducting magnet, which generate small gradient magnetic fields that 
add and subtract from the main Bo field.   
 
Selective excitation (slice selection) 
If a magnetic field gradient is applied across the object of interest the 
precessional frequencies vary spatially with the gradient.  As described in 
section 2.4 the B1 field must be at the Larmor frequency for spins to rotate into 
the transverse plane.  By limiting the radiofrequency bandwidth of the B1 pulse 
whilst the gradient is applied the B1 field is limited to only effect spins in a finite 
spatial area (Figure 2-3).   
 
                                            
1 In parallel imaging the position of the multiple coils is also used as part of the 
image generation process. 
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Figure 2-3 – By applying an additional gradient, Gz, whilst exposing the object 
only to a limited bandwidth of B1 frequencies only spins in a  finite slice are 
excited.   
 
Localisation within the excited slab is performed by exploiting the Fourier 
transform (FT), which transforms time domain signals into the frequency domain 
and vice versa.  Applying a frequency encoding magnetic field gradient in the x 
direction causes spins at higher field strengths to precess at higher frequencies.  
In other words frequency has become a function of x: 
                
Equation 2-5 
Where      is the precessional frequency at a position x along the x-axis and 
Gx is the gradient strength dB/dx.  The time domain signal will consist of signal 
from all the spin frequencies from the entire excited slab.  However, the Fourier 
transform converts this time domain signal onto a frequency axis.  As the 
signals have been encoded such that frequency is synonymous with position 
the frequency axis can be reinterpreted as spatial position (Figure 2-4). 
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Figure 2-4 – Precessional frequency increases with x due to the magnetic field 
gradient Gx.  The measured signal is the sum of all spin frequencies and 
amplitudes.  The Fourier transform represents these on a frequency axis.  As 
frequency is synonymous with spatial position, by virtue of the frequency 
encoding gradient Gx, the frequency axis can be reinterpreted as position along 
the x direction2. 
 
The final spatial dimension is encoded in terms of the phase of the spins.  Prior 
to frequency encoding a phase encoding magnetic field gradient is applied, 
orthogonal to the frequency encoding direction, which varies the spin frequency 
for a short interval before the phase encoding gradient is turned off (Figure 2-4).  
In this case phase is encoded with distance y: 
                
 
 
 
Equation 2-6 
                                            
2 The final amplitudes in Figure 2-4 have been drawn to reflect proton density 
(the number of spins at a given frequency).  In most MR images the signal 
strength is dominated by T1 and T2 contrast. 
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Where      , is the change in phase at position y,  T is time for which the 
phase encoding pulse is applied and Gy is the phase encoding gradient 
        . 
Before phase 
encode
After phase 
encode
B
y
Bo + Gy
Bo
 
Figure 2-5 – After the application of a phase encoding gradient for a short time in 
the y direction the spin’s phase is a function of distance along y. 
 
The Fourier transform can only analyse time variant signals and so cannot 
decode a single phase encoding step.  Therefore, the process is repeated over 
a range of phase encoding gradients.  The signals from each phase encoding 
step are arranged in order of phase encoding gradient amplitude in a matrix 
known as k-space.  In the frequency encoding direction the data represents 
time variant changes in signal whose Fourier transforms are frequencies, which 
have been encoded to represent position along x.  In the phase encoding 
direction the data represents the rate of change of phase at each position in the 
object over all of the phase encoding steps.  The rate of change of phase will be 
higher at the outer edges of the object where the gradient changes were most 
extreme.  The Fourier transform in this direction will represent rate of change of 
phase as simply another frequency, which has been encoded to represent 
distance along the y direction.  Thus, by representing the data in this way and 
performing a 2D Fourier transform an image of the MR signal is produced.  
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Figure 2-6 – Signal acquisitions acquired with  increasing phase encoding 
gradient strength are arranged sequentially in a matrix called k-space.  In the 
frequency encoding direction the FT transforms the data onto a frequency axis 
    .  In the phase encoding direction the FT transforms the data to a rate of 
change of phase axis 
     
  
. 
2.6. Pulse sequences 
2.6.1. Gradient recalled echo (GRE) 
The MR pulse sequence, of which there are an enormous variety, refers to the 
particular series of RF pulses and gradients, with associated timings, used to 
generate the image.  Here the description is limited only to sequences that are 
used in myocardial perfusion DCE-MRI.  The pulse sequence diagram for 
gradient recalled echo (GRE) is shown in Figure 2-7.  In an MR acquisition, 
before each line of k-space is acquired a time TR (the relaxation time) must be 
left to allow the longitudinal magnetization to recover sufficiently before applying 
the next RF pulse.  This parameter controls the degree to which T1 differences 
between substances effect the image contrast.  To generate a T1-weighted 
image after a 90o RF pulse TR needs to be of the order of a few hundred 
milliseconds making the acquisition time for the full k-space long.  By using a 
flip angle α < 90o much shorter TRs can be used, albeit with poorer image 
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contrast.  The top line of the pulse sequence diagram in Figure 2-7 depicts the 
αo RF pulse in conjunction with a gradient in the slice selection direction.  The 
application of any gradient causes dephasing of the spins, which is an 
undesirable loss of signal coherence in this instance, and so an immediate 
rephasing pulse is applied in the opposite direction to undo the dephasing in the 
slice selection direction.  This is followed by the phase encoding gradient Gp, 
which causes dephasing necessary for the image formation.  Simultaneously, a 
dephasing gradient is applied in the frequency encoding direction prior to the 
frequency encoding gradient.  The frequency encoding gradient then 
immediately rephases and then continues to dephase the signal whilst the 
acquisition is made.  This results in the generation of a symmetric echo with a 
peak signal strength at the centre of k-space.  The centre of k-space contains 
the low spatial frequency information, which is the most critical for image 
contrast.  The time between the RF pulse and the centre of the read-out signal 
is the echo time (TE) and controls the strength of the effect of T2* contrast on 
the image. 
o o o
rf
Gs
Gp
Gf
S
TR
TE
 
Figure 2-7 – Gradient recalled echo.  The αo RF pulse is applied in conjunction 
with the slice selection gradient Gs, followed by a rephasing gradient.  The phase 
encoding gradient ,Gp, is applied in conjunction with the a dephasing gradient Gf, 
after which the signal is acquired during the frequency rephasing gradient.  
 
2.6.2. Fast sequences 
At very low flip angles TR can be set so low that the transverse signal has not 
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completely dephased by the onset of subsequent RF pulses, leading to image 
artifacts.  Spoiled gradient echo uses a spoiler gradient to dephase transverse 
magnetization to destroy transverse magnetization prior to the next RF pulse.  
Conversely, balanced steady state free precession (bSSFP) „rewinds‟ the signal 
dephased by the applied gradients by applying additional balancing gradients to 
rephase the MR signal before each subsequent RF pulse.  The remnant 
transverse magnetization is then superimposed onto the magnetization 
generated by subsequent RF pulses generating high signal.  Echo planar 
imaging (EPI) uses rapidly alternating frequency encoding gradients, 
interspersed by phase encoding pulses, to refocus multiple gradient echoes 
following a single RF pulse. Single-shot EPI acquires all of the echoes required 
to fill k-space in a single echo train, however T2* decay throughout the echo 
train causes the images to be heavily T2*-weighted resulting in relatively poor 
image quality. For cardiac perfusion imaging a hybrid-EPI (also known as 
segmented EPI) approach is typically employed where a number of shorter 
echo trains are acquired by applying multiple RF pulses.  This reduces the 
detrimental effect of T2* weighting, improving the image quality while 
maintaining some of the speed advantage provided by the EPI technique 
(Figure 2-8). 
TR
o o
GS
GP
rf
GF
 
Figure 2-8 - Hybrid Echo Planar Imaging (hybrid-EPI).  The slope of the frequency 
encoding gradient is rapidly alternated, generating a train of gradient echoes 
following a single RF excitation pulse.  Phase encoding gradients are applied 
between each frequency encoding gradient to ensure each gradient echo fills a 
different line of k-space.  In hybrid-EPI multiple RF pulses are used, each 
followed by an echo train. (ETL = 5 in this case). 
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2.6.3. The preparation pulse 
To reduce acquisition time the perfusion sequences described above employ 
small flip angles and very short TRs resulting in poor T1-contrast.  For this 
reason a preparation pulse can be applied prior to the read-out pulse sequence 
with a sufficiently long saturation time (TS) to establish a high T1-contrast before 
the read-out sequence is employed.  For instance a spoiled gradient echo read-
out sequence uses small flip angle RF pulses so that Mz is only partially 
decreased, and full recovery occurs earlier after the read-out.  This enables 
short repetition times (TR), but also limits the changes in contrast between 
substances (Figure 2-9a).  If a 90o preparation-pulse is applied with a long delay 
before the read-out then the image contrast is increased (Figure 2-9b), before 
the fast read-out sequence is applied.  The time between the preparation pulses 
and the central, contrast defining, line of k-space, ko, is known as the saturation 
time (TS). 
o o o o o
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a) Spoiled gradient echo
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Figure 2-9 – a) small flip angles and short TRs in spoiled gradient echo creates 
poor T1 image contrast.  b) The use of a 90
o saturation pulse and a long 
saturation time (TS) establishes strong T1 contrast before applying the spoiled 
gradient echo read-out. 
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2.7. MR contrast agents 
MR contrast agents enhance MR signal by modifying tissue T1 and T2 relaxation 
times.  The most commonly used contrast agents exploit the strong 
paramagnetic properties of the lanthanide ion gadolinium (Gd).  Local field 
interactions between the seven unpaired electrons of the Gd ion and the 
hydrogen nuclei within adjacent water molecules cause a reduction in both the 
T1 and T2 of the surrounding tissue.  The Gd ion is bound, or chelated, to a 
larger electron-donating molecule or ligand to render it safe for in-vivo human 
use, except in cases of impaired renal function (10–12).  The ability of a given 
contrast agent to influence relaxation rates is expressed in terms of its relaxivity 
which is the change in relaxation rate per unit concentration expressed in mM-1 
.s-1.  If the concentration in mM of contrast agent is C and the T1 relaxivity is r1 
then the observed relaxation rate of the tissue T1 (observed) can be related to its 
native relaxation rate T1(native) as follows (13):   
1/T1 (observed) = 1/T1 (native) + r1 . C 
Equation 2-7 
There is a corresponding expression for the observed T2 relaxation rate of the 
substance T2 (observed) as follows:   
1/T2 (observed) = 1/T2(native) + r2 . C 
Equation 2-8 
Where r2 is the T2 relaxivity and T2(native) is the native relaxation rate.  Relating 
T1(observed) to the final image signal intensity (SI) value is more complicated.  SI is 
dependent on T1, T2, proton density, the MR imaging sequence and its 
parameters.  Figure 2-10 shows a plot of SI versus contrast agent 
concentration.  At low concentrations T1 shortening is the dominant effect of the 
contrast agent so that the SI increases with concentration. However at higher 
concentrations the T2 shortening effect becomes dominant and SI begins to fall.  
If the images are to be used for quantitative analysis then the contrast-induced 
changes in SI must directly reflect changes in Gd concentration.  At low 
concentrations this assumption holds because the relationship between SI and 
Gd concentration is approximately linear.  At higher concentrations this 
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relationship becomes non-linear and quantitation of concentration based on 
uncorrected SI values will yield erroneous results.  At still higher values the 
signal becomes saturated and it is no longer possible to derive a single 
concentration from the measured SI value because the relationship between SI 
and CA concentration ceases to be monotonic. 
 
1%    2%  4%   8%   10% 20% 40% 60%  80% 100%
T2* relationship T 1 relationship
 
Figure 2-10 - Signal intensity values over a range of concentrations for a spoiled 
gradient echo pulse sequence.  The solid line shows the combined effect of T1 
and T2* on signal intensity.  The two dashed curves show the separate 
dependencies of the signal behaviour for T1 or T2* alone. At low concentrations 
the effect of T1 shortening is dominant, while at higher concentrations the T2* 
shortening dominates.  A series of samples imaged with increasing percentage 
concentrations of Gadolinium are shown underneath the plot as a visual 
demonstration of the effect. 
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Extra-vascular, extra-cellular contrast agents are the most commonly used in 
clinical practice.  These agents are small enough to leak through the capillaries 
from the vascular space into the extra-vascular, extra-cellular space but not 
through cell membranes.  It is this property of the contrast agent that enables 
late gadolinium enhancement of myocardial infarcts where the extravascular, 
extracellular space is enlarged.  Intravascular contrast agents, which stay within 
the vascular space, are less commonly used but may be preferable for 
quantitative perfusion imaging as they allow simpler mathematical models to be 
used for flow quantification as no account needs to be taken of leakage from the 
vascular space (14). 
 
2.8. Dynamic contrast enhanced magnetic resonance imaging 
(DCE-MRI) myocardial perfusion3 
In order to assess myocardial perfusion, blood passing into the myocardium 
needs to alter image signal intensity so that areas of reduced perfusion can be 
detected.  This is typically achieved using a signal enhancing contrast agent.  
The contrast agent is injected intravenously whilst multiple images of the heart 
in the same anatomical position and the same cardiac phase are acquired in 
successive heart beats (Figure 2-11).  Typically short-axis images are acquired 
but a long-axis image is also sometimes additionally acquired in order to cover 
the apex of the heart.  The acquisition protocol needs to take into account the 
trade-off between spatial requirements (i.e. coverage, resolution) and the 
temporal resolution. 
                                            
3 This section is based on a previously published review paper, Biglands, 2012 
(9). 
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Figure 2-11 - Contrast agent is injected intravenously whilst multiple images of 
the heart are acquired to create a dynamic series showing the contrast agent 
passing through the heart.  Contrast agent can be seen as signal enhancement 
in the right ventricle (RV) followed by the left ventricle (LV) and more gradually in 
the myocardium, before finally washing out. 
 
The essential requirements of a DCE-MRI cardiac perfusion imaging sequence 
can be summarised as follows: All data for multiple images must be acquired 
within a single heart beat and the effects of cardiac and respiratory motion must 
be minimised.  In addition the image contrast must be T1-weighted to maximise 
the effect of the contrast agent on image signal intensity. In order to fulfil these 
requirements, the choice of pulse sequence, method of contrast generation and 
approaches to minimise motion effects must be carefully considered. 
 
2.8.1. The perfusion pulse sequence: read-out sequence 
In DCE-MRI the image appearance changes significantly between contiguous 
frames due to the passage of the contrast agent through the heart so multi-shot 
k-space imaging strategies that fill k-space over multiple cardiac cycles are not 
applicable.  Therefore, in order to acquire images quickly, DCE-MRI perfusion 
imaging is generally performed as a single shot technique with a fast (or turbo) 
spoiled gradient echo (FGE), balanced steady state free precession (bSSFP), 
or echo planar imaging (EPI) pulse sequence.  Despite numerous comparison 
studies there is still no consensus on the optimal data acquisition pulse 
sequence for perfusion imaging. Objective measures of pulse sequence 
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performance include the speed of acquisition, the level of artifact and the signal-
to-noise ratio (SNR) and contrast-to-noise ratio (CNR).  SNR is the ratio of the 
signal intensity of a particular tissue to the background image intensity in an 
area where signal is absent, while CNR is the ratio of the signal difference 
between two particular tissues and the background image intensity.  As FGE 
uses a RF pulse per read-out line it is less susceptible to fluctuations in k-
space, which should theoretically make it less susceptible to ghosting artifacts.   
 
Nevertheless, hybrid EPI has been shown practically to be less artifact prone 
than FGE (15).  Hybrid-EPI is also faster, allowing increases in coverage and 
resolution.  By maintaining steady state transverse magnetization bSSFP 
sequences generate the greatest signal of the three methods (16).  The higher 
SNR of bSSFP images allow a much higher bandwidth to be selected leading to 
shorter TE and TR making bSSFP a faster sequence than FGE and SSFP has 
been shown to have better sensitivity for detecting perfusion defects (17), also 
due to its high image SNR and CNR.   
 
However, of the three sequences SSFP is the most prone to artifacts (18) 
caused by off resonance magnetization.  It has a greater occurrence of 
susceptibility artifact and ghosting and is prone to truncation artifact in the 
endocardium due to the increased difference in signal intensity between the 
blood and the myocardium (19).  Due to the large number of causes of artifacts 
with bSSFP it tends to be the least robust sequence, being both capable of 
producing high quality images but prone to significant image artifacts. 
 
2.8.2. The perfusion pulse sequence: T1-weighting and TS 
DCE-MR images should be T1-weighted in order to maximise the effect of the 
contrast agent on signal intensity.  This is achieved using a preparation pulse 
(section 2.6), with the amount of T1 weighting controlled by the saturation time 
(TS) (Figure 2-12).  Perfusion imaging is usually carried out using a saturation 
recovery preparation pulse as inversion recovery increases the total scan time, 
and is more vulnerable to RR variation (18).  For visual analysis of perfusion 
defects the T1 weighting can be optimised to maximise T1 contrast using a long 
TS.  However, unnecessarily long TS values take up too much of the RR-
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interval and limit coverage and spatial resolution.  Furthermore, if the images 
are to be used for quantitative imaging, shorter TS values are preferable to 
minimise the non-linearity in the relationship between CA concentration and 
signal intensity. 
 
2.8.3. The perfusion pulse sequence: trigger delay (TD) 
RR interval
ECG
Acquisition 
gradients
TS
TD
TS
TD
TS
TD
Saturation 
Pulse
Gf
RF
Imaging slice 
position
Contrast 
injection
ko ko ko
  
Figure 2-12 - The trigger delay (TD) sets the point at which the centre of k-space, 
k0, is acquired within each RR-interval. The saturation time (TS) determines the 
time between the saturation pulse and the centre of k-space, thereby controlling  
the T1-weighted contrast of the image for a particular image slice. 
 
In perfusion imaging each single-shot image acquisition is acquired quickly 
enough to avoid the detrimental effect of cardiac motion.  The use of ECG 
triggering serves only to determine at what phase of the cardiac cycle the heart 
will be imaged. This is set by the trigger delay (TD), which is the time from the 
ECG R-wave to the time of the acquisition of the central line of k-space, ko, 
(Figure 2-12).  In a single slice acquisition this can be set to any point of the 
cardiac cycle. TD does not change with RR interval so if the heart rate 
increases during imaging the cardiac phase of the image will change during 
imaging.  The fastest heart motion is during systole and early diastole, thus 
imaging at mid-diastole should minimise motion artifacts.  Conversely there is a 
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preference for imaging in systole if quantitative analysis is foreseen, as the 
thicker myocardial wall in systole allows larger ROIs within the myocardium and 
subsequently improved SNR in contrast uptake curves. 
 
2.8.4. Coverage and resolution 
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Figure 2-13 - With a single slice acquisition per RR interval (top) there is flexible 
choice for the optimal cardiac phase and T1-weighted image contrast, but poor 
coverage of the LV. For multiple slice acquisitions, the use of a separate 
preparation pulse for each slice (centre) allows the same image contrast for each 
slice (fixed TS) but the two slices are acquired at different cardiac phases due to 
their different trigger delays and the number of slices is limited.  Using a pre-
pulse shared by all the slice acquisitions (bottom) potentially allows more slices 
to be acquired, but  leads to each slice having both a different T1-contrast 
behaviour, and a different cardiac phase. 
 
For the detection of sub-endocardial perfusion defects there is a requirement to 
maximise spatial resolution but this increases the acquisition time for each slice 
which renders the acquisition more prone to cardiac motion and limits the 
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number of slices that can be acquired within a heartbeat, thus limiting coverage.  
However, endocardial perfusion defects may occur at any point in the left 
ventricular wall and so maximising the coverage of the left ventricle is also 
important.  The AHA recommend that three short-axis slices are acquired to 
cover basal, mid and apical regions of the left ventricle (20) and that a spatial 
resolution of at least 2.5mm (21,22) is necessary to be able to reliably detect 
sub-endocardial defects.  The achievement of all of these requirements within a 
single RR-interval is challenging.  One approach to increase coverage along the 
long-axis of the left ventricle is to acquire an increased number of slices over 2  
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Figure 2-14 - For every image in the dynamic sequence contours describing the 
myocardium and a region in the blood pool are drawn.  The average signal 
intensity from within each region is plotted for each time point to generate plots 
of signal intensity versus time that show the increase in signal intensity in both 
the  myocardium (green) and the blood pool (red).   
 
RR-intervals, which has the effect of decreasing the temporal resolution of the 
dynamic series.  This is a less desirable option if a quantitative assessment of 
perfusion is required (18,21).  A further alternative is to abandon the 
requirement that each read-out pulse has a separate preparation pulse (23).  
The delay following the saturation pulse, TS, is the longest time delay in the 
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sequence and so the use of a shared saturation pulse applied to all three slices, 
followed by three slice data acquisitions reduces the acquisition time 
significantly (Figure 2-13).  However, this approach results in a different image 
contrast for each slice, with the longer TS slices less suited to quantitative 
analysis. 
 
2.8.5. Factors relevant to quantitation of myocardial blood flow 
In order to quantify myocardial blood flow (MBF) signal vs. time uptake curves 
must be obtained.   Regions of interest (ROIs) are drawn on each frame of the 
dynamic series of images to define the myocardium and an area within the left 
ventricular blood pool.  Signal intensities for each of these regions are then 
plotted at each time point to generate dynamic uptake curves.  The blood pool 
curve is taken to represent the contrast agent passing into the myocardium or 
the arterial input function (AIF) and the myocardial region represents the 
contrast agent remaining within the myocardium (Figure 2-14).  These curves 
can be analysed to obtain semi-quantitative or quantitative estimates of MBF. 
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Figure 2-15 - The left hand graph shows the difference between the assumed 
linear relationship between signal intensity and Gd concentration (dotted line) 
and the true relationship (solid line).  The right hand graph shows how the non-
linear relationship at higher concentrations can propagate into a peak height 
error in the measured blood pool curve (the arterial input function or AIF) 
causing an overestimate in MBF. 
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2.8.6. Non-linearity effects at high gadolinium concentrations 
If perfusion data are to be used for MBF quantitation then an extra 
consideration becomes relevant in terms of the MR acquisition.  The non-
linearity in the relationship between gadolinium concentration and signal 
intensity (SI) must be minimised.  Typically for perfusion measurements 
contrast agent doses do not exceed 0.1mmol/kg and so the SI to concentration 
curve has negligible influence from T2
* shortening (Figure 2-10).  Figure 2-15 
illustrates how the non-linearity in the relationship between signal intensity and 
Gd concentration causes blunting of the AIF peak yielding overestimates in 
MBF.  The degree of non-linearity depends on the dose and injection rate of the 
administered contrast agent, the type of MR pulse sequence (EPI, FFE, SSFP) 
and the saturation time (TS).  Acquisition protocols for quantitative perfusion 
imaging attempt to optimise these factors to ameliorate the effect of this non-
linearity on the MBF estimate. 
 
The simplest method is to administer a low dose of contrast agent so that the 
relationship between MR signal intensity and Gd concentration is in the 
approximately linear region (Figure 2-15).  Contrast agent doses need to be 
around 0.01 mmol/kg to ensure linearity in the blood pool (24).  These low 
doses reduce the CNR and SNR of the images rendering visual analysis (still 
the main-stay of clinical reporting) difficult.  The myocardial curve enhances less 
dramatically than the AIF due to the lower concentration within the myocardium 
and such low administered doses can reduce the change in signal in the 
myocardium to such an extent that MBF estimates become significantly affected 
by image noise, compromising the precision of the MBF estimate.   
 
To tackle these issues dual-bolus strategies have been proposed that employ 
two contrast injections.  Firstly a low dose bolus is injected from which the AIF 
will be acquired but the poor CNR myocardial data will be discarded.  This is 
followed by a higher dose bolus from which only the myocardial curves will be 
used.  The method is practically challenging as it requires the patient to undergo 
a total of four contrast injections (if they are to be imaged under rest and stress 
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conditions), but has shown good agreement with PET MBF values (5).  
However the increased accuracy of the dual-bolus technique has not been 
shown to increase its diagnostic value over single bolus (25).  This might be 
explained by the introduction of extra noise from the separate pre-bolus 
analysis. 
 
An alternative approach is to reduce non-linearities by altering sequence 
parameters.  The dual-sequence strategy uses a sequence with very short TS 
(~10ms) and low image resolution followed by a more typical TS (~100ms) 
acquisition (26).  The short TS images exhibit a more linear SI to concentration 
relationship and are used to generate the AIF curve, whereas the longer TS 
images are used for the myocardial enhancement curve.  Acquiring two 
acquisitions for each heart position requires a corresponding reduction in 
coverage and, as with dual-bolus, the AIF images will suffer from lower CNR 
than the myocardial images. 
 
Non-linearity correction attempts to convert the SI vs. time curve to a 
concentration vs. time curve post hoc. (27,28).  In this approach the MR 
imaging sequence equation is used to convert each SI value into a T1 value 
(using prior knowledge of the imaging parameters) (29–31).  If the native tissue 
T1 has been measured prior to the perfusion scan then the contrast enhanced 
T1 values can be converted to concentrations.  If the SI value lies in the 
approximately linear, or non-linear region (Figure 2-15) then it should be 
possible to convert it to CA concentration.  However, if the curve has passed 
into the plateau region then the solution to the pulse sequence equation will 
become error prone and the correction becomes useless.  Such conversions 
are also susceptible to errors in the native T1 measurement and errors in the 
pulse sequence parameters. 
 
2.9. The dark rim artifact (DRA) 
All MR images are susceptible to image artifacts.  However in cardiac perfusion 
imaging the dark rim artifact (DRA) is particularly problematic as it mimics the 
very perfusion defects that the investigation is designed to show.  DRAs 
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manifest as transient signal voids at the endocardial boundary and can be 
mistaken for genuine sub-endocardial perfusion defects.  They differ from 
genuine hypoperfusion events in that they typically last only a few heart beats 
(32) and they can cause the myocardial signal intensity to drop below the 
baseline (pre-contrast) signal value (33).  A number of comparison studies have 
been conducted to investigate which sequences are most prone to DRAs 
(16,17,34) showing that bSSFP is the acquisition sequence most affected.  The 
cause of a given DRA is difficult to pinpoint as multiple factors have been shown 
to contribute.  Motion during image acquisition can generate abrupt 
discontinuities in k-space which translate into banding artifacts at tissue 
boundaries in the image (35).  Magnetic susceptibility effects may also cause 
DRA due to increased magnetic field distortions around boundaries in the image 
and temporal changes in magnetic susceptibility on the arrival of contrast agent 
(17,33).  This effect is most prominent in bSSFP due to its higher sensitivity to 
changes in magnetic susceptibility which cause local changes to the Larmor 
frequency. These off-resonance effects become worse at stronger 
concentrations of contrast agent.  The presence of truncation artifact at the high 
contrast boundary between the blood pool and myocardium is another potential 
cause of DRA (22).  This is caused by an insufficient content of high spatial 
frequency data in k-space which means that the Fourier transform is unable to 
accurately represent true high contrast boundaries in the image.  This causes 
signal variations adjacent to these boundaries that appear as bright and dark 
bands.  This effect becomes worse at higher contrast levels such as with higher 
bolus concentrations and injection rates, and when using bSSFP as the 
acquisition sequence. 
 
2.10. Summary 
The basics of MRI, including the origin of the MR signal and basic pulse 
sequences, have been described with a focus on the imaging methods used in 
CMR perfusion imaging.  The demanding imaging requirements for CMR 
perfusion imaging have been described and the options and compromises as to 
how these demands are to be met have been discussed.  The next chapter will 
discuss coronary heart disease and myocardial ischaemia, explaining the role 
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that these CMR perfusion techniques play in its diagnosis.
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3. Background: ischaemia and myocardial 
perfusion 
3.1. Introduction 
MRI is by no means the only method for diagnosing coronary heart disease 
(CHD).  Most medical imaging modalities have methods for detecting the 
disease with their own sets of advantages and disadvantages.  After a 
discussion of basic cardiac anatomy and function, CHD and its treatments are 
briefly described in this chapter.  An overview of the main methods for diagnosis 
of these conditions is then given considering the methods used, the associated 
advantages and disadvantages and the diagnostic performance of each test.  
As befitting a thesis on MR perfusion, a more detailed description of the 
performance of MR is given considering the impact of visual, semi-quantitative 
and fully quantitative analysis on diagnostic performance as reported in the 
cardiac MR literature. 
 
3.2. Cardiac anatomy 
The human heart consists of four chambers: the right and left atria and the right 
and left ventricles.  The right side of the heart is dedicated to reoxygenating the 
blood via the lungs, whereas the left side pumps oxygenated blood to the rest of 
the body.  This gives the left side of the heart a higher workload than the right, 
which is why the left ventricular muscle wall is thicker than that of the right 
ventricle.  This process is illustrated schematically in Figure 3-1 a).  For such an 
active organ as the heart sufficient nutrients could not diffuse quickly enough 
through the heart wall to supply all the myocardial cells.  Instead, the coronary 
arteries, branching directly from the ascending aorta, encircle the heart and 
provide the heart with blood (Figure 3-1 b).  The finer details of the coronary 
circulation vary between individuals, with a major distinction being drawn 
between left and right dominant circulations dependant on which artery provides 
blood to the posterior descending artery, which supplies blood to the posterior 
third of the interventricular septum (the wall between the ventricles).   
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Figure 3-1 – a) Oxygenated blood from the pulmonary veins enters the left atrium 
(LA) and is pumped into the left ventricle (LV), which pumps oxygenated blood to 
the rest of the body.  The deoxygenated blood returns via the inferior and 
superior vena cavae into the right atrium where it passes into the right ventricle 
to be pumped to the lungs for reoxygenation via the pulmonary arteries.  b) The 
right coronary artery (RCA) and left main stem (LMS) branch directly from the 
ascending aorta.  The LMS bifurcates into the left anterior descending artery 
(LAD) and the left circumflex (LCX).  
 
The coronary circulation also contains multiple anastomoses, where two or 
more arteries interconnect.  These interconnections provide alternative routes 
for blood and can allow myocardial perfusion to persist when single arteries 
become blocked.  These complications make the mapping of an ischaemic 
blood vessel to the corresponding myocardial region in a medical image difficult.  
The process is further confounded by the possibility for coronary 
collateralization, where microscopic cardiac collateral vessels widen their lumen 
in order to preserve blood flow to ischaemic regions of the myocardium.    
 
3.3. Coronary heart disease (CHD) 
Coronary heart disease affects  nearly 2.7 million people in the UK (1).  
Ischaemic heart disease (IHD) occurs when the cardiac blood supply is 
reduced, typically due to the narrowing of one or more coronary arteries by 
atherosclerotic plaques (coronary artery disease (CAD)).  The reduced blood 
supply causes hypoxia (reduced oxygen supply) in the myocardium, especially 
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under stress conditions.  Chronic hypoxia causes cells to enter a „hibernation‟ 
state, where function is dramatically reduced and the patient may experience 
pain (angina pectoris).  However the cells are still viable and if the oxygen 
supply is re-established they will recover.  Complete and acute obstruction of 
blood flow, most commonly through thrombus formation on a vulnerable plaque, 
may result in myocardial infarction (commonly called a heart attack).  Here the 
cells in the affected region of the heart die and are replaced by non-contractile 
scar tissue.  If the sufferer survives the event the scar tissue can manifest as 
abnormal contractile function in the heart.      
 
Lifestyle changes (exercise, stopping smoking and diet improvements) can slow 
the progression of ischaemia.  Cholesterol lowering agents stabilise the plaque, 
making it less susceptible to attracting blood clots.  Beta blockers reduce the 
heart rate thus reducing oxygen demand and reducing hypoxia, whilst nitrates 
increase blood supply by vasodilation (widening of the blood vessels).  Medical 
therapy typically consists of a combination of these approaches whereas 
mechanical interventions involve physically restoring the blood flow to the heart. 
 
a) b) c)
 
Figure 3-2 – PTCA.  a) X-ray with iodinated contrast agent of right coronary artery 
showing a significant stenosis.  b) X-ray without contrast agent showing balloon 
angioplasty and the radio-opaque catheter guidewire.  c) X-ray with contrast 
agent showing the opened artery post angioplasty and stent placement4 
 
Percutaneous transluminal coronary angioplasty (PTCA), also known as 
percutaneous coronary intervention (PCI) involves the insertion of a catheter 
                                            
4 Images provided by Andy Davies, University of Leeds. 
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into an artery in the arm or leg.  The catheter is then fed to the stenotic site, 
under X-ray guidance, and a balloon is inflated to squash the plaque against the 
artery wall.  Because 30-50% of PTCA re-opened arteries restenose within six 
months of the procedure a stent (resembling a small spring) is then deployed in 
the artery to keep the artery open (Figure 3-2).  
 
A Coronary artery bypass graft (CABG) uses a section of artery or vein from 
another part of the body (typically the chest wall for arterial grafts and the leg for 
venous grafts) to connect the aorta directly to a region downstream from the 
stenosis.  This effectively bypasses the problem area and allows blood to flow 
beyond the diseased artery.   
 
Revascularisation aims to restore blood supply to living but hypo-perfused 
tissue.  However if the tissue is infarcted (cell death) then revascularization will 
have no benefit.  There is a small but significant risk to the patient undergoing 
arterial catheterization and so it is important to avoid the procedure when it will 
be of no benefit to the patient.  MR viability imaging provides imaging of 
myocardial scar.  Images are acquired 5-15 minutes post contrast injection.  In 
scar tissue cell walls break down increasing the extravascular space and the 
wash-in and wash-out characteristics of this space are slower (36) thus the scar 
manifests as a bright, contrast filled zone, on late gadolinium enhanced (LGE) 
images.  These images provide important diagnostic information about whether 
or not a given patients prognosis will be improved by revascularization (37). 
3.4. Diagnosing coronary heart disease 
3.4.1. The cascade of ischaemia 
The cascade of ischaemia (38) describes the order in which detectable events 
occur in response to ischaemia.  Initially only subendocardial perfusion defects 
are detectable (39).  More severe stenosis leads to transmural hypoperfusion 
followed by diastolic (relaxed heart), and then systolic (contracted heart), wall 
motion abnormalities.  Finally electrocardiogram (ECG) (See section 3.4.4) 
changes become detectable and angina symptoms may manifest.  Therefore, 
imaging modalities which can detect subendocardial perfusion defects have the 
potential to be the most powerful test for early detection of myocardial 
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ischaemia. 
 
The argument may be made, and in many cases may be quite valid, that an 
even earlier test for ischaemia is possible by imaging the coronary artery 
stenosis itself, as is routinely performed in X-ray angiography.  However, the 
relationship between coronary artery stenosis and myocardial ischaemia is not 
straightforward.  It has been widely demonstrated that an anatomical 
assessment alone is unreliable in predicting the functional significance of a 
coronary stenosis. Multiple other physiological processes determine the 
functional relevance of an epicardial stenosis.  A perfusion defect demonstrates 
a mismatch between blood demand and blood supply at a specific myocardial 
site.  Syndrome-X patients manifest such defects without exhibiting any 
coronary stenosis (40), whereas other patients with significant coronary 
stenosis have been found to have no myocardial ischaemia due to collateral 
flow maintaining myocardial blood flow.  Thus a reliable method for detecting 
subendocardial hypo-perfusion has the potential to be the most direct and 
diagnostically powerful test for detecting ischaemic heart disease. 
 
3.4.2. Stress testing 
Auto-regulation maintains myocardial blood flow in the heart even in the 
presence of ischaemia until the degree of stenosis becomes critical.  For this 
reason it is necessary to perform tests under stress conditions in order to reveal 
myocardial ischaemia in a diagnostic test.  In ECG based tests, where the 
patient‟s mobility is not limited, stress is simply induced by requiring the patient 
to exercise, either on a treadmill or an exercise bike.  With investigations that 
limit patient movement due to the constraints of the imaging apparatus, stress is 
typically induced pharmacologically using an infusion of either a positive 
inotropic agent such as dobutamine or a vasodilator like adenosine.  
Dobutamine increases the heart rate and contractility actually inducing 
ischaemia in patients, whereas adenosine dilates the coronary arteries to their 
maximum, increasing myocardial blood flow without inducing ischameia.  
Whether the differences between maximal vasodilation, induced ischameia and 
physical stress are relevant in terms of diagnosing CHD from perfusion imaging 
is yet to be established. 
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3.4.3. Myocardial perfusion reserve (MPR) 
Diagnostic studies using quantitative or semi-quantitative myocardial blood flow 
(MBF) estimates often express their results in terms of the myocardial perfusion 
reserve (MPR). The MPR is the ratio of the stress and resting myocardial blood 
flows: 
    
         
       
 
Equation 3-1 
The rationale for expressing perfusion measures in this way goes back to the 
concept of coronary flow reserve (CFR) (41).  The ultimate effect of a given 
stenosis depends on the ability of the coronary circulation to compensate for the 
increased impedance to blood flow by vasodilation.  To make a CFR 
measurement rest and stress coronary flow measurements are made 
downstream from a given stenosis, with the stress measurement made under 
adenosine induced, maximal vasodilation.  The ratio of the stress and rest 
measurements can be taken as a measure of the ability of the system to 
maintain flow in the face of a given stenosis i.e. its reserve of possible flow 
increase before maximal vasodilation occurs.  The concept is illustrated in 
Figure 3-3, which is reproduced from (41).  Stress and resting coronary flow 
rates are shown at a range of stenosis levels.  The CFR measures the ratio 
between the vasodilated and rest flows.  The coronary pressure (being the 
pressure gradient that drives blood down the artery) reduces non-linearly with 
the degree of stenosis, giving a corresponding reduction in CFR.  
Autoregularory reserve is exhausted between 85% and 90% stenosis, with 90% 
stenosis giving slight reductions in flow even under resting conditions. 
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Figure 3-3 – Coronary Flow Reserve.  The dotted line describes the coronary flow 
at maximal vasodilation and the solid line the flow at rest.  Each solid circle 
corresponds to a different percentage degree of coronary stenosis.  Reproduced 
from (41) 
 
The MPR is an analogous measure to CFR based on MBF measurements 
made in the myocardium itself.  The relationship between coronary stenosis and 
MBF is more complicated than that for coronary flow, due to the high 
interconnectivity of the arterial pathways and the possibilities for 
collateralization.  However MPR can be taken as a measure of the ability of the 
entire coronary and myocardial system to maintain blood flow in the event of 
coronary stenosis and has been shown to be a good measure of the presence 
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of CAD (Table 3-1). 
 
3.4.4. Electrocardiogram (ECG) 
P
Q
R
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T
Atria repolarise
Ventricles depolarise
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Ventricular 
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Figure 3-4 – Normal ECG plot.  The P wave corresponds to the depolarisation of 
the AV node and atrial contraction.  The QRS complex corresponds to the 
simultaneous repolarisation of the atria and depolarisation and contraction of 
the ventricles (systole).  The T wave corresponds to repolarisation of the 
ventricles. 
 
The pacing of heart contraction is controlled by a network of specialised fibres; 
the autorythmic fibres.  An electrical action potential initiated by the sinoatrial 
(SA) node is conducted down the heart, through the atria (causing them to 
contract first) and finally to the Purkinje fibres which rapidly conduct the 
potential from the apex of the heart upward causing ventricular contraction.  The 
passage of these potentials through the heart generates current that can be 
detected by electrodes placed on the surface of the body.   The resulting plot is 
known as the electrocardiogram (ECG) and has peaks and troughs 
corresponding to the electrical stimuli that cause the heart to beat.  
Abnormalities in the ECG trace can be correlated with a range of cardiac 
abnormalities.  Under stress conditions cardiac depression of the ST segment 
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(below baseline) is an indicator of ischaemia.  The ST segment represents the 
time when the ventricular fibres are depolarized and is depressed when the 
heart is receiving insufficient oxygen.  The ECG test is easy to perform and is 
often the first test performed when patients present with chest pain but has 
limited diagnostic accuracy for ischaemic heart disease (sensitivity 73-90%, 
specificity 50-74%) (42). 
 
3.4.5. X-ray angiography 
X-ray angiography obtains images of the coronary artery tree and enables direct 
visualisation of coronary stenosis rather than the resulting perfusion defect.  In 
the operating theatre a radio-opaque catheter is inserted into an artery in the leg 
or arm and guided through the vascular system to the ostia of the coronary 
arteries in the ascending aorta.  The procedure is done under the guidance of 
fluoroscopy X-ray.  A relatively low dose (thus low image quality), X-ray movie is 
displayed to enable the cardiologist to navigate the catheter to the correct place.  
A short bolus of iodine based X-ray contrast agent (e.g Ultravist at around 370 
mg/ml Iodine) is then injected into either the right or left coronary artery whilst a 
higher dose, high quality X-ray movie is recorded for several heart beats.  The 
resulting movie can then be assessed to give a qualitative or quantitative 
assessment of the degree of stenosis.  An example of a stenosis imaged in this 
way is shown in Figure 3-2 a).  The coronary arteries bifurcate multiple times 
and the artery routes are tortuous. Therefore, a single planar X-ray view may 
miss stenoses if they happen to be obscured by other arteries at a given 
imaging angle or if the stenosis does not manifest around the complete 
circumference of the artery wall.  For this reason multiple views of the coronary 
tree are taken ideally, using repeated contrast boluses or multi-detector 
systems.  Alternatively three-dimensional views of the coronary arteries can be 
acquired using a computed tomography (CT) angiogram.  Acquiring X-ray 
images from a range of imaging angles around the patient during the infusion of 
a radio-opaque contrast agent yields high resolution, 3D images of the coronary 
arteries.   
 
Routinely a visual, qualitative analysis of the degree of stenosis is made from 
the X-ray angiogram, expressed as the percentage narrowing relative to the 
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adjacent, healthy lumen size.  Quantitative coronary angiography (QCA) makes 
a measurement or the degree of stenosis using semi-automated software (e.g. 
QCAPlus software, Sanders Data Systems, Palo Alto, California, USA).  A line 
is drawn manually along the artery through the stenotic region.  The software 
then expresses the narrowest part of the defined region as a percentage of the 
healthy artery lumen, calculated from the outer portions of the selected artery 
length.   
 
X-ray angiography is the gold-standard assessment for the diagnosis of 
coronary artery disease and the presence and severity of coronary stenosis. In 
clinical practice, angiographic stenosis severity is often also assumed to 
correlate with myocardial ischaemia.  However, there are a number of important 
limitations, which should be understood.  Firstly there are problems regarding 
the acquisition and interpretation of the data.  Qualitative analysis of X-ray 
angiography is associated with significant observer variability (43,44).  The 
variability can be improved by using quantitative analysis (45), however 
significant variability has also been found between QCA software 
implementations (46).  QCA is also susceptible to errors when there is diffuse 
disease as the „normal‟, unstenosed lumen diameter is difficult to locate (47).  
Furthermore the assumption that arterial flow reduction is correlated with 
stenotic diameter is too simplistic.  Models taking into account stenosis size and 
length and allowing for the additive value of multiple stenoses have been 
validated but these are complicated and difficult to introduce into routine clinical 
practice (48).  These limitations can be overcome by measuring the fractional 
flow reserve (FFR) across the stenosis.  To make this measurement a sensor 
on the tip of the wire is used to measure pressure and flow before and after the 
stenosis giving a direct measurement of the impact of the stenosis on coronary 
blood flow.  FFR measurements are becoming more common in research 
studies using angiography as the gold-standard.      
 
Secondly, the assumption that a reduction in arterial flow is directly linked to a 
resultant and proportional reduction in myocardial blood flow (MBF) is too 
simplistic.  The ability of the cardiac system to utilise collateral arteries in the 
presence of stenoses means that some stenoses may not manifestly reduce 
MBF at all.  Conversely there are cases of patients exhibiting the symptoms of 
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ischaemic heart disease, including myocardial perfusion defects, with no 
detectable coronary stenoses; the so called „Syndrome X‟ (40). 
 
Finally, it is important to recognise the risks associated with X-ray angiography.  
The investigation has a small but significant morbidity and mortality at ~0.5% for 
procedural death, myocardial infarction or stroke. Furthermore, it involves 
ionising radiation with the subsequent risk of developing a solid tumour 
estimated at 1 in 2500 (49,50). 
 
3.4.6. Single photon emission computed tomography (SPECT) 
Gamma camera
 
Figure 3-5 – SPECT – Multiple planar gamma camera images are taken at a range 
of viewing angles which can be reconstructed to generate a transaxial view of 
the distribution of radioactive tracer in the myocardium. 
 
Nuclear medicine based techniques use a radioactive tracer that is injected into 
the patient.  This can then be imaged using radiosensitive imaging equipment.  
Single photon computed tomography (SPECT) uses a gamma camera, 
mounted on a rotating gantry to acquire planar images representing the 
distribution of radioactive tracer within the patient at multiple viewing angles 
(Figure 3-5).  These planar views can then be reconstructed into cross-sectional 
views of the heart, typically using a filtered back-projection, or an iterative 
reconstruction method.  Unlike MRI perfusion, SPECT perfusion imaging does 
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not image the passage of contrast agent through the myocardium.  Rather the 
tracer builds up in the myocardial tissue over time with underperfused regions 
showing as a relative shortage of tracer and appearing as „cold spots‟ on the 
resulting image (Figure 3-6).   
 
 
Figure 3-6 – Transaxial SPECT images acquired at stress (rows 1 & 3) and rest 
(rows 2 & 4) in 10 slices through the heart.  A reversible perfusion defect in the 
anterior wall manifests as an under-perfused area at stress with normal 
perfusion rest.5  
 
Typical radio-tracers are Thallium-201, Tc99m methoxyisobutylisonitrile (MIBI) or 
Tc99m tetrafosmin, which are taken up by the myocytes.  All have shown similar 
sensitivities and specificities for detecting CAD, with Thallium-201 having worse 
image quality due to its lower energy gamma rays (51,52).  Stress can be 
achieved with physical exercise (using a treadmill or bicycle prior to imaging), 
but is commonly pharmaceutically induced with adenosise or dypridamole, 
achieving comparable diagnostic accuracies to exercise (53,54). 
 
                                            
5 Images provided by Dr Penny Thorley, Leeds Teaching hospitals 
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Myocardial SPECT imaging is susceptible to artifacts due to cardiac motion and 
tissue attenuation.  Heart wall motion can lead to underestimates in regional 
uptake and so acquisitions should be ECG-gated (55) as illustrated in Figure 
3-7. 
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Figure 3-7 – Cardiac SPECT ECG gating.  The ECG RR interval is broken down 
into N temporal bins.  Data acquired during each temporal bin from multiple RR-
intervals is averaged to create a series of images representing one heart beat. 
 
In order for gamma-photons to be detected they must pass from the heart 
through the body of the patient to the gamma camera.  Attenuation within the 
patient is a well recognised problem leading to poor image quality and, in some 
cases, mimics the appearance of perfusion defects.  In order to ameliorate 
attenuation artifacts CT imaging can be used.  The CT image, which represents 
the tissue densities of the image in Hounsfield units (HU), can be incorporated 
into the SPECT reconstruction to correct for tissue attenuation and significantly 
ameliorate attenuation artifacts.  Attenuation corrected SPECT data have been 
shown to improve agreement with PET studies (56) and to improve the 
specificity and sensitivity of the diagnostic test (57). 
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Cardiac SPECT images can be reported visually by simply locating „cold-spots‟ 
on the images.  However, semi-quantitative analysis of cardiac SPECT images 
is possible.  Typically multiple slices are represented as a single polar plot by 
dividing each slice into radial regions and taking the maximum pixel value.  
These polar plots are then normalised and compared to a database of pixel 
values from normal healthy patients and the difference used to automatically 
classify a given region as unhealthy or not.  Such methods have been shown to 
improve the detection of CAD from cardiac SPECT data (58–60).   
 
Cardiac SPECT is a well accepted and well validated technique.  However its 
resolution is relatively poor and subendocardial artifacts, visible in MRI, are not 
detectable.  It also exposes the patient to a radiation dose, which can be 
avoided with other modalities. 
 
3.4.7. Positron emission tomography (PET) 
In order to obtain an image that represents a planar transmission of gamma 
rays from the source distribution within the patient gamma cameras use parallel 
hole lead collimators.  The collimator successfully limits detection events to rays 
travelling perpendicular to the gamma camera but also reduces the count 
sensitivity of the system.  Positron emission tomography (PET) overcomes this 
fundamental limitation of the gamma camera by using coincidence detection.  
Radioactive tracers that decay by positron emission are used on PET imaging.  
After travelling a few millimetres an emitted positron annihilates with an electron 
creating two 511KeV gamma-rays travelling in opposite directions.  The PET 
scanner consists of a ring of detectors surrounding the patient.  When two 
detection events occur within the same temporal detection window (6-12ns) 
they are assumed to originate from the same annihilation event (Figure 3-8).  
The finite temporal window is necessary to allow for the different transit times of 
the two gamma rays.  The source of the annihilation event must lie along the 
line connecting the coincidence detectors.  A reconstruction algorithm is used to 
deduce the original radioactive source distribution from multiple lines of 
coincidence detected during a PET acquisition. 
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Figure 3-8 – Coincidence detection in PET.  A positron travels a small distance 
before annihilating with an electron to produce two 180o opposed gamma-rays 
which are detected within a small temporal window at two points in the PET 
detector ring.  The line connecting the two detectors is the line along which the 
annihilation event must have occurred.   
 
For quantitative myocardial perfusion PET imaging an intravenous injection is 
made of one of a variety of positron emitting tracers such as 82Rb, 13N-
Ammonia, 15O-Water.  Like SPECT tracers these cross the capillary walls and 
are taken up by the myocardial cells (myocytes).  Unlike SPECT however 
dynamic imaging is possible in PET, albeit with an inferior temporal resolution to 
MRI (~5s as opposed to ~1s in MRI).  The ability of PET to obtain dynamic 
transaxial views of the heart means that radioactivity counts vs. time plots can 
be generated.  Based on these tracer-kinetic models such as those described in 
chapter 4 can be used to calculate quantitative estimates of myocardial blood 
flow.  As with SPECT, attenuation is a significant factor and has to be corrected 
for using pre-PET CT scanning, or an equivalent transmission imaging 
technique (61).  Data must be corrected for radioactive decay and detector 
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dead-time.  With the exception of 15O PET tracers the extraction of tracer from 
the blood into the myocardium is reduced as the perfusion is increased.  The 
relationship between extraction and flow is non-linear and, if it cannot be 
corrected for using mathematical models, it leads to an underestimate in the 
estimated MBF (62).  Image resolution, though superior to SPECT, is still lower 
than MRI techniques and partial volume effects must be corrected for when 
trying to obtain separate arterial input function (AIF) and myocardial uptake 
curves from regions of interest (ROIs) placed on PET images.  PET is 
associated with a significant radiation dose (especially with the accompanying 
CT scan), which is a cause for concern, especially if repeated scans are 
necessary.   
 
PET measurements have been validated against  microsphere blood 
measurements in animal studies (63–67).  In a recent meta-analysis 
investigating the diagnostic accuracies of SPECT, PET and MRI, PET was 
found to achieve the highest diagnostic performance (AUC analysis), although 
CMR had the highest sensitivity at 89% (68) and other studies have shown 
comparable performances (69).  On the basis of such evidence quantitative 
PET MBF values have been used as a reference standard against which to 
compare MR MBF estimates.  In the absence of more absolute measurements 
of MBF in humans this is a strong reference measure for justifying any MRI 
methodology.  However, care should be taken in the interpretation of PET 
measurements.  PET based diagnostic accuracy studies have found that the 
optimal hyperaemic MBF cut-off values for diagnosing CAD is dependent on 
PET methodology and tracer (62,70,71).  This suggests that PET MBF 
estimates are strongly correlated with CAD, but not absolute measures of the 
true MBF.  The same argument is true for quantitative CMR measurements and 
so this is not an argument for the superiority of MRI, but care should be taken 
when „validating‟ any MBF estimate against PET.  A set of MBF measurements 
that reflect disease status but do not fall in the same MBF range as the PET 
measurements should not be classed as incorrect on that basis. 
 
3.4.8. Echocardiography 
Echocardiography refers to the application of ultrasound imaging to the heart.  
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Ultrasound generates images using a transducer that generates and records 
high frequency sound signals.  Sound waves, travelling at different speeds in 
different tissues reflect from tissue interfaces and are recorded by the 
transducer.  These recorded echoes are used to build up images of the tissue 
surfaces.  Perfusion measurements with echocardiography have been made 
possible through the development of ultrasound contrast agents.  These consist 
of microbubbles which are highly reflective to ultrasound signals.  These 
contrast agents have been used in dogs to show that measurements of the 
transit times of the bubbles through the myocardium can reflect MBF in dogs 
with artificially occluded arteries (72).  The method was later shown to have a 
comparable diagnostic performance to SPECT in humans (73).  As a non-
ionising imaging alternative the method shows promise, however, to date the 
method is in use in research studies only and larger clinical trials are required 
before it can to be accepted into clinical practice. 
 
3.4.9. Computed tomography (CT) 
By far the most common use of CT in the context of myocardial ischaemia is CT 
angiography, described briefly in section 3.4.5.  However, CT based quantitative 
myocardial perfusion estimates are also possible, though rarely performed, 
using iodine based contrast agents and electron beam CT (EBCT), also known 
as ultrafast CT.  Conventional CT mechanically moves the X-ray tube around 
the patient in order to rapidly generate multiple viewing angles.  In EBCT 
electromagnetic coils are used to direct a beam of electrons onto any given 
point on a ring shaped tungsten target surrounding the patient.  It is the impact 
of the electrons onto this circular target which generates the X-rays for imaging.  
The reduction in mechanical moving parts involved in EBCT  enables images to 
be acquired much more quickly and makes the temporal resolution necessary 
for CT based perfusion imaging possible.  An iodine based contrast agent is 
injected into the patient and dynamic images are acquired.  MBFs can be 
quantified using similar models to those described in chapter 4.  The method 
has been validated in animal studies against radioactive microspheres (74) and 
in humans against SPECT (75,76) with promising results.  However the method 
does underestimate MBF at high flow rates.  Although EBCT systems are the 
fastest CT scanners they are expensive and there are comparatively few 
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imaging systems in use.  This fact, combined with the significant radiation dose 
associated with dynamic CT, makes the future of CT based cardiac perfusion 
measurements uncertain. 
 
3.4.10. Magnetic resonance imaging (MRI) 
Perfusion imaging in MRI uses a gadolinium based MR signal enhancing 
contrast agent.  Dynamic images, captured every RR-interval, show the 
passage of the contrast agent bolus through the heart.  For quantitative analysis 
regions of interest (ROIs) drawn over the myocardium and within the blood pool 
are used to generate signal vs. time uptake plots.  These data are analysed to 
generate estimates of blood flow.  The imaging process is described in greater 
detail in section 2.8 and a description of the models used to estimate MBF is 
given in chapter 4. 
 
Many studies have correlated quantitative and semi-quantitative analyses of MR 
perfusion estimates with microsphere measurements in animals (5,77–81) and 
against PET measurements in humans (5,29,80,82).  One of the reasons for so 
many validation studies is due to the lack of standardization in the MR 
approach.  The choice of imaging sequence, contrast agent injection scheme 
and analysis methodology for MBF estimation may all affect the final result.  
One of the aims of this thesis is to provide evidence for standardisation in MR 
perfusion analysis schemes.  The reproducibility of MR derived perfusion 
measurements has also been evaluated (83–86).  The results are not excellent, 
with only good to moderate reproducibility, but this performance is no worse 
than PET reproducibility values (87,88). 
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Ref No. 
patients 
MR assessment 
method 
X-ray 
assessment 
method 
Sensitivity Specificity 
(89) 42 Visual > 50% stenosis 0.85 0.67 
(90) 79 Visual > 50% stenosis 0.91 0.62 
(91) 30 Visual > 50% stenosis 0.79 0.83 
(3) 533 Visual > 50% stenosis 0.67 0.61 
(92) 136 Visual > 70% stenosis 0.85 0.88 
(93) 104 Visual > 70% stenosis 0.90 0.85 
(94) 75 Visual > 70% stenosis 0.93 0.75 
(95) 40 Visual > 70% stenosis 0.81 0.68 
(96) 101 Visual > 70%, (> 50% 
LMS)  
0.91 0.94 
(2) 752 Visual > 70%, (> 50% 
LMS) 
0.86 0.83 
Visual analysis average values 0.81 0.76 
(97) 44 Semi-quantitative > 50% stenosis 0.93 0.75 
(98) 43 Semi-quantitative > 50% stenosis 0.88 0.90 
(99) 48 Semi-quantitative > 50% stenosis 0.88 0.85 
(100) 92 Semi-quantitative > 70% stenosis 0.88 0.82 
(101) 20 Semi-quantitative > 75% stenosis 0.90 0.83 
(102) 84 Semi-quantitative > 75% stenosis 0.88 0.90 
(103) 31 Semi-quantitative FFR distinguish in 
range 50% - 75% 
0.88 0.87 
Semi-quantitative average values 0.89 0.85 
(91) 30 Quantitative > 50% stenosis 0.88 0.67 
(104) 37 Quantitative > 50% stenosis 0.85 0.49 
(103) 31 Quantitative FFR distinguish in 
range 50% - 75% 
0.77 0.86 
Quantitative average values 0.83 0.66 
Table 3-1 – Table summarising diagnostic performance studies for CMR against 
X-ray angiography.  Averages, weighted for study population, are shown for 
studies with visual, semi-quantitative and quantitative CMR data analysis. 
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The diagnostic accuracy of MR perfusion measurements has been assessed in 
a number of investigations summarized in Table 3-1.  The studies are grouped 
in terms of whether the CMR analysis was performed using visual, semi-
quantitative or quantitative analyses.  It is difficult to say whether this data 
represents an improved diagnostic performance with semi-quantitative and 
quantitative methods over visual analysis.  Indeed the fully quantitative scores 
reported here appear to have a lower diagnostic accuracy.  One of the 
motivating factors for pursuing quantitative over semi-quantitative methods is 
due to the reported non-linearity of semi-quantitative MBF estimates with 
increasing MBF.  In a comparison of semi-quantitative and quantitative 
perfusion methods Christian et al. found that, whereas quantitative MBF 
measurements agreed well with microsphere measurements in animals, semi-
quantitative measurements substantially underestimated hyperaemic MBFs 
(77).  However, these reported improvements in the quantitative approach have 
not propagated into an improvement in diagnostic accuracy detectable in the 
studies presented in Table 3-1. 
 
There is still no consensus on an ideal protocol for acquiring DCE-MRI data for 
quantitative perfusion and imperfect data may be one reason for a lack of 
improvement with quantitation.  For instance, of the three quantitative studies in 
Table 3-1, two studies (103,104) use a contrast dose that has been shown to 
lead to non-linearity effects and overestimates of MBF (105), without attempting 
to apply a correction.  One of the motivations for quantitation is the detection of 
triple-vessel disease where the entire myocardium is similarly under-perfused.  
In this case visual detection of a perfusion defect is difficult whereas, 
quantitative analysis has been shown to be able to detect triple-vessel disease 
and to distinguish the increased ischaemic burden between single and triple 
vessel disease (91).  As the incidence of 3 vessel disease is relatively small, 
another reason for the lack of a detectable improvement may be that the studies 
are underpowered to show such differences, particularly given the variety of 
acquisition protocols used.   
 
Two large trials assessing the diagnostic performance of CMR with respect to 
SPECT, using X-ray angiography as the reference standard have recently been 
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published.  The MR-IMPACT II trial (3) assessed 533 patients and achieved a 
sensitivity of 0.67 and 0.61, with CMR achieving a superior sensitivity but 
inferior specificity to the SPECT performance in that trial.  The CE-MARC trial 
(described in detail in section 5.2.1) is the largest clinical CMR trial to date and 
recruited 752 patients.  CMR achieved a sensitivity and specificity of 0.86 (0.82, 
0.90) and 0.83 (0.79, 0.87) respectively, outperforming SPECT sensitivity but 
not specificity.  These trials provide much needed, large patient cohort evidence 
supporting the wider use of CMR in the clinical investigation of CHD.  However, 
both trials evaluated the CMR data with visual analysis only.  A well conducted 
quantitative analysis of a trial of this size would provide more persuasive 
evidence as to the impact of quantitation on diagnostic accuracy. 
 
3.4.11. The AHA mapping 
In 2002 Cerquieira et al (106) published recommendations for a standardized 
myocardial segmentation and nomenclature for tomographic imaging of the 
heart, which has been widely applied in the cardiac imaging community.  For 
imaging modalities that represent myocardial perfusion a segmentation model is 
recommended that subdivides the imaged myocardium into 17 separate 
segments (Figure 3-9).  The 17th segment corresponds to the apical cap, which 
is frequently discarded from investigations as it requires a separate long-axis 
acquisition (with associated scanning time) and is often too thin to provide any 
meaningful information.  A diagnosis of ischaemia can be made by simply 
considering whether the MBF in any of the segments falls below a certain value, 
or visually appears hypoperfused.  However the AHA mapping associates each 
of the 17 segments with one of the three coronary arteries (Figure 3-9 c) 
meaning that in principle a separate diagnosis for each coronary artery could be 
made or the perfusion image could be used to deduce the location of the 
coronary stenosis.  In fact the coronary architecture varies from patient to 
patient and so the validity of this mapping will depend on the patient in each 
case, with the greatest variability at the apical cap which can in fact be supplied 
by any of the three arteries.  Nevertheless, in the absence of separate images 
of the coronary arteries registered to the perfusion dataset the AHA mapping is 
the closest approximation to knowing which artery provides each territory.  
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Figure 3-9 – The AHA segmentation model.  Three transaxial imaging slices and 
a long-axis view (a) are subdivided into a 17 segment bulls-eye view (b).  This 
can be used to each territory to the corresponding coronary artery (c). 
 
3.4.12. The role of CMR in diagnosing myocardial ischaemia 
MR perfusion imaging is now proven to be as good as SPECT (the most 
commonly used test) in diagnosing ischaemic heart disease, with the largest 
current clinical trial reporting an improvement in diagnostic sensitivity (2).  There 
is reason to believe that CMR should out-perform nuclear medicine techniques 
due to its superior image resolution.  Typically image resolution for SPECT is 
10mm, with PET achieving 6mm.  CMR achieves 3mm as standard with studies 
incorporating techniques such as temporal under-sampling achieving 1.5mm 
image resolution (107).  This gives MR the ability to detect subendocardial 
defects, which has the potential to increase its sensitivity for detection of CAD 
(108).  A significant advantage of the MRI investigation, which can often be 
overlooked when making direct comparisons of diagnostic performance, is the 
versatility of investigations that can be performed in a single imaging session.  
In a one hour CMR investigation images for investigating cardiac perfusion, 
wall-motion abnormalities, tissue viability and MR angiography images of the 
coronary arteries themselves can be obtained without the patient moving from 
the investigation couch (109,110).  This so called „one-stop‟, comprehensive 
investigation is more convenient for the patient and has the potential to be more 
cost-effective.  The lack of ionising radiation exposure with MR is also a 
significant advantage, and enables longitudinal measurements to be made 
without concerns of increasing radiation exposure.   
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There are however disadvantages with MR.  Patients with non MR safe 
implants are contraindicated and the recent concerns over the link between 
gadolinium contrast agents and nephrogenic systemic fibrosis (NSF) mean that 
renally impaired patients are contraindicated for gadolinium based contrast 
agents (111–114).  Due to the nature of the image acquisition MR is prone to 
image artifacts that are often not intuitive and can obscure images entirely, 
rendering them unfit for diagnostic purposes.  Peculiar to DCE-MRI cardiac 
perfusion imaging is the dark rim artifact (DRA) which mimics the appearance of 
a perfusion defect, although experienced observers can distinguish the two.  
There are a number of potential causes of the artifact (see section 2.9) but they 
are reduced with increasing resolution (107) and the continuing improvements 
in this area have the potential to reduce their impact substantially.  Finally, MRI 
is an expensive investigation to perform.  However, due to the number 
investigations it can perform in a single visit, it may still be a cost-effective 
alternative to other perfusion assessment methods.   
3.5. Summary 
Coronary heart disease and myocardial ischaemia have been described along 
with the current treatments and interventions for these conditions.  The 
techniques for diagnosing CHD and ischaemia have been described and the 
advantages and disadvantages of each modality have been discussed.  An 
analysis of the diagnostic accuracy of cardiac perfusion DCE-MRI has been 
presented in terms of visual analysis as well as considering semi-quantitative 
and quantitative analysis methods.  The methods for estimating myocardial 
blood flow using semi-quantitative and quantitative analysis of cardiac DCE-MRI 
perfusion data is the subject of the next chapter.  
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4. Quantitative myocardial perfusion 
4.1. Introduction 
Previous sections have described how the MRI dataset of the contrast agent 
passing through the heart is acquired and how the resulting data series is 
processed to generate an uptake curve (chapter 2).  This section provides a 
background to understanding some of the methods employed to estimate 
myocardial blood flow (MBF) based on this uptake curve.  After a brief 
description of semi-quantitative methods a description of deconvolution 
approaches is given.  A description of tracer kinetic model based MBF 
measurements is then given including a description of each of the methods 
compared in chapter 9. 
 
4.2. Semi-quantitative analysis  
Semi-quantitative methods do not attempt to make absolute measurements of 
myocardial blood flow (MBF).  Rather they measure some property of the 
uptake curve that is thought to correlate with MBF.  Figure 4-1 illustrates some 
of the key curve parameters.  These have been interpreted as semi-quantitative 
measures of MBF in a variety of ways, some of which are described below: 
Contrast enhancement ratio (CER) is expressed as: 
    
                 
        
 
Equation 4-1 
 
Where SIpk_myo is the peak of the myocardial uptake curve and SIbl_myo is the 
pre-contrast baseline.  This is a measure of peak enhancement, i.e. the 
maximum effect of the contrast agent on signal intensity, after accounting for 
the native signal intensity.  Consequently CER is a measure of the 
accumulation of contrast agent but takes no account of the rate of delivery or 
clearance of contrast agent, and so should not be expected to correlate well 
with MBF. 
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Figure 4-1 – Semi-quantitative analysis parameters.  Diagram showing the 
baseline (SIbl) and peak height SI values for the AIF (SIpk_AIF) and myocardium 
(SIpk_myo) as well as the AIF (USAIF) and myocardial (USmyo) up-slopes and the area 
under the myocardial curve up to the AIF peak position (AIFmyo). 
 
Upslope Index is the ratio of the AIF and myocardial up-slopes i.e. 
     
     
 .  
The individual up-slopes are calculated by a „sliding window‟ method.  A straight 
line is fitted to n contiguous time points from t1 to tn and the gradient measured.  
The procedure is then repeated for time points ti to ti+n for i=1:Nt-n, where Nt is 
the number of time points in the sequence.  The maximum calculated straight 
line gradient is then taken as the up-slope.  The up-slope of the myocardial 
curve is intuitively linked to flow.  As the rate of flow increases the rate of 
change of signal due to contrast agent will increase.  However, the shape of the 
myocardial uptake curve, and therefore its up-slope, depends on the shape of 
the AIF.  In an attempt to factor this in to the perfusion measurement the 
myocardial up-slope measurements are normalised by dividing by the AIF up-
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slopes.  The problem is that the up-slope is an obviously limited measure of the 
full curve shape.  The relationship between AIF and myocardial curves can only 
be fully accounted for using fully quantitative, deconvolution based methods.    
 
Area under the curve (AUC) measures the area under the myocardial uptake 
curve from the bolus arrival time (BAT) to the point corresponding to the peak 
enhancement in the AIF, tAIF_pk.  The AUC will be more sensitive to different 
aspects of the uptake curve shape than the up-slope method, however it 
incorporates no measurement of the AIF and is therefore susceptible to 
changes in AIF which depend on a range of factors other than MBF, such as 
injection rate, bolus volume, and the degree of dispersion within the vasculature 
prior to reaching the heart. 
 
The AUC method has been correlated with quantitative MBF measurements in 
animals (115) and the up-slope index has been shown to be a diagnostically 
sensitive measure of CAD in humans (see Table 3-1).  However in a 
comparison of semi-quantitative and quantitative methods significant non-
linearities between semi-quantitative measurements and microsphere 
measurements were found in dogs (77).  In general the semi-quantitative 
measures began to underestimate MBF at higher flow rates.  This plateauing 
occurred at around 1ml/min/g with CER, 2ml/min/g with upslope index and 
3ml/g/min with AUC.  This was reflected in the linear correlation scores, CER 
(r=0.75), upslope index (r=0.69) and AUC (r=0.89).  However, the 
corresponding quantitative Fermi deconvolution based correlation was excellent 
at r=0.95.  The study illustrates how semi-quantitative measures can achieve a 
strong diagnostic performance in clinical trials, by virtue of their significant 
correlation with flow, without achieving an absolute quantification of MBF. 
 
4.3. Quantitative analysis 
4.3.1. The central volume principle 
The fundamental measurement on which quantitative perfusion estimates are 
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based is the signal intensity at a given time t in the myocardium.  This is related 
to contrast agent concentration (see section 2.7) so that we have an estimate of 
the quantity of contrast agent in the myocardium at time t, Cmyo(t).  For the most 
simple perfusion analysis the myocardium is represented as a single 
compartment with an arterial input of concentration Ca(t) at time t, and venous 
output Cv(t).  Such a representation is model-independent in the sense that no 
functional tissue structure is specified.  If the system is closed and stationary ( 
Figure 4-2) then, from the principle of mass balance the amount of tracer within 
the compartment is simply the difference between the amount of tracer washed 
into the compartment and that washed out: 
        
  
                   
Equation 4-2 
The contrast agent resides in the blood plasma and cannot penetrate the red 
blood cells in the blood.  Ca and Cv are plasma concentrations, as opposed to 
blood concentrations, that can be related to the concentration in the blood, Cb, 
via the hematocrit (Hct) which is a measure of the percentage volume of red 
blood cells in the blood: 
             
Equation 4-3 
 
F is the flow rate of blood plasma through the compartment. 
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Figure 4-2 - A single compartment model.  It is a closed system in that it has a 
single input Ca(t) and output Cv(t).  The system is stationary if the distribution of 
flows f1:N remains constant over the duration of the measurement.  The system is 
linear if the response of the myocardial tissue to an injected dose is linearly 
proportional to that injected dose.  
 
For any linear and stationary system the outflow concentration can also be 
expressed as a convolution of the inflow concentration with transfer function h(t) 
(116,117): 
            
 
 
         
                 
Equation 4-4 
The symbol „*‟ represents the convolution operation.  The transfer function h(t) 
represents the frequency distribution of transit times in the compartment, i.e. the 
distribution of times taken for CA molecules to traverse the compartment.  By 
substituting this expression for Cv(t) into Equation 4-2 an expression for Cmyo(t) 
that is independent of Cv(t) (which we cannot measure) can be written: 
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Equation 4-5 
Introducing the flow weighted impulse response function Rf(t): 
                  
 
 
          
 
Equation 4-6 
Equation 4-4 becomes: 
                     
Equation 4-7 
R(t) is the tissue response function which represents the fraction of contrast 
agent  that remains in the compartment at time t, where t=0 corresponds to the 
time of injection.  By this definition, at time zero, it has value one (R(t=0) = 1) 
signifying that no tracer can instantaneously traverse the ROI.  Therefore from 
Equation 4-6 Rf(t=0) = F.  This means that if Equation 4-7 can be solved for Rf(t) 
then it is possible to estimate the flow by evaluating Rf(t=0). 
 
4.3.2.  Deconvolution 
If estimates for Cmyo(t) and Ca(t) are obtained from ROIs placed over the 
myocardium and the left ventricular blood pool in the dynamic image series then 
it might be expected that it would be possible to solve Equation 4-7 by 
performing deconvolution.  However, deconvolution is a mathematically ill-
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posed problem.  This means that there are multiple solutions for Rf(t) that give a 
good fit to the same data set.  In practice this means that very small changes in 
Ca(t) or Cmyo(t) yield large changes in the resulting Rf(t).  It is easier to 
understand why this is so if one considers the Fourier convolution method for 
performing deconvolution in the Fourier domain.  The Fourier convolution 
theorem states that convolution in the time domain is equivalent to point-wise 
multiplication of the Fourier transforms of the two quantities in the convolution 
integral: 
                     
                            
Equation 4-8 
Where      represents the Fourier transform of x.  Thus the flow weighted 
response function can be calculated as follows: 
       
   
          
        
  
Equation 4-9 
As Ca(t) will be a smoothly varying function          will contain some 
frequencies with zero, or very small amplitude, giving infinite, or very large, 
corresponding values in Rf(t) (118).  Hence the solution described in Equation 
4-9 is unstable. 
 
4.3.3. Fermi-constrained deconvolution 
In cardiac perfusion the most widely accepted method for constraining Equation 
4-7 is to represent Rf(t) as a Fermi function, which is a three parameter 
monotonically decaying curve (119,120): 
      
 
    
     
 
 
Equation 4-10 
Once the form for Rf(t) has been defined like this the deconvolution problem 
becomes a matter of finding the parameters for Equation 4-10 that best fit the 
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given Cmyo(t) after convolution (Equation 4-7). Thus the deconvolution process 
is reduced to a three parameter fit, which can be approached robustly with 
linear least squares fitting techniques.  The Fermi function is a decreasing 
exponential with a shoulder near t=0.  The early flattening of the curve allows 
for the initial filling stage of the compartment and the later exponential fall off is 
due to the decreasing fraction of CA left in the compartment with increasing 
time.  Fermi-constrained deconvolution can be described as parametric 
deconvolution, as it provides a parametrisation of the response function which is 
not based on an underlying model of the tissue structure.  The choice of the 
Fermi-function to constrain the data is empirical, not theoretical.  It has a shape 
that resembles response functions derived using detailed models of the 
vasculature or those derived using model-independent methods (section 4.3.4), 
but it is not based on a theory of indicator passage through the myocardium.  In 
practice Fermi-constrained deconvolution only performs comparably with other 
models if the data is limited to the first-pass only.  Failure to reduce the data 
before fitting this way results in a 25% overestimate in blood flow with the Fermi 
model (4).   
 
4.3.4. Model independent analysis 
Model-independent deconvolution methods perform deconvolution without 
inherently assuming a structure for Rf(t).  Rather than imposing a theoretical 
model or a given parameterisation on the response function these models only 
impose general side constraints on the solution to Equation 4-7.  This can be 
done by posing the problem as a matrix inversion problem and adding an 
additional side constraint.  Expressing the convolution in Equation 4-7 as the 
convolution integral: 
                        
 
 
 
Equation 4-11 
Adopting the convention that the value of a vector Rf at the ith time point is Rfi,  
Equation 4-11 can be discretised as follows: 
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Equation 4-12 
Where A is a matrix constructed of the N elements of Ca(t) such that matrix 
multiplication with A performs convolution with Ca(t): 
   
      
        
    
            
     
Equation 4-13 
Thus: 
          
Equation 4-14 
And the solution for Rf(t) can in principle be obtained by inverting A: 
    
        
Equation 4-15 
Again this is an ill-posed problem and Equation 4-15 yields unstable solutions 
for Rf(t).  Posed as a matrix inversion problem, singular value decomposition 
(SVD) can be used to find the best solution to Equation 4-15 in the least 
squares sense.  We seek the response function that minimises: 
               
 
  
Equation 4-16 
Equation 4-16 is in the correct form to apply the SVD to find Rf(t) (121)(122) : 
              
        
  
         
  
    
  
   
 
Equation 4-17 
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where ui and vi represent the i
th columns of the output matrices from the SVD 
algorithm U and V respectively and σi represents the i
th value along the leading 
diagonal of Σ, of length s, that is the ith singular value. Equation 4-17 gives the 
closest solution to Equation 4-16 in the least squares sense.  However if there 
are small singular values in σ then very large values will be generated in the Rf 
and the solution will show large spurious oscillations (81).  The problem can be 
tackled using truncated SVD where only singular values up to a certain cut off 
(Ns < N) are included in Equation 4-17. 
     
An alternative method for regularizing the solution, frequently utilised in the 
cardiac perfusion literature (81,123), is that of Tikhonov regularization (121), 
which incorporates an additional side constraint into Equation 4-16.  The matrix 
L applied to Rf incorporates an additional constraint, dependent on the response 
function, into minimisation: 
                     
 
           
 
  
Equation 4-18 
Typically L is the identity matrix, but the first order differential matrix can also be 
used, in which case the solution is constrained by the temporal gradient of the 
response function which forces the solution to be smooth to a degree dictated 
by the value in the coefficient λ.   
 
Truncated SVD and Tikhonov regularization both provide a framework for a 
generalised, model-independent solution to Equation 4-17.  However they are 
both critically dependent on a single parameter (the cut-off point Ns for TSVD 
and the parameter λ in Tikhonov regularization).  A common approach for 
finding the optimal value for these parameters is L-curve analyses (121) which 
is described in the context of Tikhonov regularization as follows.  The technique 
plots the two components of Equation 4-18 over a range of values of λ, on a log 
scale.  When the smoothness constraint is dominant there is a large change in 
         as λ  changes.  Conversely when the unconstrained solution is 
dominant                   change rapidly with λ .  The resulting plot has an 
„L‟ shape, hence „L-curve‟ analysis (Figure 4-3), with the optimal value for λ at 
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the corner of the „L‟, i.e. at the maximum point of curvature. 
 
Figure 4-3 – L-curve analysis - the y-axis (log||Lx||) shows the smoothness 
constraint alone, whilst the x-axis plots only the unconstrained solution log||Ax-
y||.  The ‘x’ marks the optimal λ value where neither component is dominant. 
 
Model-independent analysis is completely model free, in that the response 
function can take any form.  Therefore the entire dataset (as opposed to just the 
first-pass in Fermi-analysis) can be incorporated into the analysis.  However, 
the lack of any constraint, apart from smoothness, on the response function 
means that unphysiological response functions (that create good fits but 
extreme MBF estimates) can be generated.  The method described here has 
been validated in human volunteers (6).  Previous validation against radioactive 
microsphere measurements in pigs was performed using a similar model-
independent strategy that represented the response function as a sum of B-
splines before applying Tikhonov regularization (81). 
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4.3.5. Tracer-kinetic modelling   
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Figure 4-4 – Contrast agent enters through a single input with concentration Ca(t) 
and leaves with concentration Cv(t).  Contrast agent flows across the capillary 
membrane from the vascular space to the extravsacular, extracellular space 
(EES).  Contrast agent cannot pass through cell membranes into the intracellular 
space. 
 
Parametric deconvolution methods (such as Fermi) and model-independent 
techniques attempt to find a response function to relate Ca and Cmyo without any 
theoretical consideration of the form of the response function.  Tracer-kinetic 
modelling approaches pose an analytic form for the response function based on 
a set of assumptions about the tracer-kinetic properties of the tissues (124).  
Depending on the complexity of the model they can generate other 
physiological parameters describing the nature of the perfused tissue, such as 
the volumes of the vascular and extravascular spaces.  However care must be 
taken that the assumptions made in the derivation of the model hold true in all 
cases of application and that the data is of sufficient quality to derive robust 
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measurements of the parameters, as more complex models can over-fit data 
and generate results which are physiologically non representative. 
 
Gd-DTPA is an extravascular contrast agent and as such leaks from the 
vascular space (inside capillaries and arteries) into the extravascular, 
extracellular space (the tissue space outside the vasculature also known as the 
interstitium) but not through cell membranes into cells (the intracellular space), 
except in necrotic cells.  Figure 4-4 illustrates these spaces and denotes the CA 
concentrations and volumes of each of the spaces accordingly.  The process 
can be modelled using the two compartment exchange model (2CXM) 
illustrated in Figure 4-5.   
vp ve
Fp
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Figure 4-5 – The two compartment exchange model.  Contrast agent flows at a 
rate Fp into the vascular space of volume fraction vp.  Indicator leaks between the 
vascular space and the EES (volume fraction ve) at a rate dictated by the product 
of the capillary surface area S and permeability P.  
 
Plasma flows at a rate Fp into the vascular space and out at the same rate.  
Whilst in the vascular space, indicator passes through capillary walls at a rate 
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dictated by the product of the capillary surface area S and the capillary 
permeability P.  The volume fraction of the vascular space and EES are defined 
relative to the volume of the tissue region: 
   
    
    
 
   
    
    
 
In the previous discussion a compartment was a space across which indicator 
could traverse with a distribution of transit times.  In this context the definition of 
a compartment becomes a well mixed space into which contrast agent 
instantaneously and homogeneously mixes.  Once this has been established 
systems of equations defining the rate of change of indicator in each 
compartment can be constructed by employing conservation of indicator mass 
which states that no indicator is created or destroyed inside the tissue.  Hence 
the rate of change of indicator for a given compartment must be the difference 
between the influx and outflux from the compartment.  The outflux from any 
compartment is equal to concentration of CA in that compartment multiplied by 
the flow rate.  Applying these principles to Figure 4-5: 
  
     
  
                                   
Equation 4-19 
  
     
  
                    
Equation 4-20 
 
The two compartment model has a bi-exponential impulse response function 
(125) and can be used for uptake curve fitting.  However in general, and 
particularly in the heart, much simpler models are used. 
 
4.3.6. One compartment (    ) 
Capillary permeability in the myocardium is high.  If permeability is high enough 
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the two compartment model becomes flow limited and it is not possible to derive 
permeability figures from the model because effectively all indicator that arrives 
permeates the capillaries immediately.  In this case the vascular space and 
EES become one compartment with a concentration Cmyo: 
                        
Equation 4-21 
If we assume that the indicator is instantaneously and well mixed, and that there 
is only a single compartment then the venous output concentration will be 
equivalent: 
                  
Equation 4-22 
      
       
     
 
  Equation 4-23 
Now utilising the original equation for the one compartment model Equation 4-2: 
        
  
           
       
     
 
Equation 4-24 
Equation 4-24 is an inhomogeneous, first-order linear differential equation with 
constant coefficient, for which an equation of the form: 
  
  
              
Has the solution: 
                         
Therefore, setting          , Equation 4-24 has the solution: 
                 
 
  
     
 
 
Equation 4-25 
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4.3.7. The uptake model 
The model can be simplified even further by removing the venous outflow from 
the model such that: 
        
  
         
Equation 4-26 
This model only holds in the early stages of contrast uptake in the myocardium 
when the finite transit time of the myocardium means that CA is entering but not 
leaving the compartment.  From Equation 4-26 it follows that: 
                  
 
 
 
Equation 4-27 
So that Fp can be measured plotting the integral of the AIF up to t against the 
myocardial concentration at t and taking the slope of the straight line fit to the 
data points.   
 
This is a very simple analysis method to perform.  The difficulty is in deciding at 
which time point the no venous output assumption ceases to hold.  This can be 
done by establishing the data set for which the best fit to the straight line is 
achieved (126).  A more pragmatic approach is to simply choose the peak of the 
AIF as the cut-off point (123). 
 
4.4. Summary 
This chapter has provided a description of some of the methods used for 
estimating myocardial blood flow in the heart.  Most of these methods are also 
used in other anatomies and imaging modalities.  However the emphasis here 
has been on the application of these methods to measure myocardial blood flow 
from cardiac perfusion DCE-MRI datasets only.  The chapter provides the 
underlying theory for the quantitative methods used in later chapters of this 
thesis.  In particular the models that are compared in chapter 9 have been 
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described in detail. 
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5. General methods 
5.1. Overview 
The research in this thesis is primarily based on data from two studies; the 
dual-phase study and the CE-MARC trial and the following chapters will refer 
to these datasets repeatedly.  The full methodologies and primary purposes 
of these two studies are outlined in section 5.2 in order to avoid unnecessary 
repetition in subsequent chapters.  In order to generate quantitative MBF 
estimates from these datasets contours depicting the myocardium, and a 
region within the left ventricular blood pool depicting the AIF, must be drawn.  
The contouring protocol used in this thesis is described in detail in section 
5.3.  All of the quantitative MBF estimates presented in this thesis were 
generated using automated curve pre-processing.  The algorithms used to 
automate pre-processing are described in section 5.4 and are tested for 
failures as assessed by human observation in section 5.5. 
 
5.2. Datasets 
5.2.1. CE-MARC 
Purpose 
The CE-MARC trial (2,23) was designed to establish the accuracy of a multi-
parametric cardiovascular magnetic resonance (CMR) protocol for 
diagnosing coronary heart disease against a reference standard of X-ray 
coronary angiography.  The trial also compared the diagnostic capabilities of 
CMR and nuclear medicine SPECT.  752 patients with suspected angina 
were assigned to the trial and 628 patients completed with assessable and 
available results in all three modalities (CMR, SPECT and X-ray 
angiography).  The trial concluded that CMR had a sensitivity of 86.5% and 
specificity of 83.4% and found a significant improvement in the sensitivity of 
CMR over SPECT in diagnosing CHD (2). 
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Method 
Out of 4065 consecutive patients  presenting at Pinderfields General 
Hospital or Leeds Teaching Hospitals with suspected angina pectoris 752 
were recruited to the trial.  Exclusion criteria were; previous coronary artery 
bypass surgery, crescendo angina, acute coronary syndrome or 
contraindication to CMR, adenosine or gadolinium based contrast agent.  
628 patients completed CMR, SPECT and X-ray angiography investigations 
and were included in the final analysis.  
R-R interval
Systole Diastole
90o
126ms
Mz
Saturation 
Pulse
272ms
418ms
time
basal middle apical
basal
middle
apical
  
Figure 5-1 – CE-MARC perfusion pulse sequence.  A single, shared 90o 
saturation pulse is used giving saturation times (TS) for the basal, middle and 
apical cardiac slices of 126ms, 272ms and 418ms respectively and resulting 
in different T1-weighting and cardiac phase for each of the three slices. 
 
Cardiac MRI 
For the MRI investigation patients were positioned supine on a dedicated 
cardiac research scanner (1.5T, Intera CV, Philips, Best, The Netherlands) 
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equipped with „Master‟ gradients (30mT/m peak gradients and 150mT/m/ms 
slew rate).  Signals were received with a 5 element cardiac phased-array RF 
coil and ECG gating and triggering was performed.  For the perfusion 
investigation patients were imaged using aT1-weighted saturation recovery 
turbo field echo (SR-TFE) imaging sequence.  Three slices were acquired 
with a single shared saturation pulse in order to fit the three image 
acquisitions in a single RR-interval.  Images were acquired with a linear k-
space ordering, with the central line of k-space acquired at 126ms for the 
basal slice, 272ms for the middle slice and 418ms for the apical slice.  Using 
a shared pre-pulse results in a different image contrast for each imaging 
slice as well as different cardiac phases for each slice.  The basal slice will 
be more systolic (and less T1-weighted) whereas the apical slice will have a 
stronger T1-weighting and will be imaged in the diastolic phase (See Figure 
5-1).   
No. lines of k-space in FAS 12 
Central line of k-space 21 
Partial Fourier 0.67 
TR/TE 2.7ms / 1.0ms 
Alpha (after FAS) 15o 
TS Basal 126ms, middle 272ms, apical 
418ms (from 90o pulse to central line 
of k-space) 
SENSE  Factor 2 
FOV 320mm – 460mm 
Typical matrix size 144x144 (reconstructed to 256x256 
by zero filling before reconstruction) 
Slice thickness 10mm 
Table 5-1 – Scan parameters for the CE-MARC perfusion imaging sequence 
 
The three slices were positioned according to the "3 of 5" technique (127). 
Pulse sequence parameters: TE 1.0 ms, TR 2.7 ms, flip angle 15°, SENSE 
factor 2, matrix 144 × 144, field of view 320–460 mm, slice thickness 10 mm 
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partial Fourier 0.67, resulting in a single slice acquisition time of 130ms 
(summarized in Table 5-1).  Imaging was carried out whilst a bolus 
intravenous injection of 0.05 mmol/kg dimeglumine gadopentetate 
(Magnevist®, Schering AG, West Sussex, UK) followed by a 15 ml saline 
flush was delivered through an arm vein at 5 ml/s using a power injector 
(Spectris®, Medrad, Pittsburgh, Pennsylvania).  The patient held their breath 
at end expiration timed to coincide with the first-pass of the bolus through 
the heart.  The patient was then directed to hold their breath for imaging for 
as long as possible thereafter and then to commence gentle breathing to 
minimise breathing motion as much as possible in subsequent image 
frames.  Stress was pharmacologically induced using an intravenous 
injection of adenosine administered at a dose of 140 mcg/kg/min. The 
patient's blood pressure was recorded every two minutes and the heart 
rhythm monitored on the vector-ECG. The perfusion study commenced 
approximately 4 minutes into the adenosine infusion.  A rest perfusion study 
was performed approximately 15 minutes after the stress investigation.  
 
Nuclear Medicine 
The nuclear medicine investigation was conducted using SPECT (Single 
Photon Emission Computed Tomography) gamma camera imaging.  As with 
the MR investigation patients were imaged under rest and stress conditions, 
with stress induced using 140 mcg/kg/min of adenosine for 4 minutes so that 
the techniques for SPECT and CMR were directly comparable.  Patients 
were injected with the radioisotope tracer 99mTc tetrofosmin (Myoview) using 
a standard dose of 400 MBq for each examination, adjusted for weight to a 
maximum of 600 MBq per examination.  SPECT images were acquired with 
the patients in the supine position.  Eight ECG gated frames per cardiac 
cycle were acquired using 64, 40s long projections at 3o over a 180o orbit 
using a 64 x64 matrix size.  Transaxial slices of 6mm were reconstructed 
using filtered back projection using a Butterworth filter with a cut-off 
frequency of 0.4 Nyquist and order of 6.  Transaxial slices were reorientated 
to the cardiac axes for analysis.  Semi-quantitative analysis of the perfusion 
data including summed stress and rest scores was performed.   Based on 
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visual comparison of rest and stress SPECT perfusion scans, each SPECT 
dataset was summarized as having fixed or inducible defects in the anterior, 
lateral, septal or inferior positions. 
 
X-ray Reference Standard 
Invasive X-ray angiography using a radio-opaque dye was performed on all 
of the patients after CMR and SPECT.  A quantitative estimate of the degree 
of coronary stenosis (expressed as a percentage reduction in vessel lumen) 
was made for each identified stenosis.  Coronary artery stenoses were then 
mapped to myocardial segments using the AHA recommended mapping 
(106) (see section 3.4.11). 
 
5.2.2. Dual phase 
Purpose 
The dual-phase study was designed to acquire DCE-MRI cardiac perfusion 
time series with identical scan parameters at systole and diastole. The 
primary purpose of this dataset was to identify differences in MBF between 
systole and diastole (128).  For this reason the pulse sequence was 
designed to optimize image quality in a single 2D slice and allow this slice to 
be scanned using identical preparation and read-out settings at two separate 
time points in the cardiac cycle. 
 
Method 
Seventeen healthy volunteers (9 male, 8 female, mean age 34 years age 
range 24–48 years) with no history of heart disease, diabetes, 
hyperlipidaemia or chronic illness were recruited into the study. All 
volunteers had normal blood pressures and showed normal left ventricular 
mass as assessed by planimetry in short-axis left ventricle stack images. 
Informed consent was taken from all volunteers in accordance with a study 
protocol approved by the regional ethics committee. All volunteers were 
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instructed to refrain from caffeine for 24 h prior to the examination.  
Volunteers underwent myocardial perfusion DCE-MR imaging on a 1.5T 
whole body imaging system (Phillips Medical Intera systems, Best, The 
Netherlands).  Volunteers were positioned supine with a flexible five element 
cardiac phased array receiver coil placed on their chest. Images were 
acquired during an intravenous injection of contrast (Magnevist, Schering, 
Berlin, Germany) at a dose of 0.05mmol/kg Gd-DTPA at a rate of 5ml/s 
followed by a 20ml saline flush via an automated infusion pump (Medrad 
Spectris Solaris,Medrad, Indianola, PA,USA). Volunteers were initially 
imaged under stress, which was pharmaceutically induced by an intravenous 
infusion of adenosine over 4 min at 140 µgmin−1 kg−1. A rest scan was 
acquired approximately 15 min later. Mid-ventricular short-axis DCE-MRI 
series were acquired at mid-systole and mid-diastole.  Images were acquired 
using a saturation recovery prepared single-shot gradient echo pulse 
sequence, (see Figure 5-2). 
R-R interval
read-out90o read-out90o
TD systole
TD diastole
TS TS
ko ko
 
Figure 5-2 – The dual-phase imaging sequence.  In a single RR-interval two 
SR-GRE images are acquired with equal saturation times (TS) from the 90o 
pulse to the central line of k-space (ko) and different trigger delays (TD) to 
place the two images in mid-systole and mid-diastole. 
 
The pulse sequence parameters are described in Table 5-2, including the 
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number of lines of k-space involved in the flip angle sweep and the position 
of the central line of k-space (ko), which were ascertained using the Phillips 
Pulse Programming Environment (PPE).  The slice thickness was 10mm and 
the mean FOV was 332 mm × 284 mm (range: 290 mm × 245 mm to 410 
mm × 338 mm). The mean scan pixel size was 2.27 mm × 1.95 mm (range: 
2.08 mm × 1.70 mm to 2.64 mm × 2.35 mm). All images were reconstructed 
to a 256 × 256 matrix size giving a mean reconstructed pixel size in the 
image of 1.30 mm × 1.11 mm (range: 1.13 mm × 0.96 mm to 1.60 mm × 
1.32 mm). Each dynamic image was obtained after an ECG triggering timed 
to image the heart in systole or diastole. Volunteers were instructed to hold 
their breath at end expiration, timed to coincide with the arrival of contrast 
into the heart, for as long as they were capable and then to resort to gentle 
breathing thereafter. This breath-holding strategy minimizes motion during 
the first-pass of contrast agent through the myocardium, which is the data 
used for MBF estimation in this study.  A total of 60 dynamic frames were 
acquired in each DCE-MRI set.  Slice positioning and the timing of 
acquisition were designed to image the same single mid-ventricular short- 
No. lines of k-space in FAS 12 
Central line of k-space 21 
Partial Fourier 0.67 
TR/TE 2.7ms / 1.0ms 
Alpha (after FAS) 15o 
TS 150ms (from 90o pulse to central line 
of k-space) 
SENSE  Factor 2 
Typical matrix size 160x160 (reconstructed to 256x256 
by zero filling before reconstruction) 
Slice thickness 10mm 
rFOV 80% 
Table 5-2 – Pulse sequence parameters for the dual-phase imaging protocol.  
 
axis slice at systole and diastole.  The position of the end-systolic slice was 
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planned using a cine series (two-chamber and four- chamber view, 30 
phases) so that it was located in the mid-ventricular position. Because of the 
longitudinal lengthening of the heart from systole to diastole, the 
myocardium at the mid-ventricular level in systole moves toward the base of 
the heart in diastole.  To allow for this movement the diastolic slice position 
was planned immediately above the middle slice, nearer to the base of the 
heart, and its position was verified in the chosen diastolic frame. Finally, the 
trigger delay for each slice of the DCE-MRI readout was selected from the 
cine images so that slice 1 was acquired in end-systole, followed by the slice 
2, which was acquired mid-diastole (see Figure 5-2). 
 
5.3. Manual contouring of myocardial perfusion imaging 
For all of the datasets described in this thesis endocardial and epicardial 
contours were manually drawn by an expert user for every frame and every 
slice of the cardiac DCE-MRI dynamic series using dedicated cardiac image 
analysis software (Mass 7.0, Medis, Leiden University, Leiden, The 
Netherlands). A further contour was drawn within the left ventricular blood 
pool, avoiding the papillary muscles to sample the blood pool (see Figure 
5-3).  In order to subdivide the myocardium into the circumferentially 
equidistant regions recommended by the AHA (106) a reliable marker is 
required to ensure that the myocardium is divided with respect to the same 
reference point.  For the dual-phase dataset this was taken to be the anterior 
insertion point (where the right ventricular wall meets the left ventricular 
myocardium).  For the CE-MARC dataset it was found that the 
corresponding posterior junction (where the right ventricular wall meets the 
left ventricular myocardium) was easier to identify, thus a more reproducible 
marker, and so this was used as the marker in that dataset. 
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Figure 5-3 – Contour example from the CE-MARC dataset.  Myocardial 
contours (green), a contour within the left ventricular blood pool representing 
the AIF (red) and the reference point marker (blue). 
 
In a given dynamic series the image exhibiting maximum contrast between 
the myocardium and surrounding tissues was used to draw the contours. 
These contours were then copied to the full time series and manually 
translated to compensate for breathing motion.  This contouring 
methodology inherently assumes that the cardiac motion in the dynamic 
series consists of rigid translations only.  In fact rotational motion and some 
non-rigid deformity is also present in these datasets.  This must be accepted 
as a limitation to the contours used in these investigations.  However, it is 
important to note that breath-holding for these acquisitions was timed to 
coincide with the first-pass of contrast agent through the myocardium, being 
the most important data for quantifying perfusion.  Throughout breath-
holding the „rigid translation only‟ assumption is reasonable.  An alternative 
contouring strategy would be to draw separate contours for every individual 
frame.  Besides the substantial increase in time and effort that using such a 
strategy would entail, it is not certain that the resulting contours would be a 
better representation of the true myocardial uptake curves.  It is very difficult 
to identify the myocardium in the low image contrast images before and after 
the main bolus and the contour errors generated due to poor image contrast 
in these frames may well exceed those generated by allowing rigid 
translation only (see Figure 5-4).  The ideal contouring methodology would 
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consist of propagating the maximal contrast contours to the rest of the 
dataset via a non-linear registration algorithm.  However image registration 
algorithms can also be unreliable (especially in the presence of image 
artifacts).  Suffice to say that, although the contouring strategy used here will 
generate errors, there is not an alternative strategy that would be 
guaranteed to yield more accurate results.  Furthermore, the protocol used 
here is commonly employed, and thus the conclusions of the work in this 
thesis should be generally applicable across centres applying similar 
contouring strategies. 
 
Figure 5-4 – Example of poor image contrast pre contrast bolus making 
accurate myocardial contouring difficult.  (Taken from the same patient as 
Figure 5-3). 
 
5.4. Automated analysis of perfusion curves 
Introduction 
Quantitative analysis of myocardial perfusion uptake curves requires pre-
processing of the curves.  Both AIF and myocardial uptake curves must be 
baseline corrected so that the native tissue has a concentration value of 
zero.  For Fermi-constrained deconvolution the post first-pass data must be 
cropped from the curves to avoid significant overestimates in MBF (4).  For 
analysis of large datasets, especially when the myocardium is subdivided 
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into multiple regions, manual pre-processing becomes prohibitively time-
consuming and one of the multiple obstacles to the acceptance of 
quantitative MBF estimates into clinical practice.  This section describes 
methods for full automation of myocardial perfusion uptake curve pre-
processing before evaluating the performance of these methods by visual 
verification. 
 
Methods 
5.4.1. Measuring the baseline 
Quantitative perfusion methods model the passage of a contrast agent bolus 
through the heart.  The pre-contrast signal intensity should therefore be 
zero, corresponding to zero contrast agent in the tissue.  If the signal values 
from the imaging system are converted to CA concentration before analysis 
then the resulting pre-contrast CA concentration will be zero by definition, 
but the conversion process requires a measurement of the pre-contrast 
baseline signal intensity in any case.  For the rest dataset, remnant contrast 
agent will be present from the stress study and so a second baseline 
subtraction step will be required to remove remnant contrast agent. 
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Figure 5-5 – Diagram illustrating two problems with using a simple baseline 
based on first n=10 data points.  a) An unusually short pre-bolus time 
incorporates some contrast enhanced points erroneously raising the 
baseline.  b) Noise in the early points generates errors in the baseline that 
would have been avoided had n been longer. 
 
A simple automated approach to baseline measurement would be to take 
the first n data-points of the data series and average them.  However the 
choice of n is clearly critical to this method.  If n is too large the method runs 
the risk of encountering a data series with an earlier injection time, thus the 
baseline will incorporate contrast enhanced data points and be set too high 
(Figure 5-5 a).  Conversely if n is too small the susceptibility to noise is 
increased (Figure 5-5 b).  High levels of noise are common in the early data 
points as image contrast is poor, making contours difficult to choose (Figure 
5-4).  In reality a large dataset will contain both types of problem.  The ideal 
solution is to have a bespoke, case specific baseline region that maximises 
the available data in each case.  The method adopted for this study uses a 
piecewise linear-linear continuous regression model to fit two conjoined 
a)
b)
Data point 
Data point incorporated into baseline 
Baseline 
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straight lines to the uptake curve.  The method was originally suggested as a 
way of estimating bolus arrival time (129).  After cropping the uptake curve 
of all data points following the point where the curve reaches half the peak 
height the curve is assumed to approximate to a linear-linear piecewise 
continuous function:   
         
                                                      
                                 
  
Equation 5-1 
C(t[i])=βo
C(t[i])=βo+ m(t[i]-t[k])
k
 
Figure 5-6 – Illustration of the method for finding the end of the baseline k.  
All data points after the curve has risen to half peak (x) are excluded.  The 
piecewise linear-linear continuous regression fits a horizontal line of 
amplitude βo to data points before k and a straight line of gradient m and 
intercept βo to points following k.  The solid line is the fit through the included 
point (o).  
 
Equation 5-1 represents the fitting of a horizontal line with amplitude βo to 
the data preceding the bolus arrival time k and a straight line of gradient m 
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and intercept βo to all data points following k.  The fit is repeated with k set to 
every data point in the series and the value of k producing the best fit to the 
data is the bolus arrival time.  Figure 5-6 illustrates the function fitted to an 
example uptake curve.  
 
5.4.2. Identifying the end of the first pass 
Tracer kinetic models that derive a tissue response function theoretically 
should be able to model enhancement curves wherever the assumptions of 
that model are valid.  Thus model independent methods (section 4.3.4) and 
the one compartment model (section 4.3.6) can be applied to full datasets.  
The use of the Fermi function to represent the response function is not 
based on a theoretical tracer-kinetic model.  It is rather a pragmatic choice 
based on the appearance of empirical response functions.  This may 
account for the importance of limiting data sets to the first-pass when using 
Fermi-constrained deconvolution to avoid poor fits and significant 
overestimates in MBF estimate (4). 
The automated method used to find the end of the first-pass is illustrated in 
Figure 5-7.  After smoothing the AIF using a spline function in order to 
reduce the impact of high frequency oscillations, due to noise and frame 
specific contouring errors, the AIF is differentiated to generate a plot of 
dSI/dt against time.  The minimum dSI/dt corresponds to the downslope of 
the first pass peak.  The next point where dSI/dt crosses the line dSI/dt=0 
corresponds to the valley immediately following the first-pass peak, i.e. the 
end of the first-pass.  All data subsequent to this point in the original uptake 
curve is then cropped to generate a first-pass only uptake curve. 
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a)
b)
(1)
(2)
 
Figure 5-7 – The AIF data points (o) are smoothed by fitting with a spline 
function (a).  The differential of the smoothed function (dSI/dt) is then 
calculated (b).  The minimum dSI/dt value corresponds to the downslope of 
the first-pass (1).  The point where dSI/dt next crosses the line dSI/dt=0 is the 
end of the first-pass (2).  
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5.4.3. Calculating the delay time 
It is not possible to gain a reliable arterial input function from the coronary 
arteries themselves. The current limitations in image resolution and the large 
amount of movement would generate very noisy AIFs.  Some authors have 
used a separate imaging slice in the aorta to gain an input function as close 
as possible to the input function that enters the myocardial tissue (31).  
However this requires dedicating an imaging slice to the aorta alone, thereby 
losing a myocardial slice and decreasing the cardiac coverage.  For this 
reason many studies, including all the myocardial perfusion studies 
presented in this thesis opt to take the AIF from the left ventricular blood 
pool.  Here a large ROI can be used to obtain a high SNR AIF.  However the 
contrast bolus generating this AIF must then pass through the aortic valve, 
into the aorta, through the coronary arteries and into the myocardium.  For 
this reason there is a significant time delay (dt) between the arrival of the 
contrast agent bolus in the left ventricle and in the myocardium.  This 
manifests as a translational shift along the time axis between the AIF and 
the myocardial uptake curve.  Uncorrected, this time delay causes an 
underestimate in the MBF.  There are a variety of ways of determining dt.  
Some investigations require a human observer to set dt manually (120).  
This becomes impractical when large numbers of datasets are to be 
analysed.  Furthermore it is often not clear what the optimal dt is from 
visually inspecting the curves and so this method may introduce errors into 
the quantitation.  An automated bolus arrival time finding algorithm has been 
described (129) but this will be susceptible to the same ambiguities in the 
curves that reduce the accuracy of the manual method.  Alternatively dt can 
be incorporated into the fitting procedure as an extra parameter in the fit.  
Although this increases the degrees of freedom in the fitting procedure, and 
may increase the likelihood finding local minima, it is a fully automated 
method and has been widely applied in the literature (123).  Alternatively, for 
the studies in this thesis, dt was determined by performing model fitting 
multiple times over a range of n values of dt.  The delay-time was 
implemented by zero padding before the AIF.  The optimal dt value was then 
chosen as that which achieved the best fit to the data.  This method is more 
computationally expensive than incorporating dt into the model fit (by factor 
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n), however it reduces the likelihood of local minima.  In our experience we 
have found this to be a more reliable method than those previously 
mentioned, although we have not conducted formal investigations to verify 
this quantitatively.  A disadvantage of this method is that it inherently limits 
the delay time to the temporal resolution of the dynamic acquisition, whereas 
fitting can set dt to any value.  To ameliorate this problem all data sets were 
interpolated by a factor of 4 to increase the apparent temporal resolution of 
the dynamic series.  In order to achieve this a piecewise cubic hermite 
interpolating polynomial (130), MATLAB® pchip, was used to preserve the 
local shape of the curve. 
 
5.5. Qualitative evaluation of automated curve pre-
processing for quantitative myocardial perfusion. 
5.5.1. Introduction 
The automated curve pre-processing algorithms described in section 5.4 
were used in all of the MBF estimates used in this thesis. Although an 
absolute gold-standard for these parameters was not available the 
performance of these algorithms was tested against human observer opinion 
as to the correct values.  In this section the performance of the automated 
algorithms was checked by human observers and the number of failures and 
the reasons for failure are discussed. 
 
5.5.2. Method 
The automated pre-processing algorithms described in section 5.4  were 
applied to all of the uptake curves in the CE-MARC subset (described in 
section 5.2.1).  This amounted to 4800 (50 patients x 2 rest/stress states x 3 
slices x 16 regions) myocardial uptake curves and 1600 AIFs (as AIFs were 
taken from the basal slice only).  Each curve was visualised using the 
Perfusion graphical user interface (GUI).  This GUI is described in detail in 
chapter 8.  It enabled rapid visual assessment of the automated pre-
processing algorithms by displaying MR images, contours and uptake curves 
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pre and post automated processing, with the baseline and first-pass cut-off 
points overlaid on the plots (Figure 5-8).  Wherever it was deemed 
necessary the automated pre-processing parameters were adjusted for later 
analysis and the parameter adjustment, and reasons for it were noted.  
Parameter adjustment was deemed necessary if it would give a more 
accurate representation of the parameter in question.  This is obviously a 
subjective criterion, but it is clear from the examples given in section 5.5.4 
that the need for manual intervention was usually obvious.  
Image with contours 
overlaid
Concentration curves 
with pre-processing 
parameters overlaid
Pre-processed 
concentration curves
Slice 
slider
Frame 
slider
Contour 
overlay 
toggles
Stress/rest selector
Region selector Pre-processing slider
Model fitMBF 
estimates
Exclude region 
from dataset
 
 
Figure 5-8 - GUI allowing simultaneous viewing of stress and rest images, 
contrast uptake curves and estimated MBFs as well as manual adjustment of 
pre-processing parameters and an exclusion button to exclude the region if 
necessary.  The black circles depict the time on the curve that the dynamic 
image shown corresponds to (see section 8.3). 
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5.5.3. Results 
The number of regions (and percentage regions) that required manual 
adjustment are shown in Table 5-3. 
Manual 
Intervention 
adjusted 
AIF 
Baseline  
Myocardial 
Baseline  
First-pass 
cut-off  
Bolus 
arrival 
delay time 
Total 
No. regions 
affected  
0 (0%) 32 (0.6%) 32 (0.6%) 0 (0%) 64  
No. Cases 
affected 
0 (0%) 3 (0.06%) 2 (2%) 0 (0%) 5 
Table 5-3 – Summary of cases where manual intervention was deemed 
necessary expressed as the number of individual regions and as a 
percentage in brackets.  The number of individual patients affected by these 
adjustments is also shown. 
 
5.5.4. Discussion 
Of the 4800 segments considered (50 patients at rest and stress over three 
slices divided into 16 regions) 64 regions required manual intervention.  Of 
these 32 required adjustment of the myocardial baseline and 32 were 
affected by adjustment of the first-pass cut-off.  Almost all the myocardial 
baseline adjustments were due to a single patient (30 regions adjusted at 
rest and stress).  The first-pass cut-off adjustments were due to 2 AIFs, 
which affected all regions.  No corrections were required in the AIF baseline 
or the bolus arrival time delay.  It is to be expected that automated baseline 
calculation would be more difficult in the myocardium than the LV blood pool 
as a single myocardial region is typically smaller (and less dramatically 
enhanced) than the LV blood region making it more susceptible to noise.   
The myocardial baseline corrections required were actually due to problems 
with the myocardial contours.  In the  patient concerned poor contour 
placement in the pre-contrast frames incorporated high signal in the 
myocardial baseline (Figure 5-9 a).  At the onset of contrast the contours 
were shifted (Figure 5-9 b) generating a dip in the myocardial curve.  The 
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true baseline value should be at the base of this dip as the preceding 
baseline was contaminated by non-myocardial signal. 
a)
b)
 
Figure 5-9 – Myocardial baseline correction was required due to problems 
with the myocardial contours.  Pre-contrast contours incorporated signal 
from surrounding structures increasing the baseline signal value (panel a).  
At contrast enhancement the contour was shifted so as not to include these 
structures (panel b). 
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The errors in the first-pass cut-off occurred in two patients only.  It is 
important to note that the first-pass cut-off was based on the AIF of the basal 
slice, which was used for all regions.  Therefore, a single failure of the 
algorithm on this AIF affected all regions for that case.  Figure 5-10 shows 
one of the AIFs that caused a failure in this study.  The valley at the peak of 
the AIF is difficult to explain.  The AIF ROI is close to some interior dark 
structure in the LV cavity and movement of the ROI into this region at the 
peak of the AIF may explain the signal loss at this point.  Another 
explanation is signal loss due to T2* effects but that is unlikely with this 
protocol (see section 6.3.1).  The cut-off algorithm searches for the first 
valley after the AIF peak, which it has found in this case, but it is evident that 
this valley is not the end of the first-pass in this case, hence the need for 
manual intervention. 
    
 
Figure 5-10 – Failure in end of first-pass finding algorithm due to a valley in 
the AIF peak. 
 
5.5.5. Conclusion 
The results show that the automated pre-processing algorithms are robust 
and reliable.  No interventions were required in the AIF baseline and the 
bolus arrival time delay parameters, meaning that complete automation for 
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these two parameters has performed as well as visual analysis.  The failures 
of the myocardial baseline and first-pass cut-off algorithms have been 
explained in terms of contouring errors.  Although these cases required 
genuine manual intervention, the automated algorithms could not be 
expected to perform well due to contouring errors generating anomalous 
uptake curves.  In conclusion the automated pre-processing algorithms have 
proved to be robust in practice although manual checks on curves are still 
advisable because of the possibility of contour error induced anomalies in 
the uptake curves. 
 
5.5.6. Limitations 
The reference standard in this investigation was visual assessment.  This is 
a subjective measure and it is possible that errors in the automated 
algorithms may have been missed as a result.  This is particularly possible in 
the case of the bolus arrival delay time which is difficult to assess visually.  
However, the author is aware of no superior, more objective, standard 
against which the curves could be compared in the context of genuine 
patient datasets.  To the author‟s knowledge visual assessment represents 
the best reference standard available.  This assessment shows that the 
automated solutions are at least as good as manual methods. 
 
5.6. Summary 
This chapter has described in detail the datasets and methods that are used 
throughout the remainder of the thesis.  A subset of the CE-MARC dataset 
(section 5.2.1) is the basis upon which the comparison of methods (chapter 
8) and the comparison of perfusion models (chapter 9) were performed.  The 
dual-phase dataset (section 5.2.2) was used in the evaluation of contour 
errors (chapter 7) and was used in the patient data based simulations in 
chapter 6.  The contouring protocol described in section 5.3 has been used 
on all the datasets described in this thesis.  The automated analysis 
methods described in section 5.4 and qualitatively validated in section 5.5 
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have been used to generate all of the MBF estimates presented in this 
research. 
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6. Signal intensity to concentration conversion 
in magnetic resonance imaging for 
quantitative myocardial perfusion 
6.1. Overview 
In order to justify the assumption that the signal measured from the MR 
image is linearly proportional to the concentration of contrast agent in the 
ROI, quantitative blood flow MRI investigations in the heart are usually 
carried out using either a low dose single bolus injection or, more recently, a 
dual-bolus protocol (see section 2.8.6).  In the single bolus case the price for 
using a small enough dose for this assumption to hold true is poor SNR in 
the resulting images.  This has an adverse affect on the contrast uptake 
curves and reduces the accuracy of visual reporting.  Dual-bolus injection 
protocols aim to avoid this issue by using separate, dedicated bolus 
concentrations for the AIF and myocardial tissue curves.  However 
administration of two boluses makes the investigation complicated, requiring 
three injection pumps (two contrast agent (CA) boluses plus saline) or a 
member of staff in the investigation room to swap syringes mid scan (131).  
Adequate separation between pre-bolus and bolus injections is difficult to 
time correctly and bolus time courses can become contaminated by the pre-
bolus.  An alternative approach is to convert the signal intensity (SI) values 
into CA concentrations by modelling the non-linear relationship between SI 
and CA concentration.  This allows simple, single-bolus acquisitions, with 
good SNR, to be used in quantitative analysis. 
 
The aim of this chapter was to derive and validate a method for converting 
signal values derived from DCE-MRI cardiac perfusion into CA 
concentrations.  The mathematical model of the pulse sequence is described 
in detail (section 6.2.1) and is then refined to incorporate a simulation of the 
flip-angle sweep used on Philips systems to reduce image artifacts (section 
6.2.3).  Simulation experiments are then used to defend potential criticisms 
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of the model.  The use of an assumed blood T1 is shown to be unlikely to 
cause significant errors in MPR (section 6.3.7), the assumption that the 
effect of T2* on signal intensity will be small is validated and the effect of flip 
angle sweep on MPR is also shown to be small (section 6.3.2).  The model 
is then validated using a T1-gel phantom showing excellent fits of the model 
to the phantom (section 6.4).  The phantom is also used to investigate the 
effect of flip angle errors on the conversion.  In-vivo tests of the model were 
not carried out due to concerns over the dual-bolus dataset on which this 
was to be performed.  These concerns were based on the significant 
discrepancy between pre-bolus and dual-bolus MBF estimates in these 
datasets.  These discrepancies are reported and preliminary investigations 
into what has caused them are described. 
 
6.2. A method for converting signal intensities to 
concentrations in myocardial perfusion imaging 
In order to use cardiac MRI perfusion data for quantitative MBF 
measurements the measured signal intensities should be linearly 
proportional to the concentration of contrast agent in the ROI.  Section 2.8.6 
explains this requirement in detail and outlines the main proposed methods 
for dealing with it.  In this section an approach is described to convert each 
signal intensity value to its corresponding T1 value using the mathematical 
description of the imaging pulse sequence.  The method was first described 
by Fritz-Hansen et al and Larsson et al. (30,31) for an inversion recovery 
FFE (IR-FFE) pulse sequence.  In the heart it is reasonable to assume a 
mono-exponential T1 recovery, i.e. that there is a fast rate of exchange 
between tissue compartments (132).  Therefore, the change in longitudinal 
relaxation rate T1 due to a given concentration c(t) of contrast agent at time t 
can be related as follows (13): 
)(
1
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1
1
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Equation 6-1 
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where T1o is the native relaxation time without CA, T1(t) is the relaxation time 
at time t with the CA and r1 is the CA relaxivity. Thus, the concentration c(t) 
of CA at time t can be expressed as: 
1
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Equation 6-2 
Therefore, CA concentration can be derived from the R1 in a given ROI 
provided that the native R1 of the tissue is known.  The problem then 
becomes one of relating a given signal intensity to R1.  The relationship 
between signal intensity and R1 can be written as: 
)( 1RfSI   
Equation 6-3 
SI is the signal intensity measured from a given region, f(R1) is an 
abbreviation for the full pulse sequence equation, described later in this 
chapter (sections 6.2.1 and 6.2.3), for which R1 is the only unknown 
parameter.  Ψ is a calibration factor, which is constant over the DCE-MRI 
experiment.  For this derivation ψ comprises the receiver gain factor Ω, the 
net magnetization vector Mo, sin(α), and the factor for T2* decay  
   
  
  
 
              
     
  
 
Equation 6-4 
Considering the left ventricular ROI containing blood only, the blood 
calibration factor ψb can be calculated using the pre-contrast (baseline) 
signal intensities (SIbo) and the native R1 value for blood (R1bo): 
)( 1bo
bo
b
Rf
SI

 
Equation 6-5 
Once obtained ψb can be used to derive R1b(t) for every time point in the 
perfusion series assuming f(R1) is invertible: 
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Equation 6-6 
         
   
      
  
  
Equation 6-7 
Ideally R1bo would be measured on a patient by patient basis.  However, 
these measurements can be time-consuming and error prone and are not 
available in all perfusion studies.  An alternative is to assume a value from 
measurements published in the cardiac MRI literature.  This is the approach 
adopted in this chapter. 
 
The above method should also be applied to the myocardial ROI.  Using a 
measured or assumed value for normal myocardial R1 is not practical in 
ischaemic patients whose native myocardial R1 will be modified by their 
disease.  An alternative is to assume that the calibration constant is the 
same for the blood and the myocardium (ψb= ψm), so that: 
         
   
      
  
  
Equation 6-8 
SIm and R1m are the myocardial signal and R1 values respectively.  This is a 
reasonable assumption within an imaging slice as one would not expect 
large changes in coil sensitivity between adjacent areas within the same 
slice.  Furthermore, most perfusion acquisition protocols will use parallel 
imaging techniques which should improve within slice B1 homogeneity. 
 
In order to generate a myocardial perfusion reserve (MPR) cardiac perfusion 
imaging is carried out under rest and stress conditions with a separate 
contrast bolus in each case.  Typically rest perfusion is conducted 10 – 15 
minutes after stress perfusion, after which time remnant CA is still present in 
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the blood and myocardium (Figure 6-1).  For this reason it is not possible to 
generate a separate calibration factor for the rest acquisition.  Therefore a 
further assumption has to be made that the calibration factor does not 
change between the stress and rest acquisitions (ψstress=ψrest) and the stress 
calibration factor is applied to the entire dataset.  This assumption is also 
reasonable as the same location is being imaged in both cases. 
15 min 
pause
time
SI
Stress acquisition Rest acquisition
Rest pre-contrast SI
Stress pre-contrast SI
SI due to remnant Gd
 
Figure 6-1: Signal intensity vs. time plot showing stress and rest data.  The 
precontrast (baseline) signal intensity for the rest scan is higher than the 
native tissue signal intensity due to remnant CA in the tissue from the stress 
scan.  The calibration factor should be derived from the stress pre-contrast 
data only. 
 
For the CE-MARC imaging sequence (section 5.2.1) a shared pre-pulse 
(section 2.8.4) was used resulting in different saturation times for each 
imaging slice.  For this reason the AIF was taken from the basal slice 
(corresponding to the shortest saturation time) for all slices, whereas the 
myocardial uptake curve was taken from each individual slice.  The coil gain 
within the imaging slice is reasonably homogeneous, justifying the 
assumption used above that the myocardial curve can be converted using 
the blood calibration factor (ψb= ψm).  However, the same assumption 
cannot be made when the AIF and myocardial uptake curves are taken from 
different imaging slices.  For this reason each myocardial uptake curve was 
converted using a calibration factor derived from the baseline blood signal 
from its own slice, even though the AIF was always taken from the basal 
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slice.  
 
6.2.1. Derivation of the SR-TFE pulse sequence equation 
The SR-TFE sequence consists of an initial 90o saturation pulse followed by 
a TFE read-out consisting of multiple low flip angle (α) RF pulses separated 
by short relaxation times (TR) (see section 2.6).  The recovery of the 
longitudinal magnetization Mz after the initial 90
o RF pulse is given by: 
              
   
  
   
Equation 6-9 
Where TS is the saturation time between the 90o RF pulse and the first TFE 
read-out RF pulse and Meq is the equilibrium magnetization of the fully 
relaxed system.  The magnetization at any point in the readout pulse can be 
determined by considering the affect of each RF pulse on Mz.  Recovery 
towards Meq from an arbitrary initial magnetization Mz(0) is described by: 
                           
  
     
            
  
           
  
     
Equation 6-10 
The magnetization after the first RF pulse of the TFE read-out train M1(+) is 
related to the magnetization before the RF pulse M1(-) by: 
                
Equation 6-11 
corresponding to point B in Figure 6-2.  Inserting this expression into 
Equation 6-10, following recovery over TR, the magnetization immediately 
prior to the next RF pulse is: 
                
   
           
   
     
Which reduces to: 
101 
                  
Equation 6-12 
Where        
   
    and       
   
    , which corresponds to point C 
in Figure 6-2.  In general the expression for the nth RF pulse can be written 
as: 
       
          
      
   
      
Equation 6-13 
TS TR TR TR
A
B
C
D
 
Figure 6-2 – Illustration of longitudinal magnetization, Mz, recovery in the SR-
TFE pulse sequence.  Initially the magnetization recovers from Mz(0) over TS 
to point A.  The initial read out flip angle then reduces Mz to point B followed 
by recovery over TR to point C.  The magnetization after n TR readout pulses 
is D. 
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Utilizing the identity:                 
    
   
.  Mn(-) corresponds to 
point D in Figure 6-2 if n=10.     
Finally incorporating, Equation 6-9: 
     
 
   
         
   
  
    
      
   
   
Equation 6-14 
 
6.2.2. SR-TFE with flip angle sweep 
The derivation described in section 6.2.1 assumes a constant flip angle α 
throughout the TFE read-out sequence.  On Philips imaging systems the 
SR-TFE pulse sequence incorporates a steadily increasing flip angle 
scheme or flip-angle sweep (FAS) at the commencement of the sequence in 
order to reduce oscillations in the evolution of the longitudinal magnetization 
which can cause ghost artifacts.  If the flip angle sweep evolves over N lines 
of k-space then the flip angle used for the nth line is given by (133):    
 

2
2
N
nNn
n

  
Equation 6-15 
In order to validate Equation 6-15 the Philips PPE environment was used to 
measure the RF pulse magnitudes for each k-space line of the acquisition. 
(Figure 6-3). 
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Figure 6-3 – RF pulse amplitudes displayed in the Philips PPE environment 
showing flip angle evolution over the initial 12 lines of k-space (rf-pulse 
durations are constant hence amplitude is proportional to flip angle). 
 
The PPE measurement tool was then used to measure the maximum 
amplitude of the RF pulse for each k-space line.  Equation 6-15 was used to 
generate angles with N=12 normalised to the maximum RF amplitude 
measured and plotted on the same scale.  The signal evolution trends were 
compared and shown to match well with differences of less than 1% 
between the measured and calculated RF pulse amplitude for each 
individual point (Figure 6-4). 
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Figure 6-4 – Measured RF amplitudes (points) and calculated values using 
Equation 6-15. 
 
6.2.3. Derivation of the SR-TFE signal intensity equation incorporating 
flip angle sweep 
The influence of variations in the flip angle can be modelled mathematically 
in a similar manner to section 6.2.1 as follows;  The magnetization after the 
first RF pulse of the TFE read-out train M1(+) is related to the magnetization 
before the RF pulse M1(-) by: 
                 
Where α1 is the 1
st flip angle in the TFE sequence.  Using Equation 6-10, 
following recovery over TR, the magnetization immediately prior to the 
second RF pulse is: 
                 
   
           
   
     
Which reduces to: 
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Where    
   
    and          
   
    . 
Iterating to the 3rd RF pulse: 
                     
Substituting in M2(-) 
       
                           
Similarly for the 4th and RF pulse: 
       
                       
                       
And in general: 
             
   
   
          
   
  
       
             
   
   
   
   
   
   
 
Equation 6-16 
6.2.4. Minimization 
In order to use Equation 6-14 and Equation 6-16 for converting signal values 
to concentrations these equations must be solved for T1.  An analytical 
solution for T1 is not possible therefore T1 must be found by minimization 
techniques.  For all of the implementations in this thesis this was done using 
a single-variable non-linear zero finding algorithm (fzero.m MATLAB7 
R2009b) (134) 
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6.3. Simulation Studies 
6.3.1. T2* effects 
Introduction 
The models described in section 6.2 do not incorporate T2* effects into the 
pulse sequence equations, i.e. they assume that the change in the 
measured signal due to T2* effects is small due to the short TE used in the 
pulse sequence.  The aim of this section was to ascertain whether T2* 
effects are indeed small enough to be discarded from the model for the 
pulse sequences used in the following studies. 
 
Theory 
Equation 6-1 relates contrast induced change in T1 to concentration via the 
T1 relaxivity.  A similar relationship exists for T2* relaxivity: 
  
        
    
       
Equation 6-17 
Equation 6-3 can be modified to incorporate T2* decay as follows: 
             
     
     
Equation 6-18 
The calibration factor is now denoted ψ  to emphasies the fact that its value 
is different to that in previous simulations, which effectively assumed a 
constant T2* decay for all contrast concentrations.  Substituting Equation 6-1 
and Equation 6-17 into Equation 6-18: 
                             
         
    
                    
      
      
Equation 6-19 
Where the constant        
 
 has been incorporated into a new calibration 
constant ψ ’: 
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Equation 6-20 
 
Method 
Using Equation 6-19 signal vs. concentration curves were generated.  Based 
on previous observations, using a similar injection protocol, the peak 
concentration in AIF was expected to be around 3mM and to not exceed 
5mM (30).  Signal vs. concentration curves were plotted with and without T2* 
effects and the percentage difference due to T2* effects was calculated at 
each TS.  The simulations were implemented in MATLAB (The Mathworks, 
Natick, MA) using a calibration factor of one ( =1).  The simulation was run 
using the range of saturation times (TS) used in the experiments in this 
thesis (TS=126ms, 150ms, 272ms, 418ms).  An assumed value of T1 
commensurate with the literature for blood in the left ventricle (1393ms) was 
used, derived from an average (weighted for study population) of the 
measurements published in (135–138).  A T1 relaxivity for Magnevist in 
blood plasma of 4.1 L mmol-1 s-1 (13) was used and a T2* relaxivity of 7.6 L 
mmol-1 s-1 (139). 
 
Results 
Figure 6-5 shows signal intensity vs. concentration plots for the four 
saturation times.  The percentage errors at 5mM and the predicted peak AIF 
concentration (3mM) are shown in Table 6-1. 
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Figure 6-5 – Signal Intensity (S) vs. concentration (C) as simulated with T2* 
effects (solid line) and without T2* effects (dotted line). 
 
TS 126ms 150ms 272ms 418ms 
Percentage 
difference at 3mM 
2.9% 3.3% 4.0% 4.1% 
Percentage 
difference at 5mM 
7.0% 7.3% 7.8% 7.8% 
Table 6-1 – Percentage errors between the T2* model and the non T2* model at 
3mM and 5mM. 
 
Discussion 
The differences in signal intensity due to T2* effects at the concentrations 
expected in cardiac perfusion imaging are small for this pulse sequence 
(~3.5% at 3mM and ~7.5% at 5mM).  This difference is unlikely to have a 
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significant effect on diagnosis as it will be of a similar magnitude and 
direction for both rest and stress scans thus having a negligible effect on 
MPR.  The representation of the data in terms of signal errors is perhaps not 
ideal and the fact that these simulations have not been used to show the 
degree of MBF error due to T2* effects is a limitation of this study.  However, 
the results presented here in terms of signal imply that the changes in MBF 
will be small. 
 
6.3.2. Comparing SR-TFE equations with and without flip angle sweep 
Introduction 
Philips MR imaging systems use a flip angle sweep (FAS) in the Cardiac 
perfusion pulse sequence.  The aim of this study was to ascertain the effect 
of the FAS on MR signal intensity, and the subsequent effect of neglecting 
FAS when converting signal intensities to concentration on quantitative MBF 
estimates and MPRs was then assessed. 
 
6.3.3. Method 
Pulse sequence simulations 
In order to allow a visual comparison of the signal evolution for the two 
models signal intensities were simulated using the no FAS model (Equation 
6-13) and the FAS model (Equation 6-15 and Equation 6-16).  The 
mathematical models were implemented in MATLAB (The Mathworks, 
Natick, MA) using a calibration factor of one ( =1).  The simulation was run 
once using an assumed value of T1 commensurate with the literature for 
blood in the left ventricle (1393ms) and once with an estimate of the T1 
expected at the peak of the AIF in the myocardial perfusion investigation 
(50ms).  The native blood T1 was derived from an average (weighted for 
study population) of the measurements published in (135–138).  
Experiments using a bolus dose of 0.1 mmol/kg (30,31) have presented 
enhancement curves with AIF peaks not exceeding 3mM.   Using our 
assumed blood T1 of 1393ms and a relaxivity for Magnevist in blood plasma 
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of 4.1 L mmol-1 s-1 (13), Equation 6-2 yields a T1 of approximately 40ms.  
Noting that this study uses a half dose of 0.05 mmol/kg we can be confident 
that our T1 values will not fall below this value thus our expected blood T1 at 
the peak of the AIF was estimated to be around 50ms and no shorter than 
40ms. 
  
To investigate variations between the models over a realistic range of T1 
values SI values from the two models were generated using T1s ranging 
from 10ms to 2000ms.  Absolute and percentage differences between the 
FAS and no FAS models were then plotted against T1. 
 
Perfusion Analysis 
The dual-phase dataset, described in detail in section 5.2.2, was used to 
make the comparison.  Manual contours depicting the myocardium and an 
area within the left ventricular pool avoiding papillary muscles were drawn 
for both rest and stress datasets on each volunteer as described in section 
5.3.  The signal uptake curves derived from the image contours were then 
converted into concentration curves using the method described in section 
6.2 using mathematical models incorporating FAS (section 6.2.3) and 
neglecting FAS (section 6.2.1).  Myocardial blood flow (MBF) values were 
then derived from both sets of curves using fully automated curve 
preparation (section 5.4) and Fermi-constrained deconvolution (section 
4.3.3).  Myocardial perfusion reserves (MPR) were calculated as the ratio of 
stress to rest MBFs.  Significant differences in stress and rest MBF values 
and MPR from the two pulse sequence models were assessed using a 
paired t-test. 
 
6.3.4. Results 
Figure 6-6 shows the evolution of signal to the central line of k-space (ko) 
with and without FAS incorporated into the simulation.  The percentage 
difference in signal at ko (difference in SI at ko / average of the two SIs at ko) 
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was 8.6% with native T1 and 4.1% at the peak of the AIF (T1=50ms).    
Figure 6-7 relates the ko SI for the two models to T1 and shows the absolute 
and percentage differences at each T1 value.  The largest absolute 
difference in SI occurred at T1=90ms, corresponding to a 6% difference in SI 
values.    
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Figure 6-6 - Evolution of signal intensity (Mz) simulated with and without 
incorporating FAS.  The central line of k-space is denoted ko. [left pane] 
simulation with native T1=1393ms.  [right pane] simulation with T1 estimate at 
peak of AIF (T1=50ms). 
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Figure 6-7 – Signal intensity vs. T1 curves for SR-TFE ignoring (solid line) and 
including (dotted line) FAS [top panel].  Absolute [central panel] and 
percentage [bottom panel] differences between the models. 
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MBF values 
The conversion algorithm successfully generated concentration curves for all 
the volunteers.  One volunteer was excluded because their concentration 
conversion yielded very high peak AIF concentrations which could not be 
representative of the true concentration.  The curve in question had a peak 
concentration 35 mM with a T1 value of 7ms.  This was due to an unusually 
small pre-contrast AIF SI value.  This yielded a small calibration factor ψ and 
correspondingly small R1 values yielding high concentrations.  The 
anomalous curve was detected visually but could have been detected by 
testing curve parameters, such as testing that the peak AIF concentration 
did not exceed 10mM or that the peak T1 was not less than 20ms, or by 
setting a limit on the ratio between the pre-contrast baseline and AIF peak SI 
values.  The reasons for the particularly low pre-contrast baseline in this 
volunteer are unknown.  Signal reduction could be caused by poor 
contouring (incorporating low signal voxels in the lung for example) or by 
image artifacts but neither of these were visually noticeable on the dataset.  
 
The no FAS vs. FAS MBF estimates at stress and rest (mean+sd) were 
2.27+0.68 vs. 1.97+0.71 and 0.81+0.28 vs. 0.72+0.30 respectively with MPR 
values of 2.9+0.62 vs. 2.83+0.78.  The difference in MBFs between 
concentration curves incorporating FAS and no FAS was significant at stress 
(p<0.0001) and rest (p<0.0001) with average differences of 0.3ml/g/min and 
0.08ml/g/min.  In each case the MBF was overestimated when FAS was not 
incorporated into the conversion.  These differences did not propagate to 
significant differences in MPR (p=0.32) with MPR differences approximately 
normally distributed around a mean positive bias of 0.07 (Figure 6-8). 
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Figure 6-8 – Bland Altman comparison of MPR values generated using signal 
to concentration conversions incorporating and not incorporating FAS. 
 
6.3.5. Discussion 
The SI vs. k-space line number plots in Figure 6-6 illustrate well the 
differences between the evolution of SI in the two models, with the no FAS 
model decreasing monotonically, whilst the FAS model increases over the 
flip angle sweep before entering a monotonic descent once the flip angle 
becomes constant.  At the central line of k-space (ko) this manifests as an 
increased SI value with the FAS model.  The magnitude of this error is more 
profound at the AIF peak (0.03 [a.u.]) than the native blood (0.005 [a.u.]).  
However, expressed proportionally to the SI the larger percentage error is in 
the non-contrast tissue (8.5% for native blood and 4% at the AIF peak).  
These errors are illustrated by Figure 6-7, which shows the difference 
between the models over a range of T1 values.  The maximum absolute 
difference (pane b) occurs at TI=90ms (corresponding to a 6% error) but the 
larger percentage errors occur at larger T1 values (pane c) due to the 
generally lower SI at these T1s (pane a).  Both of these errors have the 
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potential to affect MBF estimates.   Clearly a change in the peak of the AIF 
will be reflected in the MBF measured, but errors in the pre-contrast baseline 
concentration will also indirectly affect the MBF measurement through the 
baseline correction, although it is likely that at these lower SIs noise will be a 
more profound cause of error then the small systematic shift between pulse 
sequence models described here. 
 
Considering the volunteer study, a failure to incorporate FAS in the 
concentration conversions yielded a small (~10%) but systematic and 
therefore statistically significant difference in MBF value.  These differences 
did not propagate to a significant change in MPR.  This is to be expected as 
a similar ~10% increase in MBF at both stress and rest should not alter 
MPR=stress MBF/rest MBF.    
 
6.3.6. Conclusion 
The error induced in concentration conversion due to neglecting FAS effects 
is small but systematic.  Absolute differences are most significant at T1s 
close to the peak of the AIF (which has most effect on MBF estimates) but 
percentage differences are more profound at native tissue T1 values.  
Neglecting FAS in the conversion has a moderately small but significant 
systematic effect on MBF estimates, however this effect does not 
significantly affect MPR measurements.   
 
Small but significant improvements in the accuracy of MBF estimates from 
cardiac myocardial perfusion datasets can be made by incorporating FAS 
into the mathematical model of the imaging pulse sequence.  However these 
improvements will not significantly impact MPR estimates.  Where possible 
FAS should be incorporated into future studies where Philips sequences that 
incorporate FAS are used but the effects are small enough to be able to 
accept results of studies that did not incorporate FAS into their modelling 
with confidence. 
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6.3.7. The effect of errors in the assumed blood T11 
Introduction  
The method for converting SI values to concentration described in section 
6.2 is dependent on the native T1 of blood.  This can be obtained by 
measurement prior to the perfusion scan (31).  However, T1 measurement is 
time consuming (both in terms of scanning time and off-line analysis) and of 
limited accuracy, especially when applied to the left ventricular blood pool 
where the native T1 is long (requiring long TIs) and flow effects may create 
signal changes that are difficult to compensate for.  Accepting then that the 
baseline T1 (whether it is assumed or measured) will have some error 
associated with it the aim of this study was to establish how robust the non-
linear conversion to concentration is to errors in T1 as expressed in the final 
MBF estimate. 
 
Method 
The dual-phase data set described in section 5.2.2 was used in the study.  A 
weighted average of the native cardiac blood values taken from (135–138) 
gave a mean + standard deviation (SD) T1 value of 1393 + 126ms, giving a 
95% confidence interval of 1141 ms to 1645 ms. Signal to concentration 
conversion was carried out using the method described in section 6.2 and 
6.2.3 (incorporating FAS) using a range of assumed T1 values 
encompassing this confidence interval.  The resulting curves were used to 
estimate MBF using Fermi-constrained deconvolution with automated curve 
pre-processing (section 5.4).  Box plots of the MBF for each assumed T1 
value were plotted for comparison. 
 
Results 
The mean MBFs (+ SD) using the reference T1 (1393ms) at stress and rest 
                                            
1 This study was previously published with a smaller volunteer dataset (158) 
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were 3.14 + 0.70 ml/g/min and 1.09 + 0.36 ml/g/min respectively.  Using the 
reference blood T1 to derive the calibration factor ψ, the mean myocardial T1 
derived from the myocardial baseline using the reference blood T1 was 1195 
+ 266ms.  Figure 6-9 shows the distribution of stress and rest MBFs and 
MPRs over the volunteers for each assumed T1 value.  With respect to the 
reference T1, the largest mean difference in MBF occurred at T1=1141ms, 
which gave an absolute mean difference in MBF at stress of 0.73 ml/g/min 
and at rest 0.29 ml/g/min, giving percentage differences of 22% and 28% 
respectively. This corresponded to a change in the MPR ratio of 0.16 (5%).  
The largest shift in MBF in a single measurement due to changing T1 was 
1.6 ml/g/min at stress and 0.53 at rest, both observed with a T1 of 1141ms.  
The largest individual increase in MPR was 1.58. 
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b)
a)
c)
Distributions of Rest MBFs vs. T1
 
Figure 6-9 – Boxplots showing the distribution of stress MBF values for each 
assumed T1 value (a), the corresponding distributions for REST MBF values 
(b) and MPRs (c). 
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Discussion  
None of the median MBFs in Figure 6-9 fall outside of the inter-quartile 
range of the MBFs estimated assuming the reference T1, suggesting that the 
variation in MBF induced by varying T1 is less pronounced than the 
experimental variation of MBFs within the reference (T1 = 1393ms) dataset.  
It could be postulated that a larger dataset than this, using data not requiring 
correction, or corrected using measured T1 values, might exhibit a narrower 
variation in MBF.  However, the weighted mean of resting MBF 
measurements taken from studies (6,29,126,140), which satisfied these 
criteria, was 0.85 + 0.32 ml/g/min.  The resting MBFs for all T1 values in this 
study maintained a standard deviation comparable with this suggesting that 
the variability in this dataset is not abnormal.  The mean derived myocardial 
T1 in the experimental data (1195 + 266ms) was higher than a weighted 
mean of myocardial T1 values taken from (135–138), 944 + 87ms, although 
still within one standard deviation of the literature value.  The effect of 
changing the assumed blood T1 on MPR values is smaller than that for MBF 
(5% maximum change in the mean MPR) due to the fact that a change in 
assumed T1 affects both rest and stress MBF in the same direction (increase 
or decrease) so resulting changes in the ratio between the measurements 
are small.   
In conclusion, errors in assumed T1 can have a substantial impact on 
individual MBF estimates.  However, the variation in MBF induced by errors 
in the assumed T1 of blood is less pronounced than the experimental 
variation in MBF estimates and is therefore unlikely to affect diagnosis 
decisions within a single patient cohort. 
 
6.4. Phantom experiments 
6.4.1. Introduction 
Section 6.2 described the method for converting SI values to concentrations 
theoretically.  This section attempts to validate the theoretical models using 
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phantom data.  The purpose of this study was to establish whether Equation 
6-16 correctly models the relationship between T1 and signal intensity for a 
given calibration factor ψ using T1-gel phantoms.   
 
6.4.2. Method 
A phantom consisting of tubes containing gels doped with different 
concentrations of gadolinium was imaged using an inversion recovery spin 
echo (IRSE) pulse sequence with TI: (50, 100, 200, 400, 800, 1600, 
3200)ms.  An additional spin echo image without an inversion pulse was 
acquired in order to normalise the recovery curves to the fully relaxed 
magnetization Mo.  The phantom was then imaged with the pulse sequence 
used for perfusion imaging in the CE-MARC study (section 5.2.1).  Regions 
of interest were drawn on each IRSE image for each tube over all the 
inversion times in order to obtain mean signal intensity values from each 
tube over time.  The IRSE signal intensities for each tube were normalised 
by dividing by the corresponding value from the spin echo image acquired 
without the inversion pulse.  The T1 value for each vial was calculated by 
fitting a mono-exponential recovery curve to the normalized mean signal 
value (S) from each tube over time with three free parameters A, B and T1: 
 
      
   
   
Equation 6-21 
 
with A~1 and B~2 post-normalization giving the standard inversion recovery 
T1 relaxation equation: 
 
      
   
   
Equation 6-22 
Regions of interest were then drawn within each tube in the perfusion 
images and mean signal intensities were plotted against the measured T1 for 
each vial.  The equation describing the signal intensity of the pulse 
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sequence, given R1=1/T1, was then fitted to the data allowing the calibration 
factor ψ as a free parameter: 
 
)( 1RfSI   
Equation 6-23 
where f(R1) is shorthand for Equation 6-16, which is a function of R1. 
 
The parameter most likely to be susceptible to inaccuracies in the model is 
the flip angle, α.  For this reason the investigation was repeated allowing 
both ψ and α as free parameters in the model to see what improvements to 
the fit could be made by varying α.  The results of this study showed lower 
flip angles than those set at the MR console.  Therefore the experiment was 
repeated with administered flip angles of (5o, 10o, 15o, 20o and 30o) to further 
investigate how the fitted flip angle related to that reportedly administered by 
the scanner. 
 
Previous simulations have dealt with the longitudinal magnetization (Mz(t)) 
only.  The sin α term, which takes the transverse component of the 
magnetization, has been incorporated into the calibration factor, ψ.  In order 
to include α as a fitted parameter this term must be included in the pulse 
sequence equation.  Incorporating this term Equation 6-16 becomes:  
 
                 
   
   
          
   
  
       
             
   
   
 
   
   
   
      
Equation 6-24 
With a modified calibration constant: 
 
         
     
  
 
Equation 6-25 
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The vector of flip angles in the read-out pulse αj-n-1 must be recalculated for 
each flip angle value.  This was done using the flip angle sweep equation 
(Equation 6-15) for each instance of α. 
 
6.4.3. Results 
 
The T1s of the tubes as measured using the IRSE sequence were 54.6, 176, 
436, 703, 856, 935, 1058, 1097.3 and 2510.5ms.  Figure 6-10 shows the 
measured signal values from each tube using the perfusion sequence and 
the fit of the mathematical model to the data.  For the apical, middle and 
basal slices the imaging TS values were 418ms, 272ms, 128ms, the 
calibration factor values were  307710, 300400, 299890 respectively.  The 
fitted R2 value was 0.99 for all slices. 
 
Figure 6-11 shows the corresponding plots allowing both ψ and α as free 
parameters For the apical, middle and basal slices  the fitted value for ψ was 
339170, 392300 and 500000  with α of 11.15o, 8.65o and 6.75o respectively.  
The fitted R2 value was 1.00 for all slices.  At a T1 of 50ms the difference 
between the ψ only fit and the fit incorporating α as well was 4.18% for the 
apical slice, 4.61% for the middle slice and 2.59% for the basal slice.  
 
Figure 6-12 shows the fits applied to the data when a range of applied flip 
angles were administered by the scanner, for the middle slice only.  Table 
6-2 shows the values of the fitted parameters. 
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a)
b)
c)
 
Figure 6-10 – Signal vs. T1 allowing ψ only as a free parameter.  Panels a, b 
and c correspond to perfusion slice 1 (apical), slice 2 (middle) and slice 3 
(basal) with TS 418ms, 272ms and 126ms respectively and were fitted by the 
model with an R2 of 0.99 in each case. 
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a)
b)
c)
 
Figure 6-11 - Signal vs. R1 allowing both ψ and α as free parameters.  Panels 
a, b and c correspond to perfusion slices 1 (apical) ,slice 2 (middle) and slice 
3 (basal) respectively and were fitted by the model with an R2 of 1.0 in each 
case. 
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a)
c)
e)
b)
d)
 
Figure 6-12 – Model fits for the middle slice for data acquired with an 
administered flip angle of a) 5o, b) 10o, c) 15o, d) 20o, e) 30o. 
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Panel in Figure 
6-12 
Administered flip 
angle 
Fitted flip angle Calibration 
factor (ψ) 
a) 5o 2.59o 5 x105 
b) 10o 4.95o 5 x 105 
c) 15o 8.65o 3.9 x 105 
d) 20o 15.58o 3.3 x105 
e) 30o 17.80o 3.3 x 105 
Table 6-2 – Administered and fitted flip angles, with corresponding calibration 
factor values for the plots displayed in Figure 6-12. 
 
6.4.4. Discussion 
The initial model, using the reported flip angle from the scanner, fitted the 
data well with R2~0.99 for all three slices suggesting that Equation 6-16 is a 
good representation of the pulse sequence.  The calibration factor Ψ was 
consistent over the three slices with only 2.5% maximum difference between 
ψ values.  The absolute error between the model and the measurement is 
largest at the shortest T1~50ms (R1~20s
-1).  This T1 value corresponds to the 
estimate of T1 at the AIF peak, which will have the most profound effect on 
MBF values.  The percentage errors between the model and the measured 
data points for the apical, middle and basal slices at this point are 3.62%, 
3.72% and 3.52% respectively.  
 
The flip angle used in the model in Figure 6-10 assumes that the flip angle 
set in the scanning parameters is delivered fully and homogeneously to the 
imaged object.  This is often not the case and so it is of value to investigate 
whether allowing α as a free parameter in the model fit generates realistic 
estimates of the actual flip angle delivered to the phantom.  Figure 6-11 
shows the improvements to the model fit after allowing α as a free parameter 
in the model fitting.  The fact that the R2 values improve is expected as there 
is an extra degree of freedom in the model.  The resulting flip angles were all 
less than the reported administered flip angle of 15o, which is consistent with 
the theory that the full flip angle has not been delivered to the phantom.    
However, the calibration factor, Ψ, varied dramatically between the slices 
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with this model.  In fact for the basal slice the unconstrained fit used a very 
small flip angle (2o) and a large calibration factor (1400000).  It is unlikely 
that the calibration factor would change so dramatically between slices 
therefore the model was constrained to an upper limit on ψ of 5x105.  After 
applying this constraint the percentage difference between the two models 
(ψ only and incorporating α as a free parameter) was less than 5% in all 
slices.  This implies that the effect of errors in administered flip angle on the 
signal intensity at the AIF peak is small and should not generate large errors 
in MBF.  Furthermore the effect should be similar for rest and stress MBF 
values and so the effect of flip angle errors on MPR should be minimal.        
 
Figure 6-12 shows the results of the model fit when the actual administered 
flip angle was varied.  The fitted data consistently underestimates the 
administered flip angle suggesting that the flip angle that the phantom 
experiences is consistently lower than that administered.  When the 
unconstrained model was fitted to these data the model tended to generate 
high ψ values and very low (<1o) flip angles.  These are unlikely to be 
representative of the true parameter values.  In order to generate Figure 
6-12 ψ was again constrained to not exceed 5x105. 
 
The need to constrain Ψ in the model means that the model is unstable with 
these datasets.  For this reason the fitted flip angles cannot be taken as 
good estimates of the actual administered flip angles.  However, in cases 
where the calibration factor was consistent and the model was stable (e.g. 
20o and 30o flip angles in Table 6-2) the fitted flip angle was still lower than 
the reported flip angle.  This implies that the administered flip angle is 
genuinely lower than that reported on the scanner console.  In any case, 
these simulations have shown that the changes in SI due to inaccurate flip 
angle distribution will be small.  This is not surprising as the predominant 
contribution to signal level will be the recovery time of the saturation pre-
pulse (TS).  
 
A limitation of the study is that it has only presented the results in terms of 
errors in signal intensity.  Propagating the errors distributions onto DCE-MRI 
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perfusion datasets and investigating the actual effect on the resulting MBF 
estimate would strengthen the study but this step has not been implemented 
in this investigation. 
 
6.4.5. Conclusion 
The signal intensity model predicts T1 phantom data with excellent 
agreement.  Investigations into the differences between the reported and 
administered flip angles have been inconclusive due to instabilities of the 
model.  However allowing flip angle as a free parameter has shown that the 
affects of flip angle errors on SI are small for the perfusion sequences 
considered and thus unlikely to affect MBF. 
 
  
130 
6.5. In-vivo experiments 
6.5.1. Introduction 
The next step in assessing the performance of the non-linear correction 
described in this chapter should be to assess its performance on in-vivo 
data.  In order to assess the non-linearity correction presented here on 
human data an independent assessment of MBF is required.  The dual-bolus 
approach (section 2.8.6) provides such an alternative.  However, the MBF 
estimates obtained from the dual-bolus datasets acquired for such 
investigations were much lower than the values expected from the literature.  
This prompted an investigation into dual-bolus protocol that was used, which 
is presented in this section 
 
The dual-bolus protocol uses a low dose pre-bolus to obtain an AIF where 
linearity can be assumed, followed by a normal dose bolus so that adequate 
SNR can be obtained in the myocardial curve.  Practically the process is 
complicated as it requires three syringes, (two bolus syringes of equal 
volumes but different concentration, and a saline flush syringe).  For this 
study the protocol recommended by Ishida et al. (131) was adopted, which 
uses a three-way tap to push the boluses into the injection line (see Figure 
6-13).  To test this protocol the method of Kostler et al. (141) was used, 
which compares the MBF acquired using the pre-bolus data alone with that 
acquired using the dual-bolus analysis.  As the linear assumption for SI 
should hold for both these analyses the results should be comparable, albeit 
with larger noise values for the pre-bolus myocardial data analysis, as has 
been shown using early dual-bolus protocols (141).      
 
6.5.2. Method  
Volunteer study 
Four healthy volunteers were recruited for the study.  The study was 
approved by the national research ethics service (05/Q1205/142) and all 
volunteers gave written informed consent.   Volunteers refrained from 
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caffeine for 24 hours before imaging.  Imaging was performed using the CE-
MARC study imaging protocol (section 5.2.1) except that the bolus injection 
protocol described in detail in (131), was used.  Two syringes of Gd-DTPA 
were prepared per perfusion scan (4 in total for rest and stress imaging).  
The two syringes contained equal volumes but the first syringe contained a 
0.005mmol/kg dose, achieved by dilution with saline solution, whereas the 
second contained 0.05mmol/kg.  Prior to imaging the pre-bolus syringe was 
attached to a 3-way tap in the line between the injector pump and the 
patient.  After the pre-bolus syringe was injected into the line the power 
injector was used to push 25ml of saline down the line, at a rate of 5ml/s, to 
force the pre-bolus into the patient.  The bolus syringe was then connected 
to the three way connector and injected into the line.  After a delay (~25s) 
the power injector was then used to push the bolus into the patient with 
another 25ml of saline.  As with the CE-MARC protocol stress imaging was 
performed first (induced with a 4 minute intravenous infusion of adenosine at 
140 mcg/kg/min) followed by rest imaging approximately 15 minutes later.   
Power 
injector
To patient
Bolus 
syringe
3-way 
connector
 
Figure 6-13 – Illustration of the dual-bolus injection method as described by 
Ishida et al. (131).  The pre-bolus syringe is connected to the three-way 
connector and injected into the line before the power injector flushes saline 
into the patient.  After a delay the process is then repeated with the full bolus 
syringe.   
 
Analysis 
The dual-bolus technique was evaluated by comparing the MBFs obtained 
using the dual-bolus analysis with the MBF obtained using the pre-bolus 
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data only.  For the dual-bolus analysis the pre-bolus AIF was multiplied by a 
factor of 10 (the bolus concentration ratio) and analysed with the myocardial 
uptake curve from the main bolus.  For the pre-bolus analysis both the AIF 
and myocardial uptake curves were taken from the pre-bolus.  The analysis 
is illustrated in Figure 6-14.  None of the data used in these analyses should 
exhibit significant non-linearity and so the resulting MBFs should be 
comparable, as has been shown with other dual-bolus protocols (141), albeit 
with a larger susceptibility to noise when using the low SNR pre-bolus tissue 
curve.  The MBF values from the two analyses were compared using a 
paired t-test.  
Pre-
bolus
Pre-
bolus
bolus bolus
Pre-bolus
pre bolus AIF
pre-bolus myo
- model fit
x 10
Dual-bolus
pre bolus AIF x 10
bolus myo
- model fit
 
Figure 6-14 – The analysis method for analysing the dual-bolus technique.  
The pre-bolus MBF is calculated using the AIF and myocardial uptake curve 
from the pre-bolus injection.  The dual-bolus MBF is calculated using the pre-
bolus AIF (dose corrected by multiplication by 10) and the bolus myocardial 
curve.  As neither result should exhibit significant non-linearity the resulting 
MBF values should not be significantly different.     
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Patient study 
As the number of volunteers in the first study was small the investigation 
was repeated on a ten patient pilot study looking into the effects of 
rheumatoid arthritis on MBF, that had been conducted using the same dual-
bolus injection protocol.  Ten patients diagnosed with rheumatoid arthritis 
gave informed consent in this small study approved by the regional ethics 
committee (10/H1307/103).  The patients underwent stress and rest, dual-
bolus DCE-MRI cardiac perfusion imaging using a protocol identical to that 
described above except that imaging was performed on a 3T magnet and an 
independent saturation pulse was used for each slice (TS = 100ms), as 
opposed to the shared pre-pulse used in the CE-MARC protocol.  Analysis 
was identical to that described in the preceding section.  In order to reduce 
the contouring time commitment only the basal slice was contoured for the 
AIF and the middle slice for myocardium.   
 
6.5.3. Results 
Volunteer study 
Mean MBF 
[ml/g/min] 
i) Pre-bolus ii) Bolus iii) Dual-
bolus 
Stress 4.77+1.24 3.42+0.68 1.16+0.23 
Rest 1.66+0.60 1.50+0.27 0.43+0.09 
MPR 3.45+1.02 2.35+0.14 3.16+0.29 
Table 6-3 – Stress MBF, rest MBF and MPR averaged over all volunteers and 
all slices (mean + standard deviation) analysed using i) pre-bolus (AIF and 
myocardial uptake curve taken from the pre-bolus), ii) bolus (AIF and 
myocardium taken from main bolus), iii) dual-bolus (AIF taken from pre-bolus 
and dose adjusted, myocardium taken from main bolus).  
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Ratio i) Pre-bolus 
/ Dual-Bolus 
ii) Pre-bolus 
/ Bolus 
iii) Bolus / 
Dual-bolus 
Stress 3.66 + 1.57 1.47 + 0.61 2.77 + 0.68 
Rest 3.91 + 1.64 1.14 +0.47 3.55 + 0.53 
MPR 1.22 + 0.89 1.68 + 1.07 0.80 + 0.25 
Table 6-4 –results expressed as ratios between analysis regimens (mean + 
standard deviation).  i) The ratio of pre-bolus to dual-bolus results, ii) the ratio 
of pre-bolus to bolus results and iii) the ratio of bolus to dual-bolus results. 
 
Table 6-3 shows the results, averaged over all volunteers and all slices, for 
stress MBF, rest MBF and MPR.  There are three analysis strategies 
displayed here: i) Pre-bolus – both AIF and myocardial curves are taken 
from the pre-bolus, ii) Bolus -  both AIF and myocardial curves are taken 
from the main bolus curves, iii) Dual–bolus – the AIF is taken from the pre-
bolus and dose corrected (multiplied by 10) whilst the myocardial curve is 
taken from the main bolus.  Table 6-4 represents the results as ratios 
between the analysis regimens. 
 
Due to the low concentration CA dose used for the pre-bolus, the myocardial 
uptake curves were particularly prone to noise.  Of the 12 (4 volunteers x 3 
slices) curves considered, six of the pre-contrast analyses were excluded 
because the data was too noisy to generate a meaningful fit of the model to 
the data. 
 
There was a significant difference between the pre-bolus and dual-bolus 
MBF values at stress (p=0.001) and rest (p=0.003) but not in the MPR 
(p=0.96).  The bolus MBFs were significantly different to the dual-bolus 
MBFs at stress (p<0.0001), rest (p<0.0001) and MPR (p=0.017). 
 
Patient Study 
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Mean MBF 
[ml/g/min] 
i) Pre-bolus ii) Bolus iii) Dual-
bolus 
Stress 2.54+0.86 3.70+0.92 1.32+0.33 
Rest 1.71+0.67 2.29+0.70 0.62+0.17 
MPR 1.81+1.28 1.70+0.44 2.21+0.76 
Table 6-5 - Stress MBF, rest MBF and MPR averaged over all patients (mean + 
standard deviation) analysed using i) pre-bolus(AIF and myocardial uptake 
curve taken from the pre-bolus), ii) bolus (AIF and myocardium taken from 
main bolus), iii) dual-bolus (AIF taken from pre-bolus and dose adjusted, 
myocardium taken from main bolus). 
 
Ratio i) Pre-bolus 
/ Dual-Bolus 
ii) Pre-bolus 
/ Bolus 
iii) Bolus / 
Dual-bolus 
Stress 2.08 + 0.82 0.69 + 0.18 2.88 + 0.61 
Rest 2.87 + 1.11 0.82 + 0.35 3.74 + 1.09 
MPR 0.94 + 0.96 1.15 + 1.0 0.80 + 0.20 
 
Table 6-6 –Results expressed as ratios between analysis regimens (mean + 
standard deviation).  i) The ratio of pre-bolus to dual-bolus results, ii) the ratio 
of pre-bolus to bolus results and iii) the ratio of bolus to dual-bolus results. 
 
Table 6-5 summarizes the MBF results from the larger, patient based data 
set, with the ratios shown in Table 6-6.  Two patients were excluded 
because the pre-bolus myocardial curves were too noisy to conduct a 
meaningful analysis.  There was a significant difference between the pre-
bolus and dual-bolus MBF values at stress (p=0.02) and rest (p=0.002) but 
not in the MPR (p=0.50).  The bolus MBFs were significantly different to the 
dual-bolus MBFs at stress (p<0.0001), rest (p=0.0001) and MPR (p=0.04). 
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6.5.4. Discussion 
 
Reference Pulse 
Sequence 
Quantitative 
perfusion 
method 
No. of 
cases 
REST STRESS 
MBF 
[ml/g/min] 
SD 
[ml/g/min 
MBF 
[ml/g/min] 
SD 
[ml/g/min 
Vallee 
1999(140) 
SR-
FLASH 
1-cmpt 
model 10 0.72 0.22 No data No data 
Kostler 
2004(141) SR-SSFP Fermi 11 0.75 0.25 No data No data 
Pack 
2008(6) 
SR-
FLASH 
Model 
independent 5 1.09 0.8 3.14 1.69 
Pack2009(4) 
SR-
FLASH Fermi 14 0.93 0.24 2.84 0.63 
Case weighted average 0.85 0.31 2.92 0.91 
Table 6-7 - Average of a selection of healthy subject, single-bolus, myocardial 
perfusion quantitation papers from the literature.  All studies were carried out 
with a single bolus dose of <= 0.02 mmol/kg. 
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Reference Pulse 
Sequence 
Bolus 
dosage 
pre/main 
[mmol/kg] 
No. of 
cases 
REST STRESS 
MBF 
[ml/g/min] 
SD 
[ml/g/min 
MBF 
[ml/g/min] 
SD 
[ml/g/min] 
Hsu 
2006(142) 
SR-EPI 0.005/0.1 10 1.02 0.22 3.39 0.59 
Hsu 
2008(27) 
SR-SSFP 0.005/0.05 10 0.64 0.1 0.91 0.21 
Icihara 
2009(126) 
SR-TFE 
(Patlak) 
0.005/0.05 10 0.86 0.25 No data No data 
Kostler 
2004(141) 
SR-SSFP 0.004/0.17* 11 0.73 0.15 No data No data 
Ritter 
2006(5) 
SR-SSFP 0.004/0.057 12 0.52 0.11 1.78 0.53 
Morton 
2012(85) 
kt turbo 
GRE 
0.0045/0.045 16 0.6 0.1 2.5 0.5 
Case weighted average 0.71 0.15 2.17 0.47 
* assuming a patient weight of 70kg 
Table 6-8 – Average of a selection of healthy subject, dual-bolus, myocardial 
perfusion quantitation papers from the literature.  All quantitative analyses 
were carried out using Fermi-constrained deconvolution except Icihara 2009, 
which used Patlak. 
 
Table 6-7 and Table 6-8 give a summary of MBF estimates in the literature 
for pre-bolus and dual-bolus protocols.  Only studies of healthy humans 
reporting MBF (as opposed to MPR), and without a concentration 
conversion, were included.  Table 6-7 gives average MBFs, weighted for 
study population, at rest and stress for published pre-bolus studies.  For the 
purposes of this analysis a pre-bolus was defined as a single bolus study 
using a bolus concentration <0.02 mmol/kg.  Table 6-8 gives corresponding 
average values for dual-bolus studies.  The results in Table 6-7 and Table 
6-8 provide evidence for the validity of the dual-bolus method in general.  
The average MBFs for rest and stress for the two methods in the literature 
agree with the standard deviation being larger for the pre-bolus method due 
to poorer SNR at lower contrast doses, in agreement with the single study 
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results of (141).   
 
Considering the results of the volunteer and patient studies presented in 
Table 6-3 to  Table 6-5 respectively, neither pre-bolus nor dual-bolus results 
agree well with these literature values.  The rest MBFs for the dual-bolus 
patient dataset do agree with the literature, however the stress MBFs are 
much lower.  This could be due to genuinely lower MBFs in this patient 
cohort but such a reduction in MBF would be surprising due to rheumatoid 
arthritis alone.  These patients were not known to be suffering from 
myocardial ischaemia. 
 
The results from the main bolus only should overestimate MBFs due to non-
linearity effects.  In the patient dataset this holds true and the bolus MBFs 
are greater than either pre-bolus or dual-bolus results in all cases.  However, 
in the volunteer dataset the pre-bolus results are greater.  The volunteer 
dataset was very small (n=4) and had a significant number of excluded 
slices due to noisy data in the pre-bolus curves and so this discrepancy is 
probably due to insufficient numbers. 
 
The philosophy of the dual-bolus method is to only use data where a linear 
relationship between SI and concentration can be reasonably assumed.  It 
has been shown that this assumption is valid for doses <0.01mmol/kg in the 
AIF and <0.05mmol/kg in the myocardium (105).  Thus the pre-bolus AIF 
and bolus myocardial uptake curves in this investigation should not be 
affected by non-linearity effects and should, in principle, generate the same 
MBF values, as has been shown previously (141) using a different injection 
scheme.  In both the volunteer and the patient study there was a significant 
difference between dual-pulse and pre-bolus based MBF estimates (see 
Table 6-4 and Table 6-6).  Dual-bolus MBFs were at least 2 times lower than 
pre-bolus MBFs in all cases.  This suggests that there are differences 
between the pre-bolus and bolus uptake curves other than the planned 
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tenfold change in concentration.    No significant difference was found 
between pre-bolus and dual-bolus MPRs implying that the differences in 
MBF are constant and proportional.   
Power 
injector Bolus 
syringe
3-way 
connector
bottle
saline
contrast 
agent
a)
b)
c)
 
Figure 6-15 – Diagram illustrating the bolus evaluation experiment.  The 
apparatus is set up as for a human study except the line is injected into a 
plastic bottle.  The bolus syringe is dyed using blue food colouring enabling 
the bolus to be qualitatively assessed visually for dispersion and clearance 
from the line. 
 
As the results of this study question the 1:10 ratio of bolus concentrations 
between the pre-bolus and bolus, a small qualitative experiment was 
conducted in order to assess the transit and clearance of the bolus through 
the line and into the patient.  The saline power injector, lines, 3-way tap and 
bolus syringe were set up as for patient injection, but the line was injected 
into a plastic bottle half filled with water.  The pre-bolus and bolus syringes 
were prepared with Gd-DTPA which was dyed with blue food colouring.  The 
dual-bolus injection protocol was carried out as normal but the, now visible, 
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bolus was inspected for dispersion in the line when stationary and for 
remnants in the line after injection of the saline flush (Figure 6-15). 
 
This qualitative experiment to try and visually assess bolus dispersion and 
clearance was conducted multiple times.  After initial injection the bolus 
stayed in the line for a few seconds, typically whilst patient breathing 
instructions or adenosine infusions were being given.  Very little dispersion 
of the bolus could be observed during this interval, which is evidence against 
the theory that different rates of diffusion (due to different bolus 
concentrations) in the line might be responsible for the MBF results.  During 
the saline flush the bolus disperses rapidly.  After the saline flush there was 
still a noticeable amount of dye in the line showing that the full bolus had not 
been injected.  This suggested that a larger flush volume should be used.  
However it was not possible to perceive a difference in the remnant volume 
left by the pre-bolus compared with that of the bolus, and so this does not 
explain the mismatch between the pre-bolus and dual-bolus results. 
 
6.5.5. Conclusion 
The results of the investigations into the dual-bolus protocol show that the 
version of the protocol used in these studies is inadequate as a reference 
standard against which to test the non-linearity correction algorithm 
presented in this chapter.  The reasons for the mismatch between the pre-
bolus and dual-bolus MBF estimates have not been found.  The mostly likely 
explanation would be that some aspect of the, relatively new, three-way tap 
method of administering the two boluses causes extra dispersion or dilution 
of the second bolus.  However, preliminary qualitative experiments using 
dyed boluses have not produced evidence to support this theory. 
 
6.6. Summary 
A method for converting cardiac perfusion DCE-MRI datasets from SI into 
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CA concentrations has been presented.  The method uses the imaging 
pulse-sequence equation, a pre-contrast signal measurement and an 
assumed T1 value for blood to calculate the concentration curve.  A detailed 
mathematical description of the imaging sequence used for studies in this 
thesis has been presented, incorporating the Philips, flip angle sweep.  The 
errors due to neglecting this flip angle sweep, neglecting T2* effects and due 
to errors in the assumed blood T1 have been investigated using simulations.  
A T1 phantom has then been used to assess the accuracy of the model and 
to investigate the likely magnitude of signal change that can be expected 
due to flip angle errors.  The conversion method has not been validated on 
in-vivo data, due to concerns about the dual-bolus data intended for this 
purpose.  An investigation into the dual-bolus protocol is presented showing 
that pre-bolus and dual-bolus MBF estimates do not match.  This suggests 
that differences are present between the pre-bolus and bolus other than the 
known ten-fold change in concentration.  Preliminary investigations into the 
source of these differences are reported. 
 
6.7. Limitations and future work 
The main limitation in this work is that an evidence based conclusion has not 
been provided to explain why the dual-bolus results do not match the pre-
bolus results.  This will be an area of further investigation.  The experiments 
to investigate bolus dispersion and clearance were qualitative and 
superficial.  The lack of ability to make quantitative measurements of the 
remnant dye in the line limits the usefulness of the experiment, particularly 
as the observed data can only be explained if one bolus concentration is 
changed by a different amount to the other.  The fact that the dye and Gd-
DTPA contrast agent are not bound chemically and may have different 
transit properties is a further limitation.  These weaknesses could be 
overcome by repeating the experiment using radioactively labelled DTPA 
(Tc99m-DTPA).  This would mimic much more closely the properties of Gd-
DTPA and quantitative measurements of the remnant tracer in the line could 
be made using a gamma counter. 
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The assessment of the plateau region in the SI vs. concentration plots is 
subjective.  A quantitative limit for when this curve plateaus could be 
achieved by applying simulated noise to these curves and establishing at 
what point a given SI yields multiple T1 values.  This would be a more 
objective way of assessing these curves. 
 
Both the volunteer (n=4) and the patient (n=8) dual-bolus studies are small 
cohorts.  The conclusions would be strengthened by larger study numbers.
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7. Evaluation of the effect of myocardial 
segmentation errors on myocardial blood 
flow estimates from DCE-MRI1 
7.1. Introduction 
To estimate myocardial blood flow (MBF) from dynamic contrast enhanced 
MRI (DCE-MRI) cardiac perfusion datasets, contours depicting the 
myocardium and arterial input function (AIF) must be drawn for each frame 
in the DCE-MRI series (See section 5.3). Manual contour drawing is time 
consuming and is a significant factor hindering the acceptance of 
quantitative perfusion into clinical practice (143). Understanding the level of 
accuracy required in the drawing of these contours is a key step in 
addressing this problem.  How much a given error is likely to affect MBF 
measurements will dictate how carefully, and thus how quickly, a human 
contour drawer can perform their task. Such insights are also important in 
the evaluation of automated segmentation algorithms, which tend to be 
evaluated with a wide range of segmentation error metrics making it difficult 
to cross compare algorithm performance, e.g. (144–146). The focus of such 
algorithms tends to be on the accuracy of segmentation of the myocardial 
region of interest in high quality datasets, with poorer quality images being 
discarded as outliers (145). However, poor quality images are a clinical 
reality and these algorithms may be aiming to achieve an unnecessary level 
of segmentation accuracy.  Given the wide variety of sources of error in MBF 
estimates, it may be the case that sacrificing segmentation accuracy in order 
to maintain robustness to poor image quality will have an insignificant effect 
on MBF estimates.  The purpose of this study was to investigate the 
relationship between geometrical errors in myocardial segmentation and 
error in MBF by imposing computationally simulated contour errors onto 17 
healthy volunteer cardiac perfusion datasets.  This relationship will provide a 
                                            
1 The investigation presented in this chapter has been previously published 
(159) 
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basis on which to decide acceptable error limits for myocardial contours, 
whether manually or automatically generated. It is also important for 
understanding whether automated segmentation algorithms evaluated in 
terms of segmentation metrics, e.g. (144), can be meaningfully compared 
with algorithms evaluated using MBF error, e.g. (146), and may be 
instructive in deciding how best to evaluate such algorithms in the future. 
 
7.2. Method 
7.2.1.  Datasets 
The study was carried out on the dual-phase data set described in section 
5.2.2 and contoured as described in section 5.3.  After contouring, the 
myocardium was divided into six circumferentially equidistant regions 
according to the model proposed by the American Heart Association (AHA) 
(106) for the mid ventricular slice. These regions were then further divided 
circumferentially into endocardial and epicardial compartments resulting in a 
total of 12 partitions as illustrated in Figure 7-2 (b). 
 
7.2.2. Inter and Intra-observer variability to validate contour error 
simulations 
To ascertain whether the contour errors simulated in this study were 
representative of human contour errors a subset of 11 patients were 
contoured a second time by the same person to assess intra-observer 
variability. A second observer also contoured the dataset to assess inter-
observer variability. To measure the error between each contour and the 
reference contour the Euclidean distance between each point on the 
reference contour and the nearest point on the contour being investigated 
was calculated. The distribution of these errors was then compared to the 
corresponding distribution between the reference contour and the random 
contour errors simulated in this paper.  This was tested using the 
Kolmogorov–Smirnoff test (147), which calculates the probability that two 
samples have been drawn from the same underlying continuous population. 
The inter/intra-observer variability data were analyzed considering stress 
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and rest and endo- and epicontours separately and then finally analyzed 
considering all cases together.  
 
7.2.3. Random contour errors  
a) b)  
Figure 7-1 - a) Example of generated contour errors. The thin line shows the 
manual contour and the bold line shows the generated erroneous contour 
generated with a maximum deviation (MD) of 0.1MW. b) A single frame of a 
cardiac perfusion sequence showing manual contouring. The left ventricular 
cavity is filled with Gd-DTPA and appears bright against the surrounding 
myocardium. 
 
Random contour errors were generated by introducing random radial 
deviations into the manual contour. The manual contour was represented as 
a circular spline by automatically placing equally spaced knot points along 
the defined contour. The knot points of the spline were offset by a random 
radial displacement allowed to range between ±MD, where MD is the 
maximum deviation, being the maximum distance the contour may deviate 
from the „true‟ contour. MD was expressed as a fraction of the mean 
myocardial width (MW) so that the degree of contour error was normalized to 
the size of the heart.  A new contour was generated from these offset knot 
values to represent the erroneous curve. Figure 7-1 (a) shows an example of 
a generated erroneous contour with MD = 0.1MW. Ten knot points were 
chosen to represent the contour to maintain a realistically smooth contour. 
Each randomly generated set of offset values was applied to contours at all 
time points in all patients. This process was repeated over 30 iterations of 
the random offset value generation. The process was repeated using MD = 
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0.1MW, 0.2MW, 0.3MW, 0.4MW and 0.5MW. F-tests and t-tests between 
the „true‟ and erroneous contour datasets were performed to test for 
significant differences in the variances and means of the distributions 
respectively.  
 
7.2.4. Systematic contour errors 
Systematic underestimates and overestimates of the myocardial region of 
interest were generated by setting the MD to a constant offset value over all 
the knot points. For each frame of the cardiac DCE-MRI perfusion dataset 
the myocardial contours were modified by systematic MD values ranging 
from −0.5MW to +0.5MW.  Figure 7-2 (a) illustrates the directions of positive 
and negative errors.  Differences were calculated, at rest and stress, 
between the MBFs estimated from modified and unmodified contours and 
the difference in the means of the resulting distributions was assessed using 
a statistical t-test. 
a) b)
Endocardium
Epicardium
1. Anterior 
2. Anterolateral
3. Inferolateral
4. Inferior
5. Inferoseptal
6. Anteroseptal
Left ventricle
Right ventricle
 
Figure 7-2 - (a) A representation of the systematic contour errors illustrating 
the directions of the positive and negative errors.    (b) Partitioning of the 
myocardial ROI. 
 
7.2.5. Segmentation metrics 
Segmentation errors were evaluated with two well recognised geometric 
segmentation metrics, Hausdorff distance (HD) (148), based on the distance 
between the two contours and Dice‟s similarity coefficient (DSC) (149,150), 
based on the overlapping areas of the two contours and in terms of error in 
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myocardial blood flow (MBF).  Maximum deviation (MD) as defined above 
was also used as a segmentation metric.  Pearson‟s correlation between 
each segmentation metric and the MBF estimate was carried out to test 
whether the measures were well correlated. 
 
7.2.6. Quantitation of MBF 
Both AIF and myocardial uptake signal curves were converted to 
concentrations using the method described in chapter 6 using an assumed 
T1 value of 1393 ms. The conversion from signal intensity to concentration 
was successful in 16/17 volunteers, with one dataset being excluded 
because the concentration conversion yielded erroneously high peak AIF 
concentrations, as described in section 6.3.4.  The MBF was quantified from 
the left ventricular blood pool and myocardial tissue concentration versus 
time curves using a Fermi-constrained deconvolution method (120), (section 
4.3.3).  Prior to MBF estimation the curves were interpolated, baseline 
corrected and temporally shifted for the difference between AIF and 
myocardial bolus arrival times using the automated methods described in 
section 5.4. 
 
7.2.7. Units of contour error 
The data in this study are expressed in terms of the maximum deviation 
(MD) that a contour is allowed to deviate from its „true‟ value. This is no less  
meaningful a measure of contour error than recognised segmentation 
metrics as we will show that these do not correlate with MBF error (section 
7.3.1).  Furthermore, it is consistent with the concept behind our philosophy 
of simulating contour errors and can be directly interpreted as a contour 
error tolerance. Expressing MD in terms of voxels would be inadequate 
because voxel sizes change between MRI acquisitions. Converting results 
into absolute spatial measures (mm or mm2) is not appropriate either, as any 
cohort of cardiac MR images will contain a range of heart sizes; thus, a 
given absolute contour error will have a more profound effect on a smaller 
heart than on a large one. For these reasons, contour errors in this study are 
expressed as a fraction of the mean myocardial width (MW) of the specific 
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heart being considered. Expressing contours this way ensures that a given 
contour error has the same effect across the entire dataset in terms of its 
relative geometric change to the myocardial contour with respect to the 
myocardium. 
 
7.3. Results 
Using the manual contours the mean (± standard deviation) MBF at rest was 
1.24 ± 0.35 ml g−1 min−1 and at stress was 3.48 ± 0.67 ml g−1 min−1. The 
mean myocardial width (MW) in the reconstructed images was 5.8 voxels 
(range: 3.3–8.6 voxels) and 6.9 mm (range: 4.2–10.3 mm). 
 
7.3.1. Segmentation metrics 
Table 7-1 shows Pearson‟s correlation scores between MBF error and 
maximum deviation (MD), Dice‟s similarity coefficient (DSC) and Hausdorff 
distance (HD) for endo- and epicardial modification at rest and stress 
considered separately and as one dataset.  Contour errors were generated 
using the random contour error simulator.  None of the segmentation metrics 
correlated with MBF error with the most significant correlation at 
r = −0.32. 
Contour Error  MD DSC HD (mm) 
Rest endocardium 0.03 0.03 0.02 
Rest epicardium -0.14 0.15 -0.17 
Stress endocardium 0.07 -0.10 0.04 
Stress epicardium -0.22 0.26 -0.32 
Rest and stress, endo- and epicontour -0.08 0.17 -0.13 
 
Table 7-1 - Table of the Pearson’s correlation r-value between MBF error 
(ml/g/min) and each of the three segmentation error metrics: maximum 
deviation (MD) expressed as a fraction of the mean myocardial width (MW), 
Dice’s similarity coefficient (DSC) (no units) and Hausdorff distance (HD) 
(mm). Results are shown considering errors in rest/stress and 
endocontour/epicontour separately and finally over all data. 
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7.3.2. Systematic contour errors 
 
Figure 7-3 - Global MBF errors versus MD (expressed as a fraction of the 
mean myocardial width) for systematic contour errors in the rest endocardial 
contour (top left) rest epicardial contour (top right), stress endocardial 
contour (bottom left) and stress epicardial contour (bottom right). Error bars 
show the standard deviations. 
 
Figure 7-3 shows the spread of MBF errors for each MD for the endocardium 
and epicardium at rest and stress over the entire myocardium. Positive MD 
values correspond to contours modified circumferentially outwards (moving 
away from the centre of the myocardial circle) and negative contours 
correspond to contours modified circumferentially inwards (see Figure 7-2 
(a)).  Errors in MBF were calculated as the difference between the MBF 
estimated with the modified contours and the MBF estimated with the 
manual contours. Student‟s t-test between the modified and unmodified MBF 
error populations yielded non-significant p-values for all MD values.   
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Figure 7-4 -  Regional MBF error versus MD (expressed as a fraction of the 
mean myocardial width) for systematic contour errors in the rest endocardial 
contour (top left) rest epicardial contour (top right), stress endocardial 
contour (bottom left) and stress epicardial contour (bottom right). 
 
Figure 7-4 shows the MBF errors for the six separate myocardial regions. 
Individual t-tests for each segment showed no significant difference in mean 
MBF except for the inferoseptal segment, where a resting epicardial MD of 
0.5MW gave (p = 0.05) and a stress endocardial MD of −0.5MW gave (p = 
0.02).  Figure 7-5 shows the corresponding analysis when the endocardium 
and epicardium were considered separately. When the epicardial contour is 
modified only the signal from the epicardium is incorporated in the analysis 
and when the endocardial contour is modified only the endocardial tissue is 
considered. The t-test for sub-myocardial segments showed generally more 
statistically significant results than for transmural segments. Significant 
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differences were seen in the endocardial inferospetal segment for MD = 
−0.5MW at rest (p < 0.05) and stress (p < 0.03), the epicardial inferoseptal 
segment at stress for MD = 0.5MW (p = 0.01) and MD = 0.4MW (p = 0.04), 
the epicardial inferior segment at rest for MD = 0.5MW (p = 0.03), the 
epicardial anterior segment for MD = 0.5MW at rest (p = 0.04) and stress  (p 
= 0.03) and in the epicardial inferior segment for MD = 0.5MW at rest (p = 
0.02) and stress (p = 0.02). 
 
 
Figure 7-5 - Regional MBF errors divided into endocardial and epicardial 
segments versus MD (expressed as a fraction of the mean myocardial width) 
for systematic contour errors in the rest endocardial contour (top left), rest 
epicardial contour (top right), stress endocardial contour (bottom left) and 
stress epicardial contour (bottom right). 
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7.3.3. Random contour errors 
 
Figure 7-6 - Box-plots of MBF errors versus MD (expressed as a fraction of 
the mean myocardial width) for random contour errors in the rest endocardial 
contour (top left), rest epicardial contour (top right), stress endocardial 
contour (bottom left) and stress epicardial contour (bottom right). Lines, box 
edges and whiskers of each box-plot correspond to the median, inter-quartile 
range and 95% percentile range of MBF errors respectively. The dashed black 
lines depict ± one standard deviation of the MBF values obtained with the 
manual contours. 
 
Mean myocardium. Figure 7-6 shows the effect of the random contour errors 
on MBFs estimated over the entire myocardium. Each box-plot represents 
MBF errors incurred using contours whose random deviations were limited 
to the given MD on the x-axis. The central line, box and whiskers correspond 
to the median, interquartile range and 95% percentile range respectively. F-
tests and t-test for differences in variance and mean MBF error between 
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manual and modified contours were non-significant (p > 0.05) in all cases 
except a MD of 0.5MW in the resting epicardium (t-test: p = 0.03). At stress 
an MD of 0.5MW in the myocardium approached statistical significance (t-
test: p = 0.07). 
 
Region 
(corresponding 
artery) 
Rest / 
Stress 
Endo / 
Epi 
MD (MW) Test p-value 
Anterior (LAD) Stress Endo 0.5 F-test 0.04 
Anterior (LAD) Stress Epi 0.5 t-test 0.04 
Inferolateral (LCX) Stress  Endo 0.5 F-test <0.01 
Inferior (RCA) Rest Endo 0.5 F-test 0.05 
Inferior (RCA) Rest Epi 0.4 t-test 0.04 
Inferior (RCA) Stress Epi 0.5 t-test 0.02 
Inferoseptal (RCA) Stress Epi 0.5 t-test 0.02 
Anteroseptal (LAD) Rest Epi 0.5 t-test 0.02 
Anteroseptal (LAD) Rest Epi 0.2 F-test <0.01 
 
Table 7-2 - Table of statistically significant MBF errors generated by random 
contour errors considering the six myocardial regions. MD corresponds to 
the maximum deviation at which MBF errors became significant. Cases where 
significant (p <0.05) differences were not observed are not shown. 
 
Regional myocardium. The effects of random contour errors on MBF in the 
six separate myocardial regions showed similar trends to Figure 7-6, with the 
spread of MBF errors increasing with MD.  Figure 7-7 shows the interquartile 
ranges for each region at each MD value for all the contours.  Statistically 
significant results are shown in  
Table 7-2. 
 
154 
 
 
Figure 7-7 – Interquartile range of MBF error for each myocardial region 
plotted against MD (expressed as a fraction of the mean myocardial width) for 
random contour errors in the rest endocardial contour (top left), rest 
epicardial contour (top right), stress endocardial contour (bottom left) and 
stress epicardial contour (bottom right). 
 
Endo- and epicardium. Considering the endocardium and epicardium as two 
separate regions showed similar trends with a more dramatic increase in the 
spread of MBF values with increasing MD. The corresponding interquartile 
range plots are shown in Figure 7-8 and all statistically significant differences 
in mean (t-test) and variance (F-test) of MBF errors are reported in Table 
7-3. 
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Figure 7-8 - Interquartile range of MBF error for each myocardial region 
divided into endocardial and epicardial segments versus MD (expressed as a 
fraction of the mean myocardial width) for random contour errors in the rest 
endocardial contour (top left), rest epicardial contour (top right), stress 
endocardial contour (bottom left) and stress epicardial contour (bottom right). 
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Region Rest / 
Stress 
Endo / 
Epi 
MD (MW) Test p-value 
Anterior(LAD) Stress Epi 0.5 t-test <0.01 
Anterior(LAD) Rest Epi  0.4 F-test 0.02 
Anterior(LAD) Stress Endo 0.4 F-test 0.02 
Anterior(LAD) Rest Endo 0.5 F-test 0.03 
Anterolateral (LCX) Rest Endo 0.4 F-test 0.02 
Anterolateral (LCX) Stress Epi 0.4 F-test 0.04 
Inferolateral (LCX) Rest Endo 0.3 t-test 0.04 
Inferolateral (LCX) Rest Endo 0.3 F-test 0.05 
Inferolateral (LCX) Stress Endo 0.4 F-test <0.01 
Inferior (RCA) Stress Epi 0.4 t-test 0.02 
Inferior (RCA) Rest Endo 0.5 t-test 0.01 
Inferior (RCA) Rest Epi 0.5 t-test 0.05 
Inferior (RCA) Stress Endo 0.5 t-test 0.01 
Inferior (RCA) Stress Endo 0.4 F-test 0.04 
Inferior (RCA) Rest Endo 0.5 F-test <0.01 
Inferoseptal (RCA) Stress Endo 0.3 t-test 0.05 
Inferoseptal (RCA) Stress Endo 0.4 F-test 0.04 
Anteroseptal (LAD) Rest Epi 0.2 t-test 0.02 
Anteroseptal (LAD) Stress Endo 0.5 t-test 0.01 
Anteroseptal (LAD) Rest Epi 0.1 F-test 0.01 
Anteroseptal (LAD) Stress Endo 0.3 F-test 0.01 
Mean Rest Epi 0.5 t-test 0.03 
Mean Stress Endo 0.5 t-test 0.05 
Mean Stress Endo 0.4 F-test 0.04 
Mean Rest Endo 0.5 F-test 0.01 
 
Table 7-3 - Table of statistically significant MBF errors generated by random 
contour errors considering the endocardium and epicardium separately. MD 
corresponds to the maximum deviation at which MBF errors became 
significant. Cases where significant (p <0.05) differences were not observed 
are not shown. 
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7.3.4. Inter- and intra-observer variability to validate contour error 
simulations 
a) b)
 
Figure 7-9 - Distribution of inter-(a) and intra-(b) observer contour errors 
(thick black lines). The corresponding distributions of contour errors between 
manual and simulated contours at each MD setting are also shown (thin 
coloured lines). 
 
Figure 7-9(a) shows the distribution of contour errors between the manually 
drawn contours of the first and second observers (inter-observer) and the 
distribution of random contour errors between the simulated and manual 
contours for each MD. Kolmogorov–Smirnoff tests between each simulated 
distribution and the inter-observer distribution yielded the following p-values: 
0.1MW(p = 0.01), 0.2MW(p = 0.08), 0.3MW(p = 0.08), 0.4MW(p = 0.38) 
and 0.5MW(p = 0.93). Figure 7-9 (b) shows the corresponding distribution for 
the repeated manually drawn contours (intra-observer). Kolmogorov–
Smirnoff tests between the simulated distributions and the intra-observer 
distribution yielded the following p-values: 0.1MW(p = 0.03), 0.2MW(p = 
0.19), 0.3MW(p = 0.19), 0.4MW(p = 0.67) and 0.5MW(p = 0.93). Figure 7-9 
includes contour errors from stress and rest, and endo- and epicontours all 
together. The separate analyses of each of these four cases for inter and 
intra-observer distributions are shown in Figure 7-10 and Figure 7-11 
respectively yielding non-significant (p < 0.05) Kolmogorov–Smirnoff tests in 
all cases. 
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Figure 7-10 - Distribution of inter observer contour errors (thick lines) for the 
rest endocardial contour (top left), rest epicardial contour (top right), stress 
endocardial contour (bottom left) and stress epicardial contour (bottom right). 
The corresponding distributions of contour errors between manual and 
simulated contours at each MD setting are also shown (thin lines). 
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Figure 7-11 - Distribution of intra observer contour errors (thick lines) for the 
rest endocardial contour (top left), rest epicardial contour (top right), stress 
endocardial contour (bottom left) and stress epicardial contour (bottom right). 
The corresponding distributions of contour errors between manual and 
simulated contours at each MD setting are also shown (thin lines). 
 
7.4.  Discussion 
Using the manual contours the mean (± standard deviation) MBF at rest was 
1.24 ± 0.35 ml/g/min and at stress was 3.48 ± 0.67 ml/g/min, which is 
consistent with other studies measuring MBF in healthy volunteers, e.g (4). 
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7.4.1.  Segmentation metrics 
None of the segmentation metrics considered correlated with MBF error for 
the random contour error simulation.  In the light of the results from the 
systematic contour error simulations this result is not surprising. A given 
contour error may correspond to a movement of either the endocardial or 
epicardial contour into any of a variety of surrounding tissues, depending on 
the position of the error along the myocardial circumference, with conflicting 
effects on MBF. The conclusion is that neither MBF error nor segmentation 
alone is an adequate measure of contour error as there are too many 
conflicting factors affecting the relationship between these two measures. 
Thus, if contour errors are random in nature then analysis in terms of MBF 
error may only show an increase in the variance of the MBF errors, with 
insignificant changes in the mean MBF. This could lead to misleading claims 
about the accuracy of an automated algorithm. If the algorithm produces 
contour errors of a systematic nature then measures of MBF error may be 
correlated with segmentation error, as described in Figure 7-3.  However the 
relationships between contour error and MBF shown are not linear and it is 
unlikely that an algorithm would induce systematic errors as uniformly as 
those simulated here. Therefore, contouring algorithms for DCE-MRI 
myocardial perfusion should ideally be evaluated by both geometric 
segmentation metrics and in terms of MBF. 
 
7.4.2.  Systematic contour errors 
The application of systematic contour errors to the dataset is useful for 
understanding how MBF errors vary depending on which contour 
(endocontour/epicontour) has moved and which direction it has moved in. 
They also serve to simulate systematic conservative or generous contouring. 
A given contourer may be overly concerned with avoiding non-myocardial 
voxels or conversely including all myocardial voxels thereby making this type 
of systematic error.  Indeed the inter-observer contour error distribution 
reported in this study Figure 7-9 (a) suggests a systematic difference in 
contours between observers of this type. It is conceivable that such global 
contour errors could occur with automated contouring algorithms as well. For 
example, active contour-based methods with non-ideal stopping functions 
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may generate consistent global over or underestimates in the contour, and 
an active appearance model driven method such as (144) will be as 
conservative as the manual dataset on which it is trained.   
 
Global myocardium, systematic errors 
Considering the whole myocardial region systematic contour errors of up to 
half the mean myocardial width did not yield statistically significant errors in 
MBF, Figure 7-3.  Systematic trends in MBF error were seen as the contours 
were modified. These trends can be explained in the light of previously 
observed physiological flow properties of the myocardium. Animal studies 
have measured the presence of a transmural MBF gradient across the 
resting myocardium favouring the endocardium, which was no longer 
observed under stress conditions (77,151,152) and these observations have 
been confirmed in humans (79) including work based on the dataset used in 
this study (108). In the light of these observations the trends in Figure 7-3 
can be explained as follows: 
 
Variation of endocardial contour at rest. The MBF error increases with 
negative contour error (as defined in Figure 7-2 a)) as the endocardial 
contour encroaches on the voxels within the left ventricular blood pool. 
Rapid signal enhancement in the left ventricular blood pool causes MBF 
overestimation (i.e. positive MBF error) when blood voxels are incorporated 
into the myocardial ROI.  With positive contour error, endocardial voxels, 
with high MBF relative to the epicardium are excluded; thus, the relative flow 
decreases and the MBF error becomes negative. 
 
Variation of epicardial contour at rest. Negative contour errors cause an 
increase in MBF error as the relatively low MBF epicardial voxels are 
excluded from the myocardial region.  Positive contour errors will incorporate 
non-myocardial voxels of zero signal enhancement (thus zero MBF) into the 
region, thus reducing MBF and causing negative MBF errors. 
 
Variation of endocardial contour at stress. As seen at rest the negative 
contour errors increase the MBF error due to the incorporation of blood 
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voxels into the myocardial ROI. At MD values greater than −0.2MW this 
effect is not apparent, which may be due to conservative contouring by the 
manual contourer. There is a clear increase in MBF error with positive 
endocontour errors which implies a reverse transmural MBF gradient (with 
the epicardium more highly perfused than the endocardium).  As the 
endocardial contour encroaches on the myocardium, the low MBF voxels in 
the endocardium are excluded, thus increasing the MBF error. 
 
Variation of the epicardial contour at stress. As at rest positive contour errors 
reduce MBF error.  There is also a reduction in MBF error with negative 
contour error which is further evidence for a reverse transmural MBF 
gradient at stress causing negative MBF errors as the higher MBF voxels in 
the epicardium are excluded. 
 
Whereas the presence of a resting transmural MBF gradient is accepted, 
there is conflicting evidence for the presence of a transmural flow gradient at 
stress. Lee et al. (79) observed no such gradient in healthy myocardial 
tissue at stress, but Christian et al. (77) observed a transmural (epi > endo) 
gradient at stress that was statistically significant in canines.  Such a reverse 
MBF gradient may be a genuine physiological phenomenon or may be due 
to measurement errors inherent in the acquisition or analysis. A possible 
explanation might be the inclusion of endocardial dark rim artifacts in the 
myocardial region of interest, which could null the endocardial MBF values 
thereby generating the observed gradient.   
 
Regional myocardium, systematic errors  
A measurement of the global MBF is of limited use in investigating coronary 
artery disease, which induces localized flow defects. The American Heart 
Association (AHA) model (106) partitions the mid-myocardial slice into six 
circumferentially equidistant regions that are associated with specific 
coronary arteries, enabling the link between the perfusion imaging result and 
the required intervention (see section 8.5). The transmural variation in MBF 
between endocardial and epicardial tissue has also been shown to be 
related to arterial stenosis (79); therefore, it is important to consider the 
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effect of contour errors on this further partitioning of the myocardium.  For 
these reasons the myocardial regions were also divided into the 12 partitions 
illustrated in Figure 7-2(b).  In general the six region curves followed the 
same general trends as those for the whole myocardium with some notable 
exceptions. At rest positive epicardial contour errors for the anteroseptal 
segment yielded positive MBF errors, opposing the general trend across the 
rest of the myocardium of negative errors.  This is due to the inclusion of 
blood voxels in the right ventricle directly adjacent to this myocardial 
segment, which exhibit rapid signal enhancement.  The effect is less 
apparent on the corresponding stress plot because the relative effect of the 
right ventricular voxels is reduced with respect to the higher genuine 
myocardial MBF at stress. At stress, the contour errors pushing the contours 
inside the myocardium (i.e. negative epicontour errors and positive 
endocontour errors) appear to effect the anterior segments more profoundly 
than the remaining segments. There is no reason to expect a stronger 
transmural gradient in the anterior myocardium so this observation is 
unexplained. In general, the trends observed in the mean myocardial data 
are somewhat obscured, either by errors in the measurement process, which 
is to be expected due to poorer SNR in the smaller segments, or by genuine 
heterogeneity of MBF gradients around the myocardium. Regional analysis 
of systematic errors, Figure 7-4, showed non-significant MBF errors except 
for the inferoseptal segment where a resting epicardial MD of 0.5MW gave 
(p = 0.05) and a stress endocardial MD of −0.5MW gave (p = 0.02); thus, a 
tolerance level of MD = 0.4MW would avoid significant errors in MBF when 
regional subdivisions are employed. 
 
 Endo and epicardium, systematic errors 
After further subdivision into endocardial and epicardial layers was made 
(Figure 7-1 (b)), significant errors in more segments at MD = ±0.5MW were 
seen. This is due to the greater percentage effect of a given voxel offset on 
the ROI. A tolerance of MD = 0.3MW was required to avoid all significant 
MBF errors with the most susceptible region being the epicardial inferior 
segment at rest which exhibited significant MBF errors at MD = 0.4MW 
(p = 0.04).  
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Recommendations, systematic errors 
These results suggest that systematic errors limited to an MD of 0.3 times 
the mean myocardial width will not incur a statistically significant MBF error, 
even with a 12 partition myocardium.  Generally, the largest MBF errors 
were seen when the contours passed outside of the myocardium, either 
epicardially or endocardially; thus, conservative contouring is preferable to 
generous contouring for healthy volunteers. Where possible, segmentation 
algorithms should err on the side of placing the endocardial contour within 
the myocardium. However, in ischaemic patients with subendocardial 
abnormalities, the placement of the subendocardial contour may be more 
critical than these volunteer based results suggest for diagnosing ischaemia. 
 
7.4.3. Random contour errors 
Global myocardium, random errors 
The box-plots in Figure 7-6 illustrate how the spread of MBF errors 
increases with MD.  For a random contour error applied to a linear MBF error 
space, one would expect the median MBF error to remain at zero 
independent of the size of the contour error. However, as the MBF is not 
linear (Figure 7-3), the median MBF error deviates from zero with increasing 
MD (Figure 7-6).  This  did not cause a statistical shift in mean MBF up to 
contour errors of 0.4MW.  The increase in spread of MBF values with 
contour error is expected but F-tests did not show this to be significant even 
at 0.5 of the mean myocardial width and the 95% confidence interval for 
MBF errors did not exceed the one standard deviation line of „true‟ MBFs up 
to MD = 0.5MW. This shows that the simulated contour errors did not induce 
a statistically significant change in the distribution of MBFs implying that the 
variance induced in MBF estimates from the simulated contour errors is not 
significant compared to the natural variance of MBF within the healthy 
population. A statistically significant effect was seen for MD = 0.5MW in the 
resting epicardium (t-test: p = 0.03).  This is predominantly caused by the 
effect of the epicardial contour bleeding into the right ventricular blood pool 
as is clarified by the segmental analysis. These results suggest that a safety 
tolerance of MD = 0.4MW would be acceptable for the analysis of MBF in the 
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global myocardium. 
 
Regional myocardium, random errors 
Regional analysis of the myocardium (Figure 7-7) yielded similar trends in 
the spread of MBF errors to Figure 7-6 with the spread in MBF error 
increasing more severely with MD than in the mean myocardium due to the 
more profound effect a given contour error has on smaller ROIs.  In general, 
statistically significant MBF errors were avoided by setting a tolerance of MD 
< 0.3MW ( 
Table 7-2). The exception was the anteroseptal segment for which 
statistically significant changes in the variance of the MBF error distributions 
were seen for the resting epicardium for MD = 0.2MW (F-test: p < 0.01). 
Bleeding of the epicardial contour into the right ventricular blood pool 
incorporates voxels with rapid signal enhancement (due to fast flowing blood 
in the right ventricle) into the myocardial ROI incurring severe changes in 
estimated MBF. At stress, the genuinely higher MBF obscures the effect of 
the right ventricular voxels and a significant effect is not observed. These 
results suggest that a safety tolerance of MD = 0.3MW would be acceptable 
for regional analysis of MBF in the healthy myocardium, excluding the 
anteroseptal segment of the resting epicardium, which requires an accuracy 
of MD = 0.1MW. 
 
 Endo and epicardium, random errors 
Considering the endo- and epicardium as separate regions the spread of 
MBF error increases more rapidly again with increasing MD due to the 
further decrease in ROI size (Figure 7-8). A tolerance of MD < 0.2MW is now 
required to avoid significant MBF errors, excepting the anteroseptal segment 
which sees significant effects even at MD = 0.1MW in the resting epicardium 
(F-test p = 0.01). Considering the mean endocardium and mean epicardium, 
a tolerance of MD < 0.3MW is sufficient to avoid significant MBF errors. 
 
Recommendations, random errors 
For a global analysis a tolerance of 0.4MW is adequate.  For regional 
analysis MD < 0.3MW is required and if further subdivision into endocardial 
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and epicardial regions is to be carried out MD < 0.2MW is required.  For any 
of the regional analyses the epicardium in the septal regions requires an 
even higher accuracy (<0.1MW) and conservative contouring is 
recommended to avoid the right ventricular blood pool.  
 
7.4.4. Inter- and intra-observer variability to validate contour error 
simulations 
Contour errors were required to be random, in the absence of knowledge of 
any more systematic form of error population, whilst maintaining a smooth 
circular form, as one would not expect a manual contourer to deliberately 
generate sharp corners or high frequency oscillations in the contour. To 
assess whether the simulated contour errors were representative of human 
contour errors, the simulated error distributions were compared with inter- 
and intra-observer contour error distributions as shown in Figure 7-9 (a) and 
(b) respectively.  The simulated distributions of contour errors were similar to 
both the inter- and intra-observer empirically observed distributions.  Visually 
the 0.4MW and 0.5MW MD simulations best matched the inter-observer 
variability , with the closest agreement to the intra-observer distribution being 
the 0.2MW and 0.3MW MD simulations.  The Kolmogorov–Smirnoff test 
results confirmed this observation showing that there is insufficient evidence 
to reject the null hypothesis that the inter/intra-observer contour errors were 
drawn from the same underlying distribution as the simulated contour errors 
for all MD values except in the MD = 0.1MW case. This result was 
maintained when the separate stress, rest, endocontour and epicontour 
distributions were analysed (Figure 7-10 and Figure 7-11).   
 
The inter-observer variation in contour errors was broader than that of intra-
observer variation.  This is unremarkable as one would expect separate 
observers to disagree more than a single observer reproducing his/her 
contours. The bimodal shape of the inter-observer contour error distribution 
was due to one of the observers being consistently more conservative in 
their contouring. This is evident when the endo- and epicontour distributions 
are considered separately.  Figure 7-10 shows a negative bias in the 
endocardial inter-observer distribution and a corresponding positive bias in 
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the epicardial distribution, consistent with a systematic difference between 
the two contourers. 
 
7.4.5.  Limitations 
This study has been carried out on healthy volunteers only. The inclusion of 
ischaemic patients, whose MBF is compromised, would incorporate a 
confounding factor into the data. Contour error limits have been 
recommended under which healthy MBF estimates do not vary significantly. 
The effect of such errors on ischaemic patients has not been investigated 
and the tolerances required there may differ.   
 
MBF varies between systole and diastole (128). To exclude this complicating 
factor from the study, only systolic images were analyzed. The systolic 
myocardium is thicker and thus easier to contour, thus providing a more 
trustworthy contour reference standard. The contour accuracy required for 
analyzing diastolic data, where the myocardial wall is thinner, may be higher.  
Thus, strictly speaking, the conclusions of this investigation should only be 
applied to systolic data. However, the contour errors and recommended 
tolerances in this study have been expressed as a fraction of the mean 
myocardial width (MW).  There is no reason why such tolerances may not be 
applied to diastolic data if the distribution of myocardial widths around the 
myocardial circumference can be assumed to be similar in diastole and 
systole.   
 
Manual contouring allowed only for rigid translations in the motion correction 
step, which is consistent with clinical practice at the institution where the 
data was acquired. The inherent assumption here is that there is no 
rotational or in-plane motion of the heart, which may not be true during 
breathing motion. However, as breathing motion has been minimized over 
the first-pass by the adopted breath-holding strategy, the errors induced due 
to this assumption should be minimal. The alternative approach of manually 
contouring each image in the dynamic series is much more time consuming 
and is difficult in low contrast images, where the myocardium and 
surrounding  tissues can be indistinguishable. There is no reason therefore 
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to suppose that the method used in this study incurs worse errors than a 
method incorporating an independent contour for each time step.   
 
Contour errors have been simulated by allowing random variations evenly 
around the contour and it has been shown that these simulations generate a 
similar distribution of contour errors to inter- and intra-observer variability 
distributions. It may be the case that contour errors are more likely over 
certain regions (e.g. where there are more poorly defined edges) than 
others; thus, an even distribution of random contours is not the best 
simulation.  
 
The implementation presented here of the method proposed by (30,31) to 
convert signal intensities to concentrations has two important limitations. 
Firstly, the method was originally validated for an inversion recovery 
sequence (29,30). Although the adaptation of the method to a saturation 
recovery sequence is mathematically simple, the method has not been 
separately validated for this sequence. Secondly, the method was originally 
based on measured T1 values.  The use of an assumed T1 for blood may 
introduce errors in to the MBF estimation process.  Extensive phantom work 
to validate this method has been undertaken in (chapter 6).  However in-vivo 
validation has not been performed.  Nevertheless, as this study is interested 
in relative changes in MBF due to contour errors it is unlikely that any errors 
in the conversion to concentration would modify the conclusions of this 
study. 
 
7.5. Conclusion 
Myocardial contour errors have been simulated for estimation of MBF.  The 
relationships between segmentation error and MBF error have been 
described and explained in terms of cardiac physiology in healthy 
volunteers.  Based on the simulated errors in MBF, contour error tolerance 
limits have been recommended as guidance limits for manual and 
automated myocardial contouring protocols. 
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The contour error evaluation metrics considered did not correlate with 
random MBF errors; thus, neither measure fully evaluates whether the 
contours are fit for purpose. Ideally, contouring algorithms for DCE-MRI 
myocardial perfusion should be evaluated by both geometric segmentation 
metrics and in terms of MBF error.  Comparisons between segmentation 
algorithms evaluated with segmentation evaluation metrics and those 
evaluated in terms of MBF error are not possible unless the segmentation 
errors are systematic in nature.   
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8. Comparisons of methods for diagnosing 
coronary artery disease using quantitative 
perfusion myocardial blood flow estimates 
8.1. Introduction 
The overarching aim of this thesis is to provide clinically persuasive evidence 
for a standard methodology for quantitative analysis of cardiac MR perfusion 
datasets.  To this end chapter 9 asks the important question of which perfusion 
model performs best in terms of diagnosing ischaemic heart disease, and 
chapter 7 has contributed towards understanding the necessary accuracy of 
myocardial contours.  This chapter is dedicated to the steps between generating 
the uptake curve and deducing a final diagnosis.  These steps are usually 
simply stated in the methods sections of diagnostic performance CMR papers 
but the rationale behind them is by no means certain.  This chapter aims to 
provide an evidence base for the analysis protocol utilised in chapter 9. 
 
The dataset used for this and the following chapter is a carefully selected sub-
set of the CE-MARC dataset.  The rationale behind choosing this sub-set is 
described in section 8.2.  Some uptake curves have been excluded from these 
investigations.  The criteria for exclusion and the characteristics of the excluded 
cases are described in section 8.3.  Non-linearity between signal and contrast 
concentration is of considerable concern to the DCE-MRI community and a 
method for correcting for these effects has been presented in this thesis 
(chapter 6).  The impact on diagnostic performance of non-linearity effects is not 
often reported, although one study has been performed showing no 
improvement with linear over non-linear data (25).  Section 8.4 investigates the 
effect of the non-linearity correction presented in chapter 6 on diagnostic 
performance.  The correct methodology for interpreting the AHA segmentation 
described in section 3.4.11 is then considered.  Should the AHA myocardial 
region to coronary artery mapping be used to provide a coronary artery specific 
diagnosis?  What is the best way to summarize multiple regional myocardial 
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territory MBF scores into a single value for the ROC curve?  Does regional 
analysis add to the diagnosis?  What diagnostic power is added by considering 
multiple slices over a single slice investigation?  These questions are 
considered in section 8.5 before final recommendations for the analysis 
methodology to be used in the next chapter are made in section 8.6. 
 
8.2. The CE-MARC sub dataset 
In 2012 Greenwood et al. published the results of the CE-MARC trial (2), which 
is, at the time of writing, the largest, prospective evaluation of CMR for 
diagnosis of coronary heart disease.  752 patients underwent stress and rest 
CMR, as well as SPECT nuclear medicine imaging and X-ray angiography.  The 
following investigations were conducted on a 50 patient subset of the CE-MARC 
cohort.  This cohort was selected to have the same proportion of risk factors 
and disease states as the full CE-MARC dataset.  The identified risk factors 
were hypertension, diabetes, smoking and age and the disease states were 
normal, single vessel disease, double vessel disease and triple vessel disease. 
 
The reference standard against which CMR measurements were compared in 
this study was the consensus diagnosis (ischaemic or healthy) from quantitative 
X-ray angiography and nuclear medicine.  Both of these methods are imperfect 
(see chapter 3) and there is ambiguity over the ideal cut-off for quantitative X-
ray with some publications using a 50% stenosis cut-off (25,104) and others 
using a higher cut-off value (91,103,153).  This generates an ambiguous range 
of cases (between 50% and 70% stenosis where the true diagnosis is uncertain.  
Some studies treat these cases as a separate stratification (91,103).  These 
ambiguous cases are part of clinical reality and should be included in any 
investigation into the diagnostic capabilities of a measurement technique.  
However the purpose of this investigation was not to report the diagnostic 
accuracy of quantitative CMR but to compare different diagnostic 
methodologies.  For this reason ambiguities were removed from the dataset to 
create as pure a reference standard as possible.  A vessel was classed as 
healthy if quantitative X-ray angiography failed to find a stenosis >50% and the 
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nuclear report was negative for a perfusion defect.  A vessel was classified as 
ischaemic if quantitative X-ray angiography reported a stenosis >70% and the 
nuclear report was positive for a defect.  Cases where there was disagreement 
between X-ray and nuclear medicine results and cases were the X-ray score 
was between 50% and 70% were excluded.     
Healthy No instance of stenosis 
>50% 
Nuclear report negative 
for defect 
Ischaemic Any instance of 
stenosis >70% 
Nuclear report positive 
for defect 
     Table 8-1 – Classification criteria for the 50 patient subset 
 
8.3. The exclusion process for the CE-MARC sub-set 
8.3.1. Method 
The MR acquisition and manual contouring process for the CE-MARC dataset 
are described in sections 5.2.1 and 5.3 respectively.  After manual contouring of 
the maximum contrast slice the contours were copied to all frames in the 
dynamic series and manually translated for each frame.  Motion correction was 
limited to rigid translation for pragmatic reasons (in that drawing individual 
contours on each frame made an already time-consuming task prohibitively so), 
but also because the difficulty of drawing myocardial contours on the early and 
late low signal contrast frames may well have generated worse contour errors 
than those encountered using rigid translation only.   
 
Rigid translation inherently assumes that all motion is in-plane motion, i.e. that 
there is no component of movement perpendicular to the imaging plane, which 
would alter the apparent size of the heart.  It also assumes that the breathing 
responsible for the cardiac movement in the image is translational not rotational.  
Neither of these assumptions are consistently valid in CMR perfusion. These 
issues were not dealt with by the automated analysis software and in some 
cases uptake curves were generated that were clearly non-diagnostic, in the 
sense that the uptake curves were so badly affected by the resulting artifacts 
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that they could not be expected to generate representative MBF values.  For 
this reason every region in the study was viewed manually and uptake curves 
that were visually assessed to be non-diagnostic were manually excluded.  In 
order to carry out this step a graphical user interface (GUI) called Perfusion was 
developed that enabled the image contours and uptake curve to be 
simultaneously evaluated and allowed manual adjustment of AIF and 
myocardial baseline, bolus arrival time and first-pass cut-off when necessary 
(Figure 8-1). 
Image with contours 
overlaid
Concentration curves 
with pre-processing 
parameters overlaid
Pre-processed 
concentration curves
Slice 
slider
Frame 
slider
Contour 
overlay 
toggles
Stress/rest selector
Region selector Pre-processing slider
Model fitMBF 
estimates
Exclude region 
from dataset
 
Figure 8-1 – GUI allowing simultaneous viewing of stress and rest images, 
contrast uptake curves and estimated MBFs as well as manual adjustment of 
pre-processing parameters and an exclusion button to exclude the region if 
necessary 
 
Regions were only excluded where the uptake curves that they generated were 
clearly non-diagnostic i.e. they could be confidently classified as not 
representing the uptake of contrast in the myocardium.  Exclusions were 
categorized into the following categories: 
- Thin myocardium (Figure 8-2). 
- Left ventricular blood pool in the myocardial region (Figure 8-4). 
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- Right ventricular blood pool in the myocardial region. 
- Other tissue (epicardial fat, lung) in the myocardial region (Figure 8-5). 
- Severe change in apparent heart slice (Due to ECG-gating failure or 
breath-hold failure) (Figure 8-3). 
- Dark rim artifact (DRA). 
 
After contouring, the myocardium was divided into 16 regions according to the 
AHA guidelines (106) resulting in 32 regions per patient (rest and stress) giving 
a total of 1600 uptake curves for analysis in the study.  Each of these curves 
were pre-processed before quantitative analysis was performed.  All pre-
processing was done using the automated algorithms described in section 5.4.  
 
8.3.2. Results 
A total of 164 out of the 1600 regions were excluded (10.3%).  The reasons for 
exclusions are summarized in Table 8-2, classified as thin myocardium, LV in 
myocardial region, RV in myocardial region, other tissue in myocardial region, 
severe change in apparent heart size and dark rim artifact.  The origins of the 
excluded regions, in terms of rest and stress scan and which slice are shown in 
Table 8-3. 
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Reason Thin 
myo 
LV in 
myo 
region 
RV in 
myo 
region 
Other 
tissue in 
myo region 
Severe 
change 
in 
apparent 
heart size  
Dark rim 
artifact 
Total 
No. of 
regions 
excluded 
(%) 
97  
(6.1%) 
32  
(2%) 
1  
(0.06%) 
4  
(0.25%) 
28 (1.8%) 2 
(0.1%) 
164 
(10.3%) 
Table 8-2 – Table of reasons for exclusion from the CE-MARC subset 
 
 STRESS REST Total 
Slice 1(apical) 2(mid) 3(basal) 1(apical) 2(mid) 3(basal) 
No. of 
regions 
excluded 
(%) 
19  
(1.2%) 
12 
(0.75%) 
52 
(3.25%) 
12  
(0.75%) 
10 
(0.6%) 
59 
(3.7%) 
164 
(10.3%) 
Table 8-3 – Table of exclusion positions from the CE-MARC subset. 
 
8.3.3. Discussion 
An exclusion rate of 10% is high, and the necessity for visual assessment of 
every region is a significant obstacle to the practicality of quantitative perfusion 
imaging.  Considerable effort in the research community has been expended in 
attempting to automate the steps for quantitative myocardial perfusion, 
myocardial segmentation, curve pre-processing and tracer-kinetic modelling.  
This result highlights the need for a further area requiring automation.  That of 
highlighting myocardial regions whose uptake curves are not valid.   
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Figure 8-2 – Example of an exclusion as displayed in the Perfusion GUI.  
Segments 5 (selected in the GUI) and 6 were excluded because the myocardium 
was so thin that the uptake curves were deemed non-myocardial. 
 
The largest contribution to exclusions was a thin myocardium, which occurred 
most commonly in the basal slice.  This is not surprising as the myocardium 
thins naturally in the basal region.  The high number of exclusions here might 
be taken as an argument against imaging in the basal region however it is 
important to note that ~90% of the basal regions were not excluded.  Continuing 
improvements in imaging resolution in myocardial perfusion (154) have the 
potential to reduce the impact of thin myocardial walls in quantitative perfusion 
in the future. 
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Figure 8-3 – Example of severe change in apparent heart size.  A sequence of 
four contiguous dynamic frames show that these four images have been imaged 
at different cardiac phases due to an ECG-gating fault.  No contour can 
satisfactorily be applied to all these images via translation only.  The resulting 
affect on the myocardial uptake curves and perfusion model fit are illustrated 
below in the Perfusion GUI. 
 
The next largest contributions were from LV blood volume bleed into the   
defined myocardial region and severe change in apparent heart size.  Severe 
changes in apparent heart size are caused either by ECG triggering artifacts or 
by complete failure of patient breath-holding during the first pass.  In the former 
case the scanning algorithm misreads the R-wave so that the image is acquired 
in a different cardiac phase and the shape of the heart is radically different.  
Within the „translation only‟ contour regimen prescribed this renders it 
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impossible for the contourer to satisfactorily contour the myocardium in every 
image and a saw tooth pattern emerges in the myocardial uptake curve, which 
generates significant errors in the model fit (Figure 8-3).  In the case of 
breathing during the first-pass the patient‟s diaphragm moves relative to the 
imaging plane so that a different area of the heart is imaged.  Similarly to ECG-
triggering faults this renders images that are not possible to contour 
satisfactorily. 
 
Figure 8-4 – Example of the LV bleed.  The highlighted region in the image shows 
blood pool enhancement bleeding into the myocardial region.  The simultaneous 
enhancement in the AIF and myocardial uptake curves is unusual (usually AIF 
enhances first) and is probably due to LV blood in the myocardial region. 
 
LV volume bleed occurs when the contours are allowed to encroach too far into 
the LV blood pool and the AIF „bleeds‟ into the myocardial region.  Figure 8-4 
shows an example case.  In the lateral posterior wall of the heart it is very 
difficult to distinguish any myocardial wall at all.  Instead of allowing a very thin 
myocardium (as in Figure 8-2) this contourer has encroached on the LV blood 
pool in order to maintain a significant myocardial region.  The resulting region is 
contaminated by the AIF, as evidenced by the early uptake in the myocardial 
uptake curve (simultaneous with the AIF enhancement point).  Whichever 
choice the contourer had made this region would need to have been excluded 
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from the study. 
 
Figure 8-5 – Poor contouring over the first pass placing segment 3 more in the 
epicardial fat than the myocardium.  This segment did not represent the 
myocardium and was therefore excluded 
 
Much less common was the inclusion of another tissue such as epicardial fat in 
the myocardium (Figure 8-5).  This was due to contour errors which were 
generally forced by the contourer having to strike a compromise between the 
shape of the heart at the beginning and the end of the sequence. 
 
The distribution of exclusions across the three slices was similar at rest and 
stress implying that there is no fundamental difference in exclusions between 
rest and stress.  The high exclusion rate may be criticised in terms of the 
manual contouring method used and the qualitative nature of the exclusion 
process.  The contouring method is imperfect in that it does not allow for 
through plane motion, or in-plane rotation, both of which occur in the dataset. 
However it is questionable whether a bespoke frame specific contouring would 
improve the contours, due to poor contrast to noise ratio at points during the 
dynamic sequence.  Furthermore, in some cases it is apparent that, at this 
resolution, there is no possible contour that would give a meaningful uptake 
curve (e.g. Figure 8-2).  
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The qualitative nature of the exclusion method used here may be susceptible to 
poor reproducibility due to human error.  The investigation would be improved if 
an automated basis for exclusion could be developed.  The largest contribution 
to the exclusions is thin myocardium.  This could be objectively calculated from 
the contours.  Automating this exclusion criterion is therefore possible and will 
be included in future work.  Other forms of error are more difficult to address 
and may be best approached by applying automated segmentation algorithms 
to reduce contouring error.  However, existing segmentation algorithms tend to 
also present high exclusion rates so applying such algorithms may not 
ultimately reduce the exclusion rate. 
 
8.4. Diagnostic evaluation of non-linearity correction 
8.4.1. Introduction 
Chapter 6 describes a method for converting CMR perfusion signal intensity 
values to concentrations.  The CE-MARC sub-set described in section 8.2 
provides an opportunity to assess this conversion in terms of the affect it has on 
the ability of a quantitative myocardial perfusion to diagnose ischaemic heart 
disease. 
 
8.4.2. Method 
Conversion to concentration 
For this study the non-linear conversion method described in chapter 6 was 
compared to a conversion based on an assumed linear relationship between 
signal intensity and contrast agent concentration.  Ignoring the effect of the 
image read-out RF pulses the signal S for the SR-TFE pulse sequence is: 
               
Equation 8-1 
Where Ψ is the calibration constant, TS is the saturation time and R1 is the 
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inverse of the longitudinal relaxation time, T1, of the tissue.  If TS.R1 is small 
then                  thus: 
          
Equation 8-2 
The contrast agent concentration at the measurement point i, can be calculated 
from the change in R1 due to the presence of contrast agent if the relaxivity r1 is 
known: 
   
 
  
           
Equation 8-3 
Where R1o is the pre-contrast R1 value and R1i is the value at some 
measurement point after contrast.  Using Equation 8-2 to represent this in terms 
of MR signal: 
   
 
       
        
Equation 8-4 
And dividing both sides by So: 
    
   
  
 
     
  
  
Equation 8-5 
Equation 8-4 holds that            so long as the coil gain remains constant, 
whereas Equation 8-5 holds that    
     
  
, so long as the native tissue R1o 
remains constant.  In this study AIFs from the basal slice were applied to all 
three slices in order to avoid more profound non-linearity and longer TS values 
in the other slices.  As the coil gain (an element of the constant ψ) may change 
between slices, Equation 8-5 was used to generate the linear assumption 
concentration curves.  Both rest and stress curves were converted to 
concentrations using So from the stress curve pre-contrast region as the rest 
curve „pre-contrast‟ region contains remnant contrast agent from the preceding 
stress study.  After concentration conversion the stress pre-contrast region had 
Co=0.  However, due to the remnant contrast agent the resting pre-contrast 
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region required further baseline correction using the rest pre-contrast region: 
             
Non-linear conversion to concentration was carried out using the method 
described in chapter 6 with the same additional baseline subtraction used in the 
rest curve analysis. 
 
Analysis 
Regional quantitative MBF estimates for all patients in the CE-MARC sub-set 
(section 8.2) were calculated using Fermi-constrained deconvolution, as it is the 
most widely used method.  For every slice the AIF was taken from the basal 
slice as it exhibits the least non-linearity and is less susceptible to absolute 
saturation (plateauing).  As the CE-MARC acquisition protocol uses a shared 
pre-pulse each slice has a different saturation time (TS).  Therefore each slice 
has a different T1-weighting, which effects the enhancement response and thus 
the MBF.  This effect should be corrected for by the non-linear conversion to 
concentration.  To remove this TS factor (which is only relevant for shared pre-
pulse sequences) from the comparison, the concentration conversion 
comparison was carried out on data from the middle slice only. The exclusion 
protocol is described in section 8.3.  Regional MBF values at stress and rest 
were converted to myocardial perfusion reserve (MPR) scores.  The method 
used for relating each MPR to the coronary artery diagnosis is described in 
section 8.5. Receiver operator curves (ROC) between the quantitative perfusion 
results and the reference standard diagnosis were generated.  The experiment 
was carried out twice; once assuming a linear relationship between MR signal 
intensity and contrast agent concentration and once using the non-linear 
conversion to concentration described in chapter 6.  The ROC curves generated 
from the two methods were compared using the DeLong DeLong Clarke-
Pearson method (155). 
 
8.4.3. Results 
The mean (+sd) MBF and MPR at rest and stress and MPR using linear and 
non-linear concentration conversions are shown in Table 8-4. 
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Concentration Conversion Stress MBF  
(mean + SD)  
[ml/g/min] 
Rest MBF  
(mean + SD) 
[ml/g/min] 
MPR  
(mean + SD) 
Linear 2.38 + 0.91 1.08 + 0.44 2.36 + 0.95 
Non-linear 1.55 + 0.86 0.70 + 0.41 2.33 + 0.88 
Table 8-4 – Table showing the mean + SD MBFs at stress and rest and the 
corresponding MPRs using linear and non-linear correction. 
 
Figure 8-6 shows the ROC curves diagnosis using concentration curves 
generated using linear and non-linear concentration conversion methods.  The 
area under the curve, with associated confidence interval and the optimal cut-off 
MPR are shown in Table 8-5. 
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Figure 8-6 - ROC curves for MPRs generated using linear and non-linear 
concentration conversion regimens p=0.16. 
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Concentration 
Conversion 
AUC (CI) Optimal MPR cut-off 
Linear 0.88 (0.79, 0.98) 1.58 
Non-linear 0.93 (0.86, 1.00) 1.30 
Table 8-5 – Area under the curve (and associated confidence interval) for the two 
concentration conversion methods, with optimal MPR cut-off values derived 
from the ROC curve. 
 
8.4.4. Discussion 
The ROC curves for MPRs generated from concentration curves derived using 
a linear assumption did not differ significantly from those derived using the non-
linear model (p=0.16), thus there is insufficient evidence to favour a non-linear 
conversion over a linear one.  However it is notable that the AUC for the non-
linear ROC curve was larger than that for the linear curve (0.93 vs 0.88), and 
the p-value, though >0.05, is still small and consistent with an 84% probability 
that the difference between the curves is not a chance observation.  The mean 
MBF values were lower with the non-linear conversion for stress MBF (p<0.001) 
and rest MBF (p<0.001), Table 8-4.  The non-linear conversion resting MBFs 
were consistent with literature values (See Table 6-7 and Table 6-8).  The mean 
stress MBF with non-linear conversion was lower than literature values, 
however the literature surveyed in Table 6-7 and Table 6-8 were taken from 
healthy volunteers and lower stress MBFs from patient data are to be expected.  
The differences between MBFs acquired using linear and non-linear 
conversions did not propagate to MPR values, where there was not a significant 
difference between the two methods (p=0.26).  The changes in MBF are 
consistent with an underestimate in MBF with linear conversion due to non-
linearity effects in the AIF.  However these effects cancel in the MPR (stress 
MBF / rest MBF) and become non-significant as has been previously shown 
(156).  This implies that, if the MPR is the final outcome measure used, then 
non-linearity effects should not prove detrimental to diagnosis.  However care 
should still be taken to avoid saturation (plateauing in the signal vs. 
concentration plot) in the AIF as this may still impact MPR based results.  The 
coefficient of variation (sd/mean) of the MPR was decreased from 0.40, with the 
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linear conversion, to 0.38, with the non-linear conversion, implying that the non-
linear conversion reduced the variability of the MPR measurement by a small 
degree.  Although the non-linear correction did not have statistically significant 
impact on the diagnostic power of the test the results do suggest some 
improvement over a linear conversion and some reduction in variability.  For 
these reasons the remaining investigations will use the non-linear concentration 
conversion method. 
 
8.4.5. Conclusion 
The non-linear conversion has been shown to make a significant difference to 
stress and rest MBF values, but these are cancelled out in the MPR 
measurement.  A small but statistically insignificant improvement in diagnostic 
power has been shown in the ROC curves when using the non-linear 
conversion.  The non-linear correction has shown a small decrease in the 
variability of the MPR measurement.  For these reasons the non-linearity 
correction will be used in the remaining sections of this chapter.   
 
8.5. A comparison of approaches for using regional 
quantitative MPR to diagnose ischaemic heart disease 
8.5.1. Introduction 
The AHA recommendations for coverage of the heart and assigning myocardial 
regions to specific coronary arteries is illustrated in Figure 8-7 (c & d) (106).  
The AHA recommendations are helpful for standardizing analysis methods 
across imaging modalities.  However they do not go so far as to specify how 
quantitative measurements for each of the regions described in Figure 8-7 
should be used to generate a final diagnosis of ischaemic heart disease.  In this 
section the aim is to use the CE-MARC subset to compare and contrast 
different methods for diagnosing CAD based on quantitative myocardial 
perfusion estimates.  Each of the questions posed in this section must be 
answered before any researcher can reduce their AHA segmented quantitative 
MBF measurements to a single diagnosis.  They are usually just stated as steps 
in the methods section, but each choice may have an affect on diagnostic 
186 
 
performance.  The questions posed are as follows:  
 
1) Does using the AHA mapping to assign regions to separate coronary arteries 
before analysis improve the diagnostic power of the test? 
The assumption that the ischaemic/non-ischaemic cut-off value is equal across 
the heart may not be valid.  Changes in myocardial wall thickness, proximity to 
coronary arteries and proximity to the right ventricle might all conceivably affect 
the „normal‟ MPR.  The AHA recommendations provide a method for assigning 
myocardial regions to coronary arteries.  A comparison between coronary artery 
specific diagnosis (with a coronary specific MPR cut-off) and a whole heart 
diagnosis (with a global MPR cut-off) was undertaken to assess whether the 
AHA coronary artery mapping improved the diagnostic power of the test. 
 
 2) Is the mean or minimum regional MPR a more powerful diagnostic indicator? 
Given a number of regional MPR scores that may or may not correspond to an 
ischaemic coronary artery what is the best way of grouping the MPR values into 
a single number for diagnosis?  Taking the minimum value could be expected to 
make the test more sensitive as it only takes a single region to fall below the 
MPR cut-off value for the diagnosis to become ischaemic.  However, the 
process by which quantitative perfusion estimates are calculated is complicated 
and each of the analysis steps is associated with a probability of error.  MR 
image artifacts, low SNR, contouring errors, curve pre-processing malfunctions 
and perfusion model fitting errors may all be responsible for outliers.  Taking the 
minimum of a group of regional MPR scores will be inherently susceptible to 
such outliers as it discards the majority of the data for the smallest value.  The 
mean MPR may be a better diagnostic measure due to its increased robustness 
against such outliers.  Although a single perfusion defect score would be 
increased by the surrounding non-ischaemic scores the mean regional MPR will 
be less susceptible to errors.  Fundamentally the choice reduces to one of 
resolution.  Is the presence of erroneous MPR scores sufficient to warrant an 
effective decrease of the spatial resolution (taking the mean MPR of all regions) 
or would the resulting reduction in resolution reduce the diagnostic power of the 
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test?   
 
3) What is the power of the test if only the middle slice is used? 
As mentioned repeatedly in this thesis the quantitative myocardial perfusion 
pathway is susceptible to errors.  However, some slices are more prone to 
errors than others.  The myocardium in the basal slice is more likely to be too 
thin for analysis (section 8.3).  The apical slice has a smaller diameter (due to 
the apical narrowing of the heart shape).  Therefore it has a smaller number of 
myocardial regions assigned to it and can also be more difficult to contour, 
especially in the endocardium in slices where the blood pool can be small.  The 
aim of this investigation was to compare the diagnostic performance of the test 
when using all slices vs. the middle slice alone.  One would hope that the 
problems were not so severe so as to expect an increase in diagnostic power if 
only middle slice data were used.  However, if the fall in diagnostic power were 
small then there might be justification for investing the limited MR acquisition 
time available in increasing image resolution on this middle slice, as opposed to 
three slice coverage. 
 
4) What is the power of the test using a global MPR? 
Following a similar argument to 2), abandoning regional analysis altogether and 
considering the whole ring of the myocardium as a single region might be a 
more robust measurement than regional analysis, with a corresponding loss in 
image resolution.  It was the aim of this study to compare global versus regional 
analysis methods for diagnostic power. 
 
8.5.2. Method 
The CE-MARC sub-set (section 8.2) with the exclusions described in section 
8.3 was used for all studies.  Based on the conclusions of section 8.4 the non-
linear conversion to concentration was applied to all of the curves before 
analysis.  Fermi-constrained deconvolution was used to generate the MBF 
estimates.  This choice was not based on any superiority of Fermi over the 
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other models but rather on its widely accepted status in the literature.  All 
analyses were carried out in MATLAB ®, using purpose specific software 
developed by the author.  After exclusions all regions were analysed in a batch 
file and regional, as well as global,  MBFs at stress and rest were stored and 
converted into MPRs.  All of the investigations described below were conducted 
on this dataset. 
 
1) Does using the AHA mapping to assign regions to separate coronary arteries 
before analysis improve the diagnostic power of the test? 
For whole heart analysis the reference standard was classed as ischaemic if 
any of the quantitative X-ray regions were >70%.  The minimum (see section 
8.5.3 part 2) of all the regional MPR values was taken as the MPR 
measurement for the patient.  A single ROC curve was then generated using 
these MPR and reference standard diagnosis values. 
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Figure 8-7 – Mapping between coronary artery stenoses and MRI segments.  
Coronary stenoses were quantified using X-ray angiography at the labelled sites 
in a).  Each artery was classed as ischaemic if any of the sites listed in b) were 
found to have >70% narrowing.  The myocardial slices imaged as illustrated in c) 
were subdivided and rearranged into the bullseye plot d) where they were 
assigned to a corresponding coronary artery according to the AHA 
recommendations. 
 
For coronary artery specific analysis the reference standard for a given 
coronary artery (LAD, RCA, LCX) was classed as ischaemic if a quantitative X-
ray stenosis >70% was identified within that coronary artery.  Lesions in the left 
main stem (LMS) were classed as ischaemia in both LCX and LAD.  This 
generated three sets of diagnoses, one per coronary artery.  To generate the 
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corresponding MPR values the AHA mapping was used to assign each 
myocardial region to a coronary artery.  The minimum MPR value for each 
group was then assigned as the MPR measurement for that patient for that 
artery.  The process is illustrated in Figure 8-7. 
 
ROC curves were generated for each case. The DeLong, DeLong, Clarke-
Pearson ROC curve comparison compares curves whose diagnostic outcomes 
are identical.  As the diagnosis for the ROC coronary artery specific and whole 
heart were different this comparison was not possible.  Therefore areas under 
the curve with confidence intervals were compared in terms of whether their 
confidence interval overlapped or not. 
 
2) Is the mean or minimum regional MPR a more powerful diagnostic indicator? 
The methodology for whole heart analysis in 1) was repeated, but two ROC 
curves were generated in each case.  One generated taking the minimum of all 
the regions as the MPR value and the other taking the mean.  DeLong, DeLong, 
Clarke-Pearson comparison of ROC curves was used to test for a statistically 
significant difference between the curves. 
 
3) What is the power of the test if only the middle slice is used? 
Analysis limited only to regions from the middle slice for each patient was used 
to generate a ROC curve.  Based on the results of part 2) the minimum MPR 
was chosen from values generated using non-linear concentration conversion.  
The resulting ROC curve was compared to the methodology using all the heart 
regions described in 1) using DeLong, Delong, Clarke-Pearson analysis. 
 
4) What is the power of the test using a global MPR? 
ROC curves were generated using the MPRs taken from the whole myocardium 
from the three slices.  The minimum MPR was taken as the value for 
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comparison against the diagnosis to generate a ROC curve.  The resulting ROC 
curve was compared against the whole heart regional analysis described in 1) 
Using DeLong, DeLong, Clarke-Pearson analysis. 
 
8.5.3. Results 
1) Does using the AHA mapping to assign regions to separate coronary arteries 
before analysis improve the diagnostic power of the test? 
Figure 8-8 shows the four ROC curves generated using all regions and using 
the three separate coronary arteries.  The associated area under the curve 
(AUC), optimal MPR cut-off value and number of ischaemic cases (out of 50) in 
each case are shown in Table 8-6. 
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Figure 8-8 – ROC curves for a) all regions and stenoses included in the analysis, 
b) only LCX stenoses, c) only LAD stenoses, d) only RCA stenoses included in 
the analysis. 
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 a) All regions b) LCX c) LAD  d) RCA  
AUC (CI)  0.95  
(0.89, 1.00)  
0.79  
(0.57, 1.00)  
0.90  
(0.80, 1.00)  
0.85  
(0.70, 1.00)  
MPR cut-off  1.30  1.30  1.29  1.30  
Number of 
Ischaemic 
cases  
19  7  12  7  
Table 8-6 – Table of area under ROC curve (AUC), MPR cut-off values and 
number of ischaemic cases in dataset for analysis from each coronary artery and 
when all regions are considered in the analysis. 
 
2) Is the mean or minimum regional MPR a more powerful diagnostic indicator? 
Figure 8-9 shows the ROC curves generated when the mean and minimum of 
all the regions are taken as the MPR for diagnosis.  The AUCs were 
significantly different (p=0.02) with the mean AUC (CI) at 0.85 (0.74, 0.96) and 
the minimum AUC at 0.95 (0.89, 1.00), with optimal MPR cut-offs at 2.17 and 
1.30 respectively. 
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Figure 8-9 – ROC curves generated using the mean and the minimum of all the 
regions as the MPR for diagnosis. 
 
3) What is the power of the test if slice 2 only is used? 
Figure 8-10 shows the ROC curves generated using data from all the slices and 
that obtained using only MPR data from the middle slice.  The AUC values 
considering all slices was 0.95(0.89, 1.00) and using the mid-slice only was 
0.93 (0.86, 1.00).  The optimal MPR cut-off was 1.30 in both cases.  The curves 
were not significantly different (p=0.44). 
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Figure 8-10 – ROC curves generated using data from all three slices versus data 
from the middle slice (slice 2) only. 
 
4) What is the power of the test using a global MPR? 
Figure 8-11 shows the ROC curves generated using the AHA regional MPR 
analysis and using only the global MPR value for each slice.  The curves are 
significantly different (p=0.02), with the regional AUC at 0.95 (0.89, 1.00) and 
the global AUC at 0.84 (0.73, 0.95) with optimal MPR cut-offs of 1.30 and 2.12 
respectively.   
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Figure 8-11 – ROC curves generated using AHA regions versus those generated 
using only the global myocardial MPR  
 
8.5.4. Discussion 
1) Does using the AHA mapping to assign regions to separate coronary arteries 
before analysis improve the diagnostic power of the test? 
The ROC curve generated using all regions obtained the best AUC value and 
the narrowest confidence interval.  Of the coronary specific analyses the LAD 
ROC curve achieved the best AUC, however this may well be due to the fact 
that there were more coronary stenoses attributed to the LAD than the other two 
arteries.  The confidence intervals for all the AUCs overlapped suggesting that 
there was no difference between the diagnostic performances.  However, it is 
interesting that the MPR cut-off values generated independently for the four 
curves were almost identical.  This suggests that assuming a single MPR cut-off 
across the heart is a valid assumption and that subdividing the myocardium into 
coronary territories will not improve diagnosis.  The LCX had a lower AUC than 
the RCA or LAD, though not significantly different.  As the LCX is more likely to 
be the shortest reaching artery this might suggest that stenoses in the LCX 
cause less profound perfusion defects (due to a higher compensatory ability in 
the other two, larger arteries) but a larger study would be required to see if this 
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were a significant observation. 
 
2) Is the mean or minimum regional MPR a more powerful diagnostic indicator? 
The analysis method using the minimum MPR of all the regions is significantly 
more powerful than the mean method.  This is clear evidence for using the 
minimum regional MPR value for quantitative diagnosis of coronary artery 
disease. 
 
3) What is the power of the test if only the middle slice is used? 
There was not a statistically significant difference between the ROC curve 
generated using the middle slice only and the ROC curve generated using all 
three slices.  50 patients (with 19 classed as ischaemic) is only a moderate 
sized dataset and this investigation could be criticised for being underpowered.  
However the fact that the AUCs and their confidence intervals were so similar 
implies that the basal and apical slices are adding little to the diagnostic power 
of the test.  This result could have significant implications for pulse sequence 
design for cardiac MR perfusion imaging.  If a comparable diagnostic 
performance can be obtained from a single imaging slice then more imaging 
time can be dedicated to improving image resolution, or perhaps imaging a 
more reliable AIF.  This should be an area of further investigation. 
 
The choice of the middle slice as the single slice was based on the higher rate 
of imaging and analysis problems with the apical and basal slices.  Setting 
these aside there may be reasons to consider these slices as the single slice 
instead of the middle slice.  For instance, the apical slice is at the end of the 
coronary tree so might be most sensitive to stenoses, whereas the middle slice 
may not manifest defects with stenoses far down the coronary pathway.  For 
this reason the investigation should be repeated using the basal and apical 
slices as the single slice. 
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4) What is the power of the test using a global MPR? 
Regional analysis is significantly better at diagnosing coronary artery disease 
than global analysis.  This implies that the coarse resolution measure of 
considering the whole myocardium as a single segment discards important 
information.  In corroboration with 2) this implies that the SNR for the AHA 
regions is adequate for diagnosing ischaemia. 
 
8.6. Conclusion 
The recommendations, based on the studies presented in this chapter, are that 
analysis should be done on uptake curves after applying non-linear correction 
(Section 8.4).  The regional territories recommended by the AHA should be 
used (Section 8.5 Qu4) and interpreted by taking the minimum MPR value from 
all the regions (Section 8.5 Qu2).  A global (all arteries) rather than artery 
specific MPR cut-off should be used (Section 8.5 Qu1).  Further evidence has 
been presented suggesting that a middle slice only analysis may have 
comparative diagnostic power to a three slice investigation (Section 8.5 Qu3), 
but further work is necessary to confirm this finding. 
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9. Comparisons of tracer kinetic models applied 
to cardiac magnetic resonance perfusion data 
9.1. Introduction 
The primary clinical motivation for quantifying MBF is to assist in the diagnosis 
of coronary artery disease.  However, there are a range of methods for 
quantifying myocardial blood flow (MBF) from dynamic contrast enhanced 
cardiac perfusion MRI datasets, with no consensus on which is the best method 
to use.  The methods vary in complexity and in the strength of their underlying 
assumptions.  They have all been validated in terms of the resulting MBF values 
against other measurements of MBF, such as radiolabelled microspheres 
(77,81,157) in animals, or PET measurements in humans (6,29).  Furthermore, 
a comparison of quantitative analysis methods has been performed on data 
from 14 healthy human subjects (4), finding non-significant differences between 
the methods in terms of MBF value.  However, to provide a persuasive 
evidence base for choosing one method over another, evaluation of these 
methods should be carried out in terms of their diagnostic capabilities.  It was 
the aim of this study to compare the diagnostic performance of four perfusion 
quantitation methods on a 50 patient cohort selected from the CE-MARC 
dataset (section 8.2). 
 
9.2. Method 
9.2.1. Patient imaging 
A 50 patient subset, with patient risk factors and disease characteristics 
representative of the whole trial dataset was taken from the CE-MARC trial (2).  
The selection criteria are described in section 8.2 and the imaging methodology 
is described in section 5.2.1.  The selected subset consisted of clear healthy, 
and ischaemic, cases with ambiguous diagnoses removed in order to create the 
cleanest reference standard possible. 
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9.2.2. Data analysis 
The myocardium, and a region in the left blood pool representing the AIF, were 
manually contoured and manual correction for breathing motion, limited to rigid 
translation, was performed using the method described in section 5.3.  The 
Fermi-constrained deconvolution (Fermi), model-Independent deconvolution 
(ModI), uptake analysis (Uptake) and the one compartment model (OneCP) 
algorithms described in chapter 4 for quantifying MBF were implemented in 
Matlab®.  The methods differ in terms of how much of the full dynamic series 
they utilise.  These differences may be significant in the final performance of the 
methods, as a method that can incorporate more data in the analysis may be 
more robust to noise.  Therefore each analysis method functioned on a bespoke 
curve preparation scheme.  The full curve analysis scheme is outlined as 
follows: 
1. The AIF was taken from the blood pool of the basal slice, where the 
saturation time was shortest in order to minimise signal saturation (see 
Figure 5-1), whilst myocardial uptake curves were taken from each 
individual slice. 
2. The myocardium was subdivided into regions according to the AHA 
recommendations as described in chapter 8. 
3. The stress curve pre-contrast baseline signal (So) was calculated as 
described in section 5.4.1. 
4. Signals were converted to concentrations using the non-linear 
conversion process described in chapter 6.  The stress So was used in 
both stress and rest conversions as the rest time series is contaminated 
by remnant Gd from the stress bolus. 
5. The rest data series was baseline corrected for remnant contrast agent 
(Ci - Co). 
6. All data were interpolated by a factor of four using piecewise hermitian 
interpolation (pchip MATLAB®) in order to increase the apparent 
temporal resolution (see section 5.4.3). 
7.  The AIF curve was temporally shifted so that the bolus arrival times of 
the two curves matched as described in section 5.4.3. 
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8. Method specific curve preparation was applied before estimating the 
MBF as follows: 
1. Fermi-Constrained deconvolution: 
1. The pre-contrast baseline data points were cropped from 
the dataset as described in section 5.4.1. 
2. The dataset was cropped after the first pass, defined as the 
first valley following the largest peak in the AIF as 
described in section 5.4.2. 
2. Model Independent deconvolution: 
1. No further preparation necessary 
3. Uptake model: 
1. The pre-contrast baseline data points were cropped from 
the dataset. 
2. All data after the AIF peak were cropped from the dataset. 
4. One compartment model: 
1. The pre-contrast baseline data points were cropped from 
the dataset. 
 
Although the pre-contrast baseline data is essential for non-linearity correction it 
is irrelevant to the perfusion model, which considers only signal changes due to 
contrast agent.  Therefore, once the curve is converted to concentration, the 
baseline data points will not aid the model fitting.  Conversely, if there are large 
variations in signal in the baseline due to noise or artifacts these will adversely 
affect the model fitting, which tries to generate a response function for all the 
data.  For these reasons the pre-contrast baseline data was cropped from the 
curves before model fitting. 
 
Further to the exclusions based on image artifacts and contouring problems 
described in section 8.3 exclusions were made based on extreme MBF or MPR 
values.  All results with a value less than 0 were excluded from the analysis.  
The upper tolerance was set at twice the maximum expected value: stress MBF 
= 8 ml/g/min, rest MBF = 4 ml/g/min and MPR = 8.  The reasons for these 
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extreme outliers are explained later (Section 9.3.2).  In most cases the errors 
causing these outliers could have been addressed by modifying the pre-curve 
analysis.  However, it is important to evaluate the methods in terms of a fully 
automated analysis, as this must be in place before these methods could hope 
to be accepted in clinical practice, given the already heavy time-expenditure 
necessary for manual contouring.  As the outliers are easy to detect based on 
the specified criteria the decision was taken to exclude them from the analysis 
so that the results reflect what might be achieved with a fully automated 
analysis. 
 
9.2.3. Generation of diagnostic results 
Based on the findings of section 8.5 regional MPRs were mapped to SPECT 
and quantitative X-ray consensus diagnosis by taking the minimum regional 
MPR from all slices as the MPR measure.  ROC curves were generated for 
each method.   
 
9.2.4. Statistical analysis of results 
Each method was compared with every other method using Bland-Altman 
analysis to assess the agreement between methods in stress MBF, rest MBF 
and MPR.  Paired t-test and Pearson‟s correlation were also performed 
between each model to look for significant differences in results and 
correlations in results.   
ROC curves from all of the methods were compared using the DeLong, 
DeLong, Pearson method (155).   
 
9.3. Results 
9.3.1. Exclusions 
Table 9-1 records the number of exclusions for each model.  Note MPR 
exclusions are only counted where both rest and stress MBF values were within 
tolerance but produced an out of tolerance MBF. 
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Method Rest MBF Stress MBF MPR 
Fermi 1 0 0 
Uptake 7 0 19 
One CP 0 0 0 
ModI 9 6 7 
Table 9-1 – Number of exclusions for stress, rest MBF and MPR for each of the 
quantitation models.  The exclusion criterion was 0 < x < 8 for stress MBF and 
MPR and 0 < x < 4 for rest MBF. 
Method Diagnosis Stress MBF (mean + SD) 
[ml/g/min]
Rest MBF (mean + SD) 
[ml/g/min]
MPR 
(mean + SD)
Fermi Healthy 1.77 + 0.88 0.76 + 0.36 2.45 + 0.72
Ischemic 1.56 + 0.89 0.97 + 0.51 1.59 + 0.58
Uptake Healthy 1.57 + 0.81 0.64 + 0.33 2.66 + 0.94
Ischemic 1.41 + 0.82 0.88 + 0.42 1.77 + 0.82
OneCP Healthy 1.70 + 0.86 0.78 + 0.38 2.25 + 0.64
Ischemic 1.60 +0.83 1.07 + 0.56 1.57 + 0.50
ModI Healthy 1.53 + 0.74 0.68 + 0.31 2.26 + 0.64
Ischemic 1.32 + 0.73 0.82 + 0.39 1.70 + 0.56
 
Table 9-2 – Mean + standard deviation stress and rest MBFs and MPR values for 
the four methods in the healthy and ischaemic patient populations as diagnosed 
by X-ray angiography and the AHA mapping. 
r Fermi Uptake OneCP ModI
Fermi 1 0.87 (0.78, 0.93) 0.97 (0.94, 0.98) 0.86 (0.76, 0.92)
Uptake 1 0.90 (0.84, 0.94) 0.75 (0.60, 0.85)
OneCP 1 0.84 (0.73, 0.91)
ModI 1
 
Table 9-3 – Pearson’s correlation r-values for comparisons between the four 
models.  In all comparisons p<0.0001. 
 
Table 9-2 shows the mean and standard deviation (SD) MBF at rest and stress 
and the MPR for each of the four models over all of the healthy and all of the 
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ischaemic patients.    
 
Table 9-3 shows the Pearson‟s correlation scores between all of the models, 
with all models having a highly significant correlation (p<0.0001).  Table 9-4 
shows the Bland-Altman bias scores for the comparisons between each of the 
models, with confidence intervals for the biases in brackets.  Paired t-test p-
values were all highly significant (p<0.001) except uptake versus model 
independent MPR (p=0.08).  The corresponding standard deviations of the 
differences are shown in Table 9-5.     
Stress Fermi Uptake OneCP ModI
Fermi 0 0.19 (-0.41, 0.79) 0.04 (-0.37, 0.44) 0.22 (-0.20, 0.64)
Uptake 0 -0.15 (-0.82, 0.51) 0.03 (-0.59, 0.65)
OneCP 0 0.19 (-0.29, 0.67)
ModI 0
Rest Fermi Uptake OneCP ModI
Fermi 0 0.11 (-0.43, 0.65) -0.04 (-0.23, 0.14) 0.07 (-0.24, 0.37)
Uptake 0 -0.15 (-0.70, 0.40) -0.04 (-0.57, 0.50)
OneCP 0 0.11 (-0.24, 0.46)
ModI 0
MPR Fermi Uptake OneCP ModI
Fermi 0 -0.18 (-1.80, 1.43) 0.17 (-0.43, 0.77) 0.14 (-0.86, 1.13)
Uptake 0 0.36 (-1.37, 2.05) 0.31 (-1.60, 2.23)
OneCP 0 -0.03 (-1.05, 0.99)
ModI 0
 
Table 9-4 – Bland-Altman bias values with confidence intervals when different 
models are compared in terms of stress MBF [ml/g/min], rest MBF [ml/g/min] and 
MPR. 
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Stress Fermi Uptake OneCP ModI
Fermi 0 0.31 0.21 0.22
Uptake 0 0.34 0.32
OneCP 0 0.24
ModI 0
Rest Fermi Uptake OneCP ModI
Fermi 0 0.28 0.09 0.16
Uptake 0 0.28 0.27
OneCP 0 0.18
ModI 0
MPR Fermi Uptake OneCP ModI
Fermi 0 0.83 0.30 0.51
Uptake 0 0.88 0.98
OneCP 0 0.52
ModI 0
 
Table 9-5 – Standard deviation of differences between models for all model 
comparisons in terms of stress MBF [ml/g/min], rest MBF [ml/g/min] and MPR. 
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Figure 9-1 – Bland-Altman comparison plots for rest MBF for all models.  Solid 
line shows mean bias, dashed lines show confidence intervals. (axes scales 
locked for comparison). 
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Figure 9-2 – Bland-Altman comparison plots for stress MBF for all models.  Solid 
line shows mean bias, dashed lines show confidence intervals (axes scales 
locked for comparison). 
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Figure 9-3 – Bland-Altman comparison plots for MPR for all models.  Solid line 
shows mean bias, dashed lines show confidence intervals (axes scales locked 
for comparison). 
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Aggregate, flow-weighted response functions from the Fermi, one compartment 
and model independent models are shown in Figure 9-7 along with the point 
wise standard deviation.  In order to generate these plots each plot was 
interpolated to a standard set of time points before a point wise average of the 
response functions was performed.  Figure 9-4 shows the ROC curves for 
MPRs generated with the four models as curve to curve comparisons.  The 
corresponding DeLong, DeLong, Pearson p-values are shown in  
Table 9-6.  The descriptive parameters for the ROC curves are shown in Table 
9-7. 
MPR Fermi Uptake OneCP ModI
Fermi 1 0.11 0.05 0.91
Uptake 1 0.54 0.29
OneCP 1 0.41
ModI 1
 
Table 9-6 - ROC curve comparison p-values (curves shown in Figure 9-4) 
 
MPR Fermi Uptake OneCP ModI
AUC 0.93 (0.84, 1.00) 0.86 (0.73, 0.98) 0.88 (0.77, 0.99) 0.92 (0.85, 0.99)
Optimal MPR
cut-off
1.34 1.18 1.43 1.32
Sensitivity [%] 89.5 (0.67, 0.99) 0.84 (0.60, 0.97) 0.90 (0.67, 0.99) 0.95 (0.74, 1.00)
Specificity [%] 90.0 (0.74, 0.98) 0.83 (0.65, 0.94) 0.77 (0.58, 0.90) 0.80 (0.61, 0.92)
 
Table 9-7 – ROC curve descriptive parameters for the four models, Area under 
the curve (AUC), optimal MPR cut-off value, sensitivity and specificity at the 
optimal cut-off, confidence intervals in brackets. 
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Figure 9-4 - ROC curve comparisons between each of the models (p-values 
shown in  
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Table 9-6. 
9.3.2. Discussion 
Exclusions 
a)
b) d)
c)
 
Figure 9-5 – Example of a failure in the uptake curve processing.  The red dotted 
curves are the AIFs, the green are the myocardial uptake curves, black solid 
lines are the model fit lines.  The blue dotted curve is the uptake plot (tissue vs. 
sum of AIF).  The red cross marks the cut-off point dictated by the peak of the 
AIF.  A shallow uptake curve results in a poor choice of delay time shift dt (a).  
When the uptake curve (b) is plotted, noise in the AIF coupled with an early cut-
off point results in a negative fit to the data (up to the cut-off point) giving a 
negative MBF.  For illustration purposes the problem has been corrected by 
manually correcting the delay time shift dt in panes (c) and (d).   
 
No MPR values had to be excluded from the one-compartment model results 
and only a single exclusion was made from Fermi model results.  The number 
of exclusions for the uptake model and the model independent method were 
small (a total of 4% and 3% respectively).  The exclusions for the uptake model 
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were due to very small or even negative rest MBFs.  The reasons for this are 
illustrated in Figure 9-5.  A shallow uptake curve makes the bolus arrival time in 
the myocardium difficult to detect resulting in a poor estimate of dt (the delay 
time between bolus arrival in the myocardium and AIF).  This results in baseline 
data points being included in the analysis resulting in a very shallow uptake 
curve, thus a low MBF.  Coupled with noise spikes in the baseline this scenario 
can actually generate negative MBFs. 
 
Excluded MPR values from the model-independent dataset were due to high 
frequency oscillations in the response function generating very high MBFs.  An 
example is illustrated in Figure 9-6.  In this example high frequency spikes in 
the latter part of the tissue curve meant that a smooth impulse response 
function was not able to fit all of the data well.  The L-curve analysis in this case 
had two „L-corners‟.  The maximum curvature was identified at the left most 
corner corresponding to a small value for λ so the smoothness constraint was 
minimised.  This resulted in high frequency, high amplitude oscillations in the 
response function that generated very large, erroneous flow estimates.  For 
illustration purposes only the curves after manually correcting the λ value are 
also shown. 
 
All of these errors could be dealt with by simple manual interventions.  They are 
also easy to detect and exclude post-hoc as described in the methods section.  
Section 8.5 recommends that regional analysis of the heart yields the best 
diagnostic power and such a diagnosis requires a large number of quantitations 
per patient (32 using the AHA recommendation on three slices).  Manual 
analysis on this number of curves would be prohibitively time consuming for 
clinical practice in a field that already has the large time penalty of manual 
contouring to contend with.  For these reasons the methodology in this study is 
restricted to a fully automated analysis with post-hoc exclusions based on 
outlying MBF values as described. 
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a)
b)
c)
d)
e)
f)
 
Figure 9-6 – Example of a model independent deconvolution failure. Due to the 
high frequency ‘spikes’ in the latter portion of the tissue curve (a) the L-curve 
analysis has a double corner (b).  Thus a small λ value has been chosen (red 
cross) causing insufficient smoothing in the response function (c) and a 
subsequent high, and incorrect, MBF.  For illustration purposes the 
corresponding plots when the λ value has been manually corrected to the 
second L-curve point are also shown (d-f). 
 
9.3.3. MBF Estimates   
The MPR values for all the methods shown in Table 9-2 are comparable with 
healthy and ischaemic MPRs based on quantitative MBFs reported previously 
213 
 
(91,104).  Healthy and ischaemic resting MBFs are comparable with those 
previously published when non-linearity effects have been excluded (see Table 
6-7 and Table 6-8).  The healthy stress MBFs are smaller than the average 
MBFs reported in these tables.  However, considering specific studies, they 
agree with the values found by (5) and exceed those of (27) emphasising the 
large variation in the „normal‟ MBF values between studies.  Stress MBFs are 
reduced in response to ischaemia, although the effect here is less significant 
than the effect observed in terms of MPR.   
 
The aggregate response functions shown in Figure 9-7 reflect the nature of the 
different models.  The one compartment model is a single exponential whereas 
the Fermi function, with the addition of an early shoulder has more flexibility, 
although on aggregate this appears as a flattening of the response function 
rather than a clear shoulder.  The model-independent function shows clear 
shoulders in both rest and stress curves.  
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Figure 9-7 – Aggregate flow-weighted impulse response functions for Fermi-
constrained deconvolution, one compartment model and model-independent 
deconvolution.  The solid line is the mean Rf at the given time with standard 
deviations shown as dashed lines. 
 
9.3.4. Comparison of perfusion models 
The four models were highly correlated (Table 9-3).  Small but significant 
differences were found between the models at rest MBF, stress MBF and at 
MPR.  These  results differs from those of (4) who found significant differences 
only at stress MBF and no significant differences in MPR using similar 
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quantitation models.  The differences in the results presented here may be due 
to the much larger dataset in this study, 50 subjects, rest and stress vs. 20  rest 
and 14 stress in Pack et al. (4) , and the fact that ischaemic patients are 
included in this.  The differences observed are small with the largest bias in 
MBF at 0.22 ml/g/min between Fermi and model-independent at stress and 
biases in MPR not exceeding the 0.36 difference found between the uptake 
model and the one compartment model.  Furthermore the 95% confidence 
interval in each case encompasses the zero difference point, thus there is 
insufficient evidence to favour any method over the others based on these 
differences.  The width of these confidence intervals in all cases is similar to 
those in (4) suggesting that any differences in implementations between the 
studies have not increased variations between methods.  Considering the 
variations of the comparisons (Table 9-5) the uptake model tends to be 
associated with larger variations in comparison with all models (an observation 
also noted by Pack et al.).  This may be due to the fact that the uptake model 
uses less data than the other models and is thus more susceptible to noise and 
artifacts in the curves.  It could also be due to the occurrence of similar, but less 
dramatic and so not excluded, errors to those illustrated in Figure 9-5.  Pack et 
al. observed a larger positive MBF bias using Fermi-deconvolution (even after 
limiting analysis to the first pass) than with the other two methods.  The data 
presented here does not corroborate this observation. 
 
9.3.5. Comparison of diagnostic power of the tests 
All of the models had a good diagnostic power with the poorest AUC from the 
uptake model still achieving an area under ROC curve of 0.86, associated with 
a sensitivity and specificity of 0.84 and 0.83 respectively.  It is not the aim of this 
study to establish the power of the tests clinically as ambiguous cases have 
been removed from the dataset, however it is encouraging that the tests 
perform well.  There were no statistically significant differences (p<0.05) 
between ROC curves of the different models, however Fermi vs. uptake 
(p=0.11) and Fermi vs. One compartment model (p=0.05), approached a 
statistically significant result, with the Fermi model performing better in both 
cases.  The poorer diagnostic performance of the uptake model might be 
explained in terms of the larger variability and susceptibility to underestimates of 
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MBF described earlier.  The stronger difference observed between Fermi and 
the one compartment model is surprising.  The main difference between these 
models is the shoulder in the Fermi function.  The model-independent response 
functions tend to incorporate this shoulder as can be seen in the aggregate 
response function in Figure 9-7.  This implies that the „true‟ response function 
should have such a shoulder.   Indeed this appearance was the original 
motivation for utilising the Fermi function in CMR perfusion.  Furthermore, the 
AUC scores and MPR-cut-off values for Fermi and model-independent are 
almost identical, whereas the other two models have lower AUCs and different 
MPR-cut-offs.  It may be then that the Fermi function‟s ability to mimic this 
shoulder shape has made it a closer approximation to the true response 
function in this dataset.  It should be stressed however that the differences 
observed here are only borderline significant and further work should be done 
before making an absolute recommendation for clinical practice. 
 
9.4. Conclusion 
All of the models generated MPRs and quantitative MBF estimates that were 
consistent with the literature.  Numbers of exclusions (based on MBF and MPR 
figures) were small enabling a fully automated analysis (post-contouring).  This 
important point means that the analysis methods described here do not place 
any extra time-processing pressure on the acceptance of such methods into 
clinical practice.   
 
Corroborating the work of (4) this study has shown that there is a strong 
correlation between the MBFs measured using four different models.  Due to 
the increased power of this investigation over (4) significant differences in the 
MBF estimates have been found, although the magnitudes of these differences 
are small.  Importantly it has been shown that these small differences do not 
have a significant impact on the diagnostic power of the MPR estimates.  In 
conclusion any of the methods described are equally capable of generating 
MPR figures for diagnosing CAD. 
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In the absence of an overriding winner in terms of diagnostic power the decision 
about which model to use might be made based on the simplicity of 
implementation.  Model-independent deconvolution is the most difficult 
algorithm to implement.  However, Fermi-deconvolution and the uptake model, 
although simple implementations in principle, become more difficult when 
automated curve processing is required as they both require a cut-off point, 
after which perfusion data is discarded.  In the case of the uptake model this 
was the reason for a number of exclusions in this study.  For the Fermi model 
only one exclusion was required.  The simplest model, taking into account the 
pre-processing steps, was the one compartment model.  The only pre-
processing steps required were baseline correction and delay time estimation 
and the deconvolution step is a simple exponential fit.  The simplicity of this 
analysis meant that no one-compartment model data was excluded.   
 
On the basis of robustness then the one-compartment and Fermi-models were 
superior.  However, although a statistically significant difference in diagnostic 
performance was not observed between these models on this dataset, it is 
interesting to note that the Fermi model achieved a specificity of 90% whereas 
the one-compartment model achieved only 77%, with comparable sensitivities.  
On this dataset there is insufficient evidence to know whether this is a chance 
observation or a genuine difference in the models, at the 95% confidence level.  
However, the borderline significance of this difference (p=0.05) suggests that a 
larger investigation might provide evidence in favour of the Fermi model in 
terms of both accuracy and robustness. 
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10. Conclusions, limitations and future direction 
10.1. Limitations and future work 
The aim of this research has been to provide an evidence basis upon which 
decisions about a standard protocol for quantitative analysis of cardiac DCE-
MRI perfusion might be made.  The philosophy has been to use diagnostic 
accuracy as the evaluation tool as diagnosis is the ultimate purpose of the 
quantitative MBF measurements.  This has been achieved regarding the 
question of the perfusion model in chapter 9.  The conclusion reached was that, 
for the data considered, there was insufficient evidence to favour one method 
above another in terms of diagnostic accuracy.  There were observable, though 
not statistically significant, differences between the diagnostic performances of 
the models which should motivate still larger studies to be conducted in future.  
However, based on the evidence presented here the decision concerning which 
is the „best‟ method should be made on robustness, i.e. how many exclusions 
were necessary?  Based on this criterion the Fermi-constrained and one-
compartment models are superior.  However, robustness was not the planned 
primary outcome measure in this work and the way in which it has been 
assessed could be improved.  The use of a simple cut-off MBF or MPR to 
exclude measurements is simplistic.  Better assessments might be devised by 
taking into account the shape of the derived response function and the model 
fit.  Ultimately any measure will have to be reduced to a cut-off value but taking 
account of these more fundamental factors might be a fairer test of whether a 
model has „failed‟.   
 
The conclusions could also be criticised in terms of the pre-processing steps 
(section 5.4).  Perhaps, the automated pre-processing used was inadequate 
and better algorithms would have yielded different results?  The methods used 
in this thesis have only been evaluated qualitatively.  In fact these methods are 
typically not evaluated at all in quantitative DCE-MRI publications and are 
sometimes not even described.  Nevertheless, they can have a profound effect 
on MBF estimates and so an objective analysis of these methods would be 
beneficial.  This could be achieved using simulated data, with different delay 
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time and baseline noise levels etc.  It would also be interesting to establish what 
impact different automated pre-processing algorithms had on the final 
diagnostic performance using the methodology set out in chapter 9. 
 
Exclusion of data from the dataset prior to analysis was also performed 
qualitatively (section 8.3).  Clearly an objective method for excluding datasets 
would be preferable as it aids generalisation of the results.  For problems such 
as LV bleed and dark rim artefact this could prove to be a research project in 
itself.  However the largest contributor to excluding data was a thin myocardium, 
which is simple to measure and this should be assessed automatically in future 
work.     
 
Given the impetus within the DCE-MRI cardiac perfusion community for 
avoiding non-linearity in the AIF it is perhaps surprising that correcting for these 
effects did not have a significant impact on diagnostic performance (section 
8.4).  Indeed, the results shown in this thesis agree with those of Groothius et 
al. (25), who compared non-linear with linear dual-bolus MR data and found no 
difference in diagnostic performance.  The results are not generalisable, as 
more profound non-linearity in other datasets could have more severe effects.  
However, they do demonstrate that non-linearity does not have a significant 
effect on diagnostic accuracy for the CE-MARC dataset.  The non-linearity 
conversion algorithm has been tested on phantom data to show that it is 
accurately modelling the signal intensities generated by the imaging system.  
However, further validation against PET measurements or animal studies would 
have provided more reassurance that the method is indeed correcting for these 
effects. 
 
The evaluation of contour errors study (chapter 7) has shown that standard 
measures of contour errors do not correlate with MBFs, which is relevant for the 
evaluation of automated contouring algorithms applied to cardiac perfusion 
DCE-MRI.   This research has also provided a framework for investigating the 
effects of contour errors using simulated contour errors, which have been 
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shown to be representative of human contourer errors.  The study is currently 
limited in applicability as it was carried out on healthy volunteers only.  As it 
stands the method could not be extended to ischaemic patients as it would not 
be possible to separate MBF changes due to contour errors and those due to 
ischaemia.  However, using the methodologies outlined in chapters 8 and 9 
diagnostic performance could be used as an outcome measure to evaluate 
contour errors on ischaemic patients.  This would provide much more clinically 
relevant information about the required accuracies in contour errors across the 
heart. 
 
Although 50 patients would be considered large in most quantitative perfusion 
publications it represents only 6.5% of the CE-MARC dataset.  To repeat these 
studies on the full CE-MARC dataset would greatly increase the evidence basis 
for driving forward a consensus opinion on analysis methods.  The wealth of 
questions that could be answered using such a dataset is substantial.  Consider 
again Figure 1-1, representing the quantitation pathway with which this thesis 
commenced.  It is apparent that the depth of focus of the research represented 
in this thesis is not uniform across the steps of the analysis pathway.  The 
choice of perfusion model has been investigated thoroughly, however only one 
of many concentration conversion methods has been assessed.   Some aspects 
of mapping regions to arteries have been considered and localisation errors 
have been characterised but not related to diagnostic performance.  A 
comprehensive analysis of each of these steps in terms of diagnostic 
performance would provide a much needed evidence base for standardising 
quantitative cardiac perfusion analysis.  Such a standard would be a significant 
step towards the clinical acceptance of quantitative MBF estimates and the 
benefits they bring to the patient population and should therefore be a focus of 
research effort in the future. 
10.2. Conclusion 
Considering the quantitation pathway illustrated in Figure 1-1, the research 
presented in this thesis has made contributions to each step in the pathway.  In 
the area of myocardial contouring a novel methodology has been described for 
221 
 
investigating the relationship between contour errors and MBF.  This has been 
used to show that established segmentation metrics such as Dice‟s similarity 
coefficient and Hausdorff distance are insufficient evaluators of contour errors.  
A set of contour error limits, based on volunteer datasets, has then been 
presented.  This approach highlights what level of contour accuracy is actually 
required; focusing researcher‟s efforts on potentially more important areas such 
as robustness in automated localisation algorithms. 
 
Regarding the mapping of AHA regions to the final diagnosis, the novel use of 
diagnostic performance to evaluate the methodology has produced a number of 
insights.  The fact that the AHA regional analysis performs better than simply 
averaging the myocardium is perhaps not surprising but, to the author‟s 
knowledge, this is the first time that it has been evidenced with this method.  
The insight that the middle slice alone performs almost as well as all three 
slices is interesting and could be the basis of an argument for focussing scan 
time on a single slice for quantitation allowing better resolution.  Again, to the 
author‟s knowledge this has not been shown before in terms of diagnostic 
performance using quantitative MBF estimates.  The result that DCE-MRI data 
in the linear concentration to signal intensity regime do not perform better than 
those in a non-linear regime has been shown before in the context of dual-bolus 
imaging (25), on a similar sized dataset (n=49).  However, the results presented 
in this thesis are the first time that this has been shown using a non-linear 
correction method. 
 
The non-linear conversion of signal intensities to concentrations presented in 
this thesis is closely based on methods that have been previously published 
(30,31).  To the author‟s knowledge, the use of an assumed T1 for blood in this 
method is novel in cardiac DCE-MRI.  The use of the full signal equation, 
incorporating flip angle sweep is also novel in this context.  The conversion has 
been tested in simulations and on T1-gel phantoms.  The method has not been 
tested in-vivo because of doubts about the validity of the dual-bolus protocol 
used and the evidence for these doubts has been described in detail.  
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A comparison of perfusion models has been presented previously, and 
evaluated in terms of the estimated MBF values (4).  Besides using a much 
larger patient cohort than that of Pack et al., the perfusion model comparison 
presented in this thesis is novel in that it has compared the models in terms of 
diagnostic performance.  The results are therefore directly applicable to clinical 
practice.  Although the performances did not differ significantly there was 
evidence for favouring Fermi-constrained deconvolution or the one-
compartment model due to their increased robustness and ease of 
implementation. 
 
Every innovation in a complicated process such as quantitative DCE-MRI 
analysis must, of course, be initially evaluated in terms of its primary outcome, 
be it a measure of contrast agent concentration, contour accuracy or MBF.  
Ultimately, however, the entire methodological pathway must be linked and 
evaluated in terms of the decision it was designed to make.  In this case this is 
the diagnosis of myocardial ischaemia.  This thesis has proposed methods for 
making this link for each step of the analysis pathway for quantitative cardiac 
DCE-MRI perfusion.  For some steps a full diagnostic performance evaluation 
has been performed and it is to be hoped that these data will contribute towards 
the evidence base upon which a consensus methodology will be agreed upon.  
For other steps only the initial evaluations have been performed.  However, the 
methods for relating each step to a final evaluation in terms of diagnostic 
performance are now clear.  It is hoped that these methods will be used in 
future to evaluate the entire pathway and help to provide an evidence based 
consensus methodology for quantitative cardiac perfusion DCE-MRI. 
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